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1.1. INTRODUCTION 
 
Yeasts are truly fascinating organisms. Their diverse activities impinge on a variety of 
commercially important sectors, including the food, beverage and pharmaceutical 
industry. The brewing of beer might just be the oldest biotechnological application of 
yeast! While most of their activities are beneficial to human life, some yeasts have 
been implicated in processes of spoilage and as agents of human disease. Not 
surprising then that the opportunistic pathogen Candida albicans has emerged as the 
major cause of morbidity and mortality in immunocompromised patients.  
 
In recent years, however, the importance of yeasts, in particular 
Saccharomyces cerevisiae, has extended far beyond traditional industrial applications 
to the ever-increasing role it plays in furthering our fundamental understanding of 
microorganisms. The relative ease and rapidity of growth, combined with a 
well-defined genetic system, and most important, a highly versatile DNA 
transformation system, has made yeast the preferred research system of most 
molecular biologists.  
 
The success of S. cerevisiae as model system is also in part due to the extent in which 
basic biological structures and processes have been conserved throughout eukaryotic 
life (Broach et al., 1991). Comparative genomics studies have shown that up to 40% 
of yeast proteins share an amino acid sequence similarity with at least one human 
protein, and 30% of genes with a proven involvement in human disease have an 
ortholog in yeast (Foury, 1997; Parsons et al., 2003). With a fully-sequenced- and 
defined genome, which allows the expression of the entire yeast proteome in vitro, 
S. cerevisiae permits, for the first time ever, the possibility of a comprehensive 
proteome-wide screen of drug function in higher eukaryotes (Martzen et al., 1999; 
Sturgeon et al., 2006). S. cerevisiae’s role at the forefront of biomedical research is 
thus firmly entrenched.  
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1.2. NUTRIENT-SENSING IN YEAST 
 
The unicellular eukaryote S. cerevisiae has a limited ability to store nutrients, and are 
consequently, completely dependent on the availability of nutrients in its immediate 
surrounding. To maximize survival in a constantly changing environment, yeast has 
evolved numerous metabolic pathways that ensure the optimal use of all available 
nutrients. The yeast cell is therefore able to assess the amount of nutrient available 
(sensing), transmit this information to the nucleus (signaling) and adjust its growth 
and developmental programs accordingly (transcriptional regulation) (Zaman et al., 
2008).  
 
Concerted research efforts have revealed a complicated network of sensing 
mechanisms and signaling pathways that governs the cell’s responses to the 
nutritional environment. For the purpose of this review, however, we will focus on the 
three most prominent nutrient-sensing pathways in S. cerevisiae: the cAMP-Protein 
Kinase A (PKA) pathway, the Fermentable Growth Medium-induced (FGM) pathway 
and the Target Of Rapamycin (TOR) pathway.  
 
1.2.1. cAMP-PKA pathway 
 
Glucose is the most abundant monosaccharide in nature, and as the preferred energy 
source of most microorganisms, it elicits profound changes in the cell’s metabolism. 
More than 40% of the S. cerevisiae genes rapidly alter their expression levels after the 
addition of glucose to cells growing on a non-fermentable carbon source (Schneper et 
al., 2004). These transcriptional changes allow the cell to use glucose exclusively 
before switching to less favourable carbon sources like galactose and mannose. The 
cAMP-PKA pathway plays an intricate part in regulating these responses to glucose. 
 
The addition of glucose to non-fermenting or stationary phase cells results in a rapid, 
albeit transient, increase in cellular cAMP (Thevelein et al., 1987; Broach, 1991; 
Thevelein, 1994). An increased cAMP level activates PKA, which in turn initiates a 
PKA-dependent phosphorylation cascade during the cell’s transition from respiratory 
to fermentative growth (Kraakman et al., 1999; Portela and Moreno, 2006). High 
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intracellular levels of cAMP therefore correlate with growth in a nutrient-rich 
environment, whereas low cAMP levels indicate growth in a nutrient-limited 
environment.  
 
cAMP is synthesized from ATP by the CYR1/CDC35-encoded adenylate cyclase 
(reviewed in Broach, 1991) (Figure 1.1). Similarly to higher eukaryotes, the yeast 
adenylate cyclase is activated by two small guanine nucleotide-binding proteins 
(G proteins), Ras1 and Ras2. Both these proteins are active in the GTP-bound state 
while the hydrolysis of GTP to GDP inactivates it. The GDP/GTP exchange is 
catalyzed by Cdc25, and possibly Sdc25 (Camus et al., 1994), and the GTP hydrolysis 
is stimulated by Ira1 and Ira2. Intracellular acidification accomplishes the activation 
of the cAMP-PKA pathway by inhibiting both Ira1 and Ira2, thus increasing the 
GTP/GDP ratio bound to Ras.  
 
Cellular cAMP levels are regulated by two cAMP phosphodiesterases, Pde1 and 
Pde2. The low-affinity phosphodiesterase Pde1 was identified as a PKA target that 
specifically downregulates cAMP signaling through a method of feedback inhibition 
(Ma et al., 1999), whereas the high-affinity phosphodiesterase Pde2 regulates the 
basal level of cellular cAMP.  
 
1.2.1.1. Glucose signaling: a dual sensing system 
 
The preference which S. cerevisiae has for glucose as its main source of carbon is 
reflected in the complexity of the sensing systems. Glucose is detected by two sensing 
systems and both systems are required for activation of the cAMP-PKA pathway 
(Rolland et al., 2000).  
 
Extracellular D-glucose and sucrose are sensed by a G protein-coupled receptor 
(GPCR) system that comprises the receptor Gpr1 and its G protein Gpa2 (Colombo et 
al., 1998; Kraakman et al., 1999). By analogy to other GPCRs, it was demonstrated 
that Gpa2 functions as a classic Gα subunit by coupling extracellular ligand activation 
of Gpr1 to an intracellular signaling event (Zaman et al., 2008). There is currently no 
evidence for the binding of glucose to Gpr1. However, the fact that mutants of Gpr1 
have been obtained in which glucose-induced, but not sucrose-induced, activation of  
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Figure 1.1: The cAMP-PKA pathway in yeast. 
 The addition of glucose to cells growing on non-fermentable carbon sources or to 
stationary phase cells results in a rapid increase in cellular cAMP. An increased 
cAMP level activates PKA, which in turn activates a PKA-dependent 
phosphorylation cascade. Glucose is detected by two sensing systems, and both 
are required for full activation of the cAMP-PKA pathway.  
 
the cAMP-PKA pathway are abolished, strongly suggests that there is a binding site 
for glucose in Gpr1 (Lemaire et al., 2004). In C. albicans, Gpr1 functions as a 
putative amino acid sensor and mediates the yeast-to-hypha morphogenetic transition 
(Maidan et al., 2005). This attribute makes CaGpr1 an attractive target for a novel 
range of antifungals (Van Dijck, 2009). 
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Upon ligand binding, Gpr1 activates Gpa2, which is, similar to the Ras proteins, 
active in the GTP-bound state and inactive when GDP is bound. A member of a 
family of regulators of G protein signaling, Rgs2; promotes the intrinsic GTPase 
activity of Gpa2, hereby inhibiting glucose-induced cAMP synthesis (Versele et al., 
1999). In contrast to other canonical Gα subunits, Gpa2 is unable to form a 
heterotrimeric G protein with the known Gβ and Gγ subunits in yeast, Ste4 and Ste18 
(Harashima et al., 2006). Instead, Gpa2 associates with two kelch-repeat proteins 
Krh1 (Gpb2) and Krh2 (Gpb1) (Batlle et al., 2003; Peeters et al., 2006; Niranjan et al., 
2007). Both Krh1 and Krh2 (Krh1/2) contain seven kelch-repeat domains that fold 
into a β propeller structure and mediate protein-protein interactions. Cells containing 
krh1Δ krh2Δ mutations display phenotypes that are typical of high PKA activity: low 
levels of storage carbohydrates, decreased stress resistance and increased 
pseudohyphal growth. Consistent with this, increased phosphorylation of PKA 
substrates was observed in krh1Δ krh2Δ mutants, confirming that Krh1/2 negatively 
regulate the cAMP-PKA pathway (Lu and Hirsch, 2005). The precise mechanism by 
which this is achieved, is still subject to debate. Two different mechanisms have been 
proposed, one in which Krh1/2 enable the association between the regulatory and 
catalytic subunits of PKA, as shown in a two-hybrid assay (Peeters et al., 2006). 
Contrary to this, Harashima et al. (2006) found that Krh1/2 bind to a conserved 
C-terminal domain in Ira1 and Ira2, stabilizing them. Without this stabilization, Ira1 
and Ira2 are more easily degraded and the resulting elevated levels of GTP-bound Ras 
lead to increased cAMP synthesis.  
 
A second, intracellular sensing mechanism requires sugar uptake and phosphorylation 
but no further metabolism of the sugar. Glucose phosphorylation in yeast is 
apparently stimulated by transport of the sugar, and catalyzed by the hexose kinases 
Hxk1 and Hxk2 and glucokinase Glk1 (Rolland et al., 2000; Rolland et al., 2001). 
How glucose phosphorylation is coupled to the Gpr1-Gpa2-dependent activation of 
the pathway remains unclear.  
 
The subsequent section deals with the target of the Ras-cAMP pathway in yeast, 
PKA. 
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1.2.1.2. PKA as central regulator of metabolism 
 
As in all eukaryotes, yeast PKA is an inactive tetramer composed of two regulatory 
subunits bound to two catalytic subunits. The regulatory subunits are encoded by a 
single gene, BCY1, and the three partially redundant catalytic subunits are encoded by 
the TPK1, TPK2 and TPK3 genes respectively. The three Tpk proteins are remarkably 
similar in amino acid sequence and structure and the C-termini are highly conserved 
over a region of 300 residues. The shorter N-terminal domains are, however, distinct 
(Gagiano et al., 2002).  
 
Triple mutants lacking all three TPK genes are inviable, but the expression of any one 
of the catalytic subunits in such a strain restores viability (Toda et al., 1987b). The 
three catalytic subunits, however, play very different roles in respect to other 
metabolic phenotypes. The deletion of TPK2, for example, abolishes the filamentous 
growth phenotype observed in yeast cells of the Σ1278b genetic background, whereas 
the deletion of TPK3 causes enhanced pseudohyphal differentiation of these cells 
(Robertson and Fink, 1998). TPK1, on the other hand, is required for the derepression 
of both the BAT1 and ILV5 genes involved in branched chain amino acid biosynthesis, 
which in effect allows the cell to exit the stationary phase (Robertson et al., 2000).  
 
The Bcy1 subunit acts as pseudo substrate for the catalytic subunits by binding and 
inhibiting their activity. cAMP binding to Bcy1 alleviates this inhibitory activity by 
causing conformational changes in the regulatory subunits that decrease their affinity 
for the catalytic subunits. The activated catalytic subunits are capable of 
phosphorylating a whole range of substrates, including proteins involved in the 
breakdown of storage carbohydrates, in stress resistance and in glycolysis and 
gluconeogenesis (Thevelein et al., 2000; Ptacek et al., 2005). Hydrolysis of cAMP by 
the phosphodiesterases restores PKA to the inactive state.  
 
In addition to being regulated by cellular cAMP levels, PKA activity is also strictly 
controlled by the subcellular compartmentalization of the individual subunits 
(Griffioen et al., 2000). In actively-growing cells, Bcy1 and Tpk1 reside almost 
exclusively in the nucleus. However, in respiring or stationary-phase cells, both Bcy1 
and Tpk1 are distributed equally over the nucleus and cytosol. Localization studies on 
Chapter I 
 
 9 
the subunits revealed that the subcellular localization of Tpk1 depends on cAMP, for 
the addition of cAMP to yeast cells causes the majority of nuclear Tpk1 to translocate 
to the cytosol (Griffioen et al., 2000; Griffioen et al., 2001). The proper cytoplasmic 
localization of Bcy1, on the other hand, requires both the Yak1-dependent 
phosphorylation of the N-terminus of Bcy1, as well as interaction with the yeast 
homologue of the mammalian A-kinase anchoring protein (AKAP), Zds1 (Griffioen 
et al., 2003). The deletion of ZDS1 was shown to decrease the levels of Bcy1 in the 
cytoplasm, whereas the overexpression of ZDS1 resulted in the opposite phenotype.  
 
Although cAMP plays a determining role in activation of PKA, a novel, 
cAMP-independent activation of PKA has been proposed. In the presence of a 
fermentable carbon source, the re-addition of a missing nutrient, such as nitrogen, 
sulphate or phosphate, causes an activation of PKA that is independent of cAMP, but 
dependent on the free catalytic subunits. The signaling pathway responsible for the 
sustained activation of PKA is the FGM pathway (Thevelein, 1994; Thevelein et al., 
2005) (see section 1.2.2.). 
 
1.2.1.3. Downstream targets 
 
As mentioned in the previous section, activated PKA can phosphorylate various 
proteins involved in growth and metabolism. The phosphorylating activity of active 
PKA is for example required to ensure the successful progression from the G1 to the S 
phase of the cell cycle (Tokiwa et al., 1994).  
 
The downstream target that I have used extensively to quantify PKA activity is the 
metabolism of storage carbohydrates trehalose and glycogen.  
 
Storage carbohydrates 
 
When fermentable carbon source levels start to wane, S. cerevisiae diverts the 
remaining hexose carbon into storage carbohydrates trehalose and glycogen. Both 
storage carbohydrates serve as a storehouse of glucose when extracellular sources are 
scarce. Trehalose, however, is more than simply a storage compound. It has the 
unique ability to exclude water from the surface of proteins and hence protect proteins 
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from denaturation in dehydrated cells (Simola et al., 2000). Trehalose’s function as 
stress protectant is further highlighted by its ability to suppress the aggregation of 
proteins that already have been denatured (Elbein et al., 2003).  
 
Trehalose is a nonreducing disaccharide of glucose that occurs naturally in insects, 
plants fungi and bacteria. It does not occur in mammalian cells, although trehalase, 
the enzyme responsible for the breakdown of trehalose, is found in humans and other 
mammals at the brush border of the intestinal mucosa, as well as in the kidney, liver, 
and blood plasma (Ouyang et al., 2009).  
 
The synthesis of trehalose in S. cerevisiae necessitates the participation of four 
different enzymes. TPS1 and TPS2 encode the trehalose-6-phosphate synthase and 
trehalose-6-phosphate phosphatase, respectively, and TPS3 and TSL1 code for two 
regulatory subunits of the TPS complex (Jules et al., 2008; Mahmud et al., 2010). 
Synthesis of trehalose occurs in two successive steps; trehalose-6-phosphate (T6P) is 
synthesized using UDP-glucose and glucose-6-phosphate as substrates, and then 
directly converted to trehalose (Elbein et al., 2003). The concentration of trehalose in 
the yeast cell is the sum of the synthetic activity of the TPS complex and the 
degradative activity of trehalase. Under optimal conditions, i.e. decreasing glucose 
levels, trehalose levels may reach 15% of cellular dry weight (De Silva-Udawatta and 
Cannon, 2001).  
 
The hydrolysis of trehalose generates two glucose molecules. Yeast carries two types 
of trehalose-degrading enzymes: the neutral trehalases (Nth1) localized in the 
cytoplasm and the acidic trehalase (Ath1) found predominantly in the vacuole. 
Recently, a third gene, NTH2, was shown to encode a functional neutral trehalase 
with a measurable, if somewhat reduced, activity during stationary phase (Jules et al., 
2008). Nth1 constitutes the main source of trehalase activity in stationary phase cells, 
but also in proliferating and germinating cells. Ath1 is mainly required for growth on 
trehalose, which accounts for its enhanced activity at the cell surface (Jules et al., 
2008).  
 
In contrast to trehalose, glycogen is a typical reserve carbohydrate that is synthesized 
during exponential growth and utilized throughout periods of starvation. Biosynthesis 
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of glycogen is mediated by the GSY1/GSY2-encoding glycogen synthase which 
catalyzes the formation of the α -1,4-glycosidic linkages of the polymer, and 
branching enzyme Glc3 which forms the α-1,6-glycosidic branchpoints (Farkas et al., 
1991; Rowen et al., 1992). Degradation of glycogen depends on the activities of 
glycogen phosphorylase (Gph1) and the debranching enzyme Gdb1 (François and 
Parrou, 2001).  
 
Glycogen synthase is controlled by multisite phosphorylation. Dephosphorylation by 
protein phosphatase Glc7 activates the enzyme, whereas protein phosphatase 2A 
(PP2A) indirectly regulates glycogen metabolism by controlling cell growth (Stark, 
1996; Ramaswamy et al., 1998) (see section 1.5.).  
 
Transcriptional control 
 
Yeast cells exposed to stresses develop within minutes metabolic responses that 
ultimately lead to the acquisition of a so-called ‘stress resistance’ state (Ruis and 
Schuller, 1995). A general characteristic of these stress conditions is the induction of 
a large number of genes which share a common promoter sequence, the cis-acting 
stress responsive element (STRE) (Martinez-Pastor et al., 1996; Schmitt and 
McEntee, 1996). Msn2 and Msn4, the two Zn-finger transcription factors, bind to the 
CCCCT core sequence of the STREs to initiate transcription and, consequently, 
trigger a general stress response (Thevelein et al., 2000). STREs have been identified 
in the promoter regions of over 180 stress-associated genes, including TPS1, TPS2 
and NTH1 (Moskvina et al., 1998) (see previous section).  
 
Subcellular localization of Msn2 and Msn4 is regulated by both PKA and stress 
conditions. PKA directly phosphorylates the Msn2 nuclear localization signal (NLS) 
which inhibits its function by restricting it to the cytoplasm. As a result, Msn2, and to 
a lesser extent Msn4, resides in the cytoplasm when PKA is active and, conversely, is 
found in the nucleus when PKA activity is low (Gorner et al., 2002; Rolland et al., 
2002).  
 
Stress conditions, in particular nitrogen starvation, heat shock and osmotic shock, 
control Msn2 subcellular localization through modification of the N-terminal nuclear 
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export signal (NES) instead of the NLS (Zaman et al., 2008). In this case, PP2A 
dephosphorylates the NES to retain the protein in the nucleus (see section 1.5.1.). 
Interesting to note, is that the deletion of MSN2 and MSN4 suppresses the lethality of 
a PKA deficient strain, placing both transcription activators downstream of PKA 
(Smith et al., 1998).  
 
1.2.2. FGM pathway  
 
The sustained activation of PKA requires a fermentable carbon source and a complete 
growth medium in which nitrogen, sulphur and phosphate are present in adequate 
amounts.  
 
Cells growing in these optimal conditions display characteristics typically associated 
with the so-called ‘high PKA phenotype’; low levels of trehalose and glycogen, 
decreased expression of STRE-regulated genes and an overall upregulation of 
ribosomal protein gene expression (Thevelein et al., 2005). Starving it for one of the 
nutrients, even in the presence of glucose, causes the cell to enter the G0 state in 
which it acquires stationary phase characteristics. 
 
This observation points to the existence of an additional signaling network, one that 
integrates information from different nutrient sensing systems into a common 
response that modifies PKA activity accordingly. This alternate pathway for the 
maintenance of PKA activity is known as the FGM pathway (Thevelein and de 
Winde, 1999; Thevelein et al., 2005) (Figure 1.2). 
 
The most compelling evidence for the existence of an additional pathway for PKA 
activation, as opposed to the classic Ras-cAMP signaling cascade, is that the 
maintenance of the high PKA phenotype is not mediated by an increase in cellular 
cAMP. Moreover, transport and phosphorylation of the sugar, a prerequisite for 
Ras-cAMP-dependent activation of PKA, is no longer required as demonstrated in 
hxk1Δ hxk2Δ glk1Δ triple mutants lacking the sugar phosphorylating enzymes. The 
FGM pathway detects the presence of sugar through either the extracellular 
Gpr1-Gpa2 sensing system, or the intracellular sugar kinase-dependent system (Giots 
et al., 2003; Van Nuland et al., 2006).  
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Figure 1.2: The FGM pathway in yeast.  
Re-addition of phosphate to cells starved for it or ammonium/amino acids to 
nitrogen-depleted cells, triggers a rapid activation of PKA targets. In addition to 
the missing nutrient, FGM signaling also requires the presence of a 
readily-fermentable carbon source. 
 
Several transporter-related nutrient sensors, or transceptors, that mediate 
nutrient-induced activation of the FGM pathway through the plasma membrane, have 
been identified: the general amino acid permease (Gap1) senses amino acids, 
inorganic phosphate is sensed by Pho84 and Pho87, and Mep1 and Mep2 sense 
ammonium (Donaton et al., 2003; Giots et al., 2003; Van Nuland et al., 2006; Van 
Zeebroeck et al., 2009). Interestingly, the activation of the FGM pathway does not 
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require the metabolization of the transported nutrient. However, the intracellular part 
of the pathway that connects the signal generated by the transceptor to its downstream 
effector PKA, remains as-yet elusive. Strong experimental evidence suggest that the 
serine/threonine kinase Sch9 may act downstream of the nitrogen sensors (Crauwels 
et al., 1997).  
 
The next section details the two components of the FGM pathway most important to 
my own research, Sch9 and Gap1. 
 
1.2.2.1. Sch9 
 
The protein kinase Sch9 is an AGC family kinase and the closest yeast homolog to the 
mammalian pro-survival Protein Kinase B (PKB)/Akt as well as the TOR-regulated 
S6 kinase (Yorimitsu et al., 2007). Originally identified as a multi-copy suppressor of 
a cdc25ts conditional mutant, overexpression of SCH9 can also suppress the lethality 
caused by cyr1Δ, ras1Δ ras2Δ, and tpk1Δ tpk2Δ tpk3Δ mutants. Conversely, 
overactivation of the Ras-cAMP pathway suppresses the slow growth phenotype 
observed in a deletion strain of SCH9. The ability of Sch9 to compensate for 
mutations in the Ras-cAMP pathway likely results from the fact that Sch9 regulates 
similar targets as Ras-cAMP. 
 
Recent biochemical data places Sch9 in both nutrient- and stress signaling pathways 
(Fabrizio et al., 2001; Kaeberlein et al., 2005b; Smets et al., 2008). Stressing the yeast 
cell through rapamycin treatment, starving it for carbon or nitrogen, or shifting the 
nitrogen source from ammonium to less-favourable urea leads to the rapid 
dephosphorylation of Sch9. Re-addition of the missing nutrient quickly restores the 
phosphorylation. In vivo studies have shown that the TOR complex 1 (TORC1) 
directly regulates Sch9 by phosphorylating six conserved serine/threonine residues on 
its C-terminal tail (see section 1.2.3.). Elimination of these phosphorylation sites on 
Sch9 diminishes the kinase activity (Jacinto and Lorberg, 2008). Pkh1 and Pkh2, the 
yeast homologues of mammalian 3-phosphoinositide-dependent kinase-1 (PDK1) also 
phosphorylate Sch9. In contrast to TORC1 though, Pkh1 and Pkh2 phosphorylates a 
specific threonine570 residue in the activation loop. Both the phosphorylation of the 
activation loop and the C-terminus are required for activation of Sch9.  
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Mounting evidence suggests that Sch9 may also regulate longevity in yeast. Calorie 
restriction (CR) in yeast, whereby cells are grown on a low glucose concentration, is a 
well-established method to increase chronological life span. The molecular 
mechanism underlying this has always been vague, until it was recently demonstrated 
that sch9Δ mutants, as well as tor1Δ cells have an increased life span (Kaeberlain et 
al., 2005a). CR of sch9Δ or tor1Δ cells had no significant influence on the lifespan, 
indicating that Sch9 and Tor1 are putative targets of CR in yeast. The 
longevity-promoting role of Sch9 and Tor1 has apparently been evolutionary 
conserved – the deletion of the Sch9 and TOR orthologs in the nematode worm 
Caenorhabditis elegans and the fruit-fly Drosophila melanogaster increased the 
lifespan as well (Hansen et al., 2007; Honjoh et al., 2009). 
 
As noted before, Sch9 forms an important part of the FGM pathway. The deletion of 
SCH9 in glucose-grown, nitrogen starved cells abolishes the nitrogen-induced 
activation of the PKA targets. Crauwels et al. (1997) reported on the absence of both 
nitrogen-induced trehalase activation and ribosomal protein gene induction in 
glucose-repressed sch9Δ cells. Repression of STRE-regulated genes was also severely 
impaired. Phosphate-induced activation of the FGM pathway, however, seems to 
operate independent of Sch9 (Giots et al., 2003). 
 
1.2.2.2. Gap1 
 
S. cerevisiae import amino acids from the extracellular environment to serve either as 
alternative nitrogen source or directly in protein synthesis. Gap1 and the proline 
utilization permease Put4 constitute the main route by which the cell is provided with 
amino acids as a source of nitrogen. Whereas Put4 can only transport proline, Gap1 
transports a wide variety of amino acids, including D-amino acids, toxic amino acid 
analogues and L-citrulline (Jauniaux and Grenson, 1990). The activity of Gap1 is 
tightly regulated through mechanisms that sense the availability, and quality, of amino 
acids in the environment. In yeast cells grown on a poor nitrogen source, like proline, 
or in the absence of nitrogen, Gap1 is transported to the plasma membrane to increase 
the cell’s uptake of amino acids. In nitrogen-rich conditions, Gap1 is downregulated 
and sorted to the vacuole for degradation (Magasanik and Kaiser, 2002; Seaman, 
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2006) (for a comprehensive overview of the transcriptional and post-translational 
regulation of Gap1, see section 1.4.).  
 
In addition to its well-documented function as an amino acid transporter, it was 
shown that Gap1 also acts as a receptor, signaling the availability of its substrate to 
the interior of the cell. The dual function of Gap1 as amino acid transporter/receptor 
(transceptor) was supported by the isolation of constitutively activating alleles 
(Donaton et al., 2003). These Gap1 mutants contain short truncations of the extreme 
C-terminus of the protein, resulting in a high PKA phenotype that affected all the 
downstream targets investigated, even in the absence of a nitrogen source (see 
“Chapter II”, section 2.3.).  
 
Further evidence highlighting Gap1’s dual role is observed in gap1Δ cells where both 
amino acid transport and signaling are absent, suggesting that S. cerevisiae lacks a 
transport-independent receptor for sensing extracellular amino acids. Moreover, 
metabolization of the transported nutrient as possible activator of the FGM pathway 
can be excluded since non-metabolizable analogues are still able to trigger a rapid 
activation of the pathway (Holsbeeks et al., 2004; Thevelein et al., 2008). Taking 
advantage of Gap1’s ability to transport L-citrulline at low concentrations, Donaton et 
al. (2003) determined PKA activity in nitrogen-starved wild-type cells, supplemented 
with 2 mM L-citrulline, and nitrogen-starved gap1Δ cells to which 50 mM 
L-citrulline were added. In both cases citrulline uptake was detected; activation of the 
FGM pathway however was only observed in the wild-type strain. These findings 
prompted a model whereby Gap1 acts as sensor and the amino acids activate the 
innate receptor function of the protein, in similar fashion as a ligand activates a 
receptor.  
 
Recent work by Van Zeebroeck et al. (2009) revealed in part the mechanism by which 
Gap1 senses amino acids. The authors employed the substituted cysteine accessibility 
method (SCAM) to identify two amino acid residues in transmembrane domain VIII, 
serine388 and valine389, which are exposed into the amino acid binding domain of 
Gap1. Blocking the binding site with MTSEA, they could demonstrate that Gap1 uses 
the same amino acid binding site for both transport and signaling. A large collection 
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of amino acid analogs was also screened for its ability to inhibit transport and trigger 
signaling. Various compounds were isolated that act as competitive and 
non-competitive inhibitors of transport, either with or without agonist function. Of 
particular relevance was the isolation of non-transported agonists that modulated 
Gap1’s activity to that of a non-transporting transceptor, i.e. signaling without 
transport. The results suggest that the Gap1-dependent signaling event apparently 
requires only the binding of the signaling agonist and partial conformational change 
of the transceptor, but not the completion of the transport cycle (Van Zeebroeck et al., 
2009).  
 
As Gap1 provides the cell with nutrients required for its growth, and the Ras-cAMP - 
and FGM pathways regulate growth according to nutrient availability, it is not 
surprising that particular connections have been identified between these pathways. 
Amitrano and colleagues (1997), for example, demonstrated an increase in 
L-citrulline uptake in cyr1-1 mutants as the exogenously-added cAMP levels were 
increased from 0.25 to 1.0 mM. The authors, however, did not determine Gap1 
activity at higher cAMP levels, which would have ruled out the probability that cells 
grown at such low cAMP levels may have a decreased viability and as a consequence, 
low permease activity. A more physiologically-pleasing link between cAMP 
concentration and Gap1 activity was recently offered (Garrett, 2008). It was shown 
that an increase in cAMP, either through an elevated Ras2 or the addition of cAMP, 
results in a decrease in Gap1 transport activity. A drop in cAMP levels or the loss of 
Ras2, in turn, results in an increase in Gap1 activity, even in the presence of a 
preferred nitrogen source. The downregulation of the permease is proposed to occur 
through a Ras2-dependent ubiquitination event, which explains the high Gap1 activity 
observed in ammonia-grown ras2Δ cells (see section 1.4.4.).  
 
1.2.3. TOR pathway 
 
The control of cell growth and proliferation in all eukaryotic cells studied so far is 
largely directed by the evolutionary-conserved Tor kinases. The Tor proteins were 
first identified in S. cerevisiae cells as the target of the toxic complex formed between 
the immunosuppressive drug rapamycin and a conserved proline-isomerase FKBP12 
(Heitman et al., 1991). Exposing yeast to rapamycin results in profound physiological 
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changes that include reserve carbohydrate accumulation, downregulation of amino 
acid permeases, inhibition of protein synthesis and eventual entry into a G0-like state; 
all phenotypes generally associated with nutrient-starved cells (De Virgilio and 
Loewith, 2006; Zurita-Martinez et al., 2007). These findings support the notion that 
Tor couples nutrient cues to the cell’s developmental program (Figure 1.3).  
 
While most eukaryotes express only one Tor protein, S. cerevisiae has two distinct 
Tor kinases, encoded by TOR1 and TOR2. The Tor proteins associate with two 
multiprotein complexes to form what is known as TORC1 and TORC2. TORC1 
comprises of Tor1, or Tor2 in tor1Δ mutants, bound to Kontroller of Growth (Kog1), 
Lst8 and Tco89, whereas TORC2 is formed by a separate pool of Tor2 bound to 
Avo1, Avo2, Avo3, Lst8 and Bit61 (Adami et al., 2007; Sturgill et al., 2008). 
Rapamycin-sensitive TORC1 promotes cell growth and G1 phase progression through 
the phosphatase regulatory network composed of the type 2A phosphatases Pph21 and 
Pph22, the related type 2A phosphatase Sit4, and the two regulators encoded by 
TAP42 and TIP41 (Urban et al., 2007). TORC2, which is insensitive to rapamycin, 
serves a unique role by controlling polarization of the cell’s actin cytoskeleton (Rohde 
et al., 2008). 
 
Recent studies, however, suggest that the exclusivity in function of TORC1 and 
TORC2 may not be as stringent as previously thought. It has been reported that Kog1, 
restricted to TORC1, regulates both actin polarization and cell wall integrity. 
Rapamycin treatment and inhibition of Tap42 or Sit4 also induced unexpected 
changes in actin organization (Araki et al., 2005). These data lend support to a 
proposed overlap in function between TORC1 and TORC2.  
 
1.2.3.1. Targets of TOR 
 
Most of the TORC1 functions are mediated through its downstream target Tap42. In 
nutrient-rich conditions, TORC1 directly phosphorylates Tap42 to stimulate its 
inhibitory binding to the catalytic subunits of PP2A and PP2A-like phosphatases - 
Pph21, Pph22, and Sit4. Upon nitrogen starvation or treatment with rapamycin, i.e. 
inhibition of TORC1, Tap42 becomes dephosphorylated and released from the 
catalytic subunits.  
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Figure 1.3: The TOR pathway in yeast.  
The rapamycin-sensitive yeast TORC1 and rapamycin-insensitive TORC2 
couples nutrient and environmental cues to cellular metabolism. The two protein 
complexes reside in separate signaling pathways and regulate different facets of 
growth. Circles containing the letter P denote phosphorylated amino acid 
residues. 
 
Liberated and activated Sit4 in turn dephosphorylates and activates targets such as the 
transcriptional activator Gln3 and the protein kinase Npr1. The ensuing nuclear 
translocation of Gln3 induces the expression of a range of nitrogen-repressed genes, 
e.g. Gap1, Mep2 and Dal5, which allows the cell to utilize less-favored nitrogen 
sources (De Virgilio and Loewith, 2006; see section 1.3.1.). 
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Based on these observations, it is tempting to formulate a model in which 
phosphorylated Tap42 bolsters growth by inhibiting PP2A activity, while rapamycin 
treatment and poor growth conditions cause growth arrest through the release of 
PP2A. Such a model, however, can not explain the discrepancy in time observed for 
rapamycin-induced gene expression to take effect compared to the much slower 
dissociation of the Tap42-PP2A complex. 
 
Furthermore, since the cell contains up to tenfold less Tap42 than PP2A catalytic 
subunits, the majority of PP2A protein in the cell are found in the unbound, active 
form. A more plausible explanation of Tap42 activity was recently offered by Yan et 
al. (2006). This group showed that the Tap42-PP2A complex is localized to 
detergent-resistant membranous fractions in the cell in close association with TORC1. 
In response to TORC1 inactivation, the Tap42-PP2A complex is released to the 
cytosol, where it slowly dissociates, probably due to the dephosphorylation of Tap42. 
The Yan model is particularly attractive as it not only accounts for the difference in 
kinetics of rapamycin action but also sheds light on the previously unknown 
mechanism by which mutations in Tap42, e.g. the tap42-11 allele, renders the cell 
rapamycin resistant (Di Como and Arndt, 1996). Yan et al. (2006) demonstrated a 
modification in the binding of the tap42-11-PP2A complex to TORC1, which is 
insensitive to rapamycin-induced dissociation. 
 
Once active, TORC1 functions as a key regulator of the general amino acid control 
(GAAC) system through the control it exerts on the GAAC transcriptional activator 
Gcn4. Upon amino acid starvation, the protein kinase Gcn2 induces the enhanced 
translation of GCN4 mRNA to upregulate the expression of most amino acid 
biosynthesis genes. Gcn2, in turn, is stimulated by the binding of uncharged tRNAs. 
Active Gcn2 phosphorylates the α subunit of eukaryotic translation initiation factor 2 
(eIF2) and in doing so, Gcn2 ensures priority to the translation of specifically GCN4 
mRNA while general protein synthesis is downregulated (Hinnebusch, 2005; 
Mascarenhas et al., 2008) (see section 1.3.2. for a more detailed overview). 
 
Recent biochemical studies suggest that Gcn2 activation may also occur in response 
to rapamycin treatment. Rapamycin apparently induces dephosphorylation of a 
specific residue on Gcn2, serine577, which results in an increased phosphorylation of 
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eIF2α and an eventual increase in Gcn4. Conversely, TORC1 represses Gcn4 
expression by boosting the phosphorylation of serine577 through the Tap42-dependent 
inhibition of the PP2A-like phosphatase Sit4. These findings were further supported 
in sit4Δ mutants or cells carrying the rapamycin-resistant tap42-11 allele; in both 
cases a decreased rapamycin-induced dephosphorylation of serine577, coupled to a 
diminished induction of eIF2α, were observed. Together, these data indicate a 
potential cross-talk mechanism in the cell where the availability of nutrients is linked 
to the synthesis of proteins (Cherkasova and Hinnebusch, 2003; Magazinnik et al., 
2005). 
 
As noted before, TORC1 has been localized, among other places, to intracellular 
membranous structures that are near, but still distinct from, the plasma membrane. 
Novel research has suggested that the relevance of TORC1 localization is not only 
physical, but, more importantly, functional as demonstrated by the Golgi-localized 
ATPase Pmr1 (Devasahayam et al., 2006; Devasahayam et al., 2007). Pmr1 transports 
Ca2+ and Mn2+ ions from the cytosol into the Golgi, and is as such part of the 
secretory pathway also used by permeases. Remarkably, deletion of PMR1 caused 
resistance to rapamycin, with wild-type sensitivity restored to the pmr1Δ cells through 
the addition of Mn2+ to the growth medium. Epistasis analysis positions Pmr1 
upstream and as a negative regulator of TORC1 activity. The mechanism by which 
Pmr1 achieves TORC1 inhibition is thought to involve the regulation of Mn2+ 
homeostasis. Tor, like most phosphatidylinositol 3-kinase-related kinases, requires 
Mn2+ as cofactor for maximal activity and may be partly localized to the Golgi, as 
suggested for mammalian Tor, where there is access to Mn2+ within the secretory 
pathway (Liu and Zheng, 2007).  
 
The prevailing theory of a prominent link between TORC1 activity and vacuolar 
function was further underscored by two recent studies. First, cells lacking any of the 
five proteins of the ‘Gap1 sorting in the endosome’ (GSE) complex, also known as 
the EGO complex, fail to recover from rapamycin treatment. The GSE/EGO complex 
is required for the delivery of Gap1 to the plasma membrane and colocalizes to the 
vacuolar and pre-vacuolar membranes (Gao and Kaiser, 2006) (see section 1.4.4.). 
Mutants of the GSE/EGO complex are also deficient in reversing rapamycin-induced 
Literature overview 
 
 22 
phenotypes like eIF2α phosphorylation, which would indicate that it functions 
upstream of TORC1 signaling. Together with TORC1, the GSE/EGO complex 
initiates recovery from rapamycin inhibition by recycling of vacuolar membranes, a 
process termed microautophagy. These results argue for a role of the GSE/EGO 
complex in relaying nutrient signals from the vacuole to TORC1 (Figure 1.3). Bearing 
in mind that the vacuole serves as an amino acid store, this seems a likely scenario 
(Gao and Kaiser, 2006; Rohde et al., 2008).  
 
Second, a genome-wide screen by Zurita-Martinez et al. (2007) identified the class C 
vacuolar protein sorting (VPS) complex, consisting of the Pep3, Pep5, Vps16, Vps33, 
Vps39 and Vps41 proteins, as another vacuole-bound complex essential in 
maintaining TORC1 signaling. The VPS complex plays a determining role in protein 
sorting, mainly by regulating the key processes of vesicle docking and fusion at the 
endosome. Deleting any component of the VPS complex, results in mutant cells that 
are unable to recover from either rapamycin-induced growth inhibition or nitrogen 
starvation. In addition, these mutants exhibit low levels of internal amino acids, in 
particular glutamate and glutamine. Combining the vpsΔ with a tor1Δ is synthetically 
lethal but interestingly, growth is restored to the double deletion strain by 
supplementing the media with glutamate or glutamine, and to a lesser degree arginine. 
These findings propose a model whereby TORC1’s localization to membranes places 
it in an ideal position to receive nutrient signals generated by the components of the 
secretory pathway, i.e. TORC1’s localization allows for its diverse function. 
 
 
1.3. AMINO ACID SIGNALING IN YEAST 
 
Yeast can utilize a wide range of organic and inorganic sources of nitrogen, but as 
with carbon sources, not all of these are utilized with the same efficiency. In order to 
use non-preferred nitrogen sources, like proline, allantoin or ornithine, S. cerevisiae 
first has to convert it into either glutamine or glutamate. Both serve as sole nitrogen 
donors for the synthesis of all nitrogenous substances found in the cell.  
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As with carbon sources, yeast has evolved a variety of physiological processes that 
allow the selective use of the more-favored nitrogen sources before switching to the 
poor ones. The regulatory mechanism encompassing this phenomenon is known as 
nitrogen catabolite repression or nitrogen discrimination pathway (Magasanik and 
Kaiser, 2002; Wong et al., 2008).  
 
1.3.1. Nitrogen Catabolite Repression (NCR) 
 
The expression of nearly all NCR genes studied so far is under direct control of 
GATA-type transcription factors. These transcription factors share a very distinct 
Zn-finger region (Cys-X2-Cys-X17-Cys-X2-Cys) that recognizes and binds to a 
5’- GATA-3’ sequence upstream of genes subject to NCR. S. cerevisiae has two 
positively-acting GATA factors, Gln3 and Gat1 (Nil1), and two repressors of 
transcription, Dal80 (Uga43) and Gzf3 (Nil2 or Deh1). Given the high sequence 
similarity between the four proteins, it is not surprising that the difference in structure 
between activator and repressor is limited to its N- and C-termini respectively. Gln3 
and Gat1 differ from Dal80 and Gzf3 by having an asparagine-rich region located 200 
residues from its N-terminus, whereas Dal80 and Gzf3 share a unique leucine zipper 
in its C-terminal domain not present in the positive transcription factors (Stanborough 
et al., 1995; Magasanik and Kaiser, 2002).  
 
Regulation of the GATA transcription factors is exerted at the level of subcellular 
localization. In the presence of poor nitrogen sources, Gln3 and Gat1 localize to the 
nucleus where they induce the expression of genes encoding permeases and enzymes 
required for transport and degradation of poor nitrogen sources. On the contrary, 
when cells are grown on good nitrogen sources, Gln3 and Gat1 are found 
predominantly in the cytosol. The anchor protein, Ure2, is proposed to control the 
nuclear localization of Gln3 by sequestering it in the cytoplasm under nitrogen 
repressing conditions - a Gln3-Ure2 complex can be isolated from cells in which NCR 
transcription is repressed and deletion of URE2 results in an increased expression of 
Gln3-sensitive genes, even in the presence of a preferred nitrogen source (Beck and 
Hall, 1999; Bertram et al., 2000; Tate et al., 2006a) (Figure 1.4). A similar 
cytoplasmic anchor for Gat1 remains to be identified.  
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Although the quality of the nitrogen source begins to explain the localization of the 
GATA factors, it does not address the molecular events behind the process. Earlier 
studies with rapamycin, however, provided the first clue to the underlying 
mechanism. Treatment of actively-growing cells with the immunosuppressive drug, 
results in the release of phosphorylated Gln3 from Ure2, its dephosphorylation and 
eventual translocation to the nucleus. Moreover, the addition of rapamycin also 
increases the rate of Gln3 electrophoretic migration, similar to that observed in cell 
extracts treated with protein phosphatases (Beck and Hall, 1999; Cooper, 2002). 
Based on these results, a simple model was formulated in which a nitrogen-rich 
environment activates the Tor proteins, which in turn boosts Gln3 phosphorylation. 
According to this model, inhibition of Tor1 through rapamycin prevents, or alters, 
Gln3 phosphorylation, and allows non-phosphorylated Gln3 to enter the nucleus. 
Further evidence in support of such a model came from the observation that in cells 
lacking the type 2A-related protein phosphatase Sit4, Gln3 remains in the cytosol 
despite rapamycin treatment. Sit4’s role in regulating the phosphorylation status of 
Gln3 was thus established.  
 
The significance of the phosphorylation status of Gln3 in determining its subcellular 
localization was extended by the finding that the nuclear transport protein Srp1 only 
binds non-phosphorylated Gln3. The Gln3-Srp1 complex translocates to the nucleus, 
allowing Gln3 to promote GATA-mediated transcription and Srp1, in association with 
Cse1, to recycle back to the cytosol. Gln3 exits the nucleus in complex with the 
nuclear export factor Crm1 (Carvalho et al., 2001). The directionality of nuclear 
transport is ensured by the Ran proteins, present either in its GTP-bound form in the 
nucleus or as GDP-bound in the cytosol (Moy and Silver, 1999). 
 
However, recent data on Gln3 phosphorylation and cellular localization has been 
difficult to reconcile with the model described previously. These results include the 
observation that, although methionine sulfoximine (MSX), a potent inhibitor of 
glutamine synthesis, and rapamycin treatment both elicit Gln3 nuclear localization, 
they generate the opposite phosphorylation profile - MSX increases Gln3 
phosphorylation whereas rapamycin decreases it. Similarly, a lack in correlation 
between dephosphorylation and localization was also demonstrated for growth on rich 
vs. poor nitrogen sources, during nitrogen starvation and after prolonged rapamycin 
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treatment, i.e. more than 30 minutes. The only time a clear correlation was observed, 
was within 10 to 20 minutes after rapamycin treatment (Tate and Cooper, 2007; 
Georis et al., 2008; Tate et al., 2009).  
 
 
 
Figure 1.4: Nitrogen catabolite repression (NCR) in yeast. 
The current model describing TORC1-dependent regulation of Gln3’s 
phosphorylation status, subcellular localization, and activation of NCR-sensitive 
transcription. Circles containing the letter P denote phosphorylated amino acid 
residues (adapted from Tate et al., 2009). 
 
Significant advances made in recent years on the mechanism of Tor signaling, also 
changed our understanding of the role it plays in Gln3 regulation. It appears that 
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Tap42, in its phosphorylated form, is required for Sit4 activity; the phosphorylated 
Tap42-Sit4 complex released from TORC1 in response to rapamycin exposure or 
nitrogen limitation, is active for as long as Tap42 is bound to Sit4. More importantly, 
was the unexpected discovery of the involvement of PP2A phosphatases in Gln3 
control. PP2A, like Sit4, dephosphorylates Gln3 in response to nitrogen sources; their 
respective activities, however, depend largely on the nitrogen source present. In cells 
grown on favored sources, Gln3 dephosphorylation occurs mainly through Sit4 
activity with Pph21 and Pph22 contributing very little to the overall process, whereas 
growth on poor nitrogen sources results in the opposite phenotype.  
 
This inverse in regulation may well be due to Gln3’s cellular localization during these 
growth conditions. On good nitrogen sources, Gln3 is found predominantly in the 
cytosol and is as such not available to the nuclear-restricted PP2A for modification. 
Once present in the nucleus, Gln3 phosphorylation status is under control of PP2A 
and immune to the cytoplasmic Sit4-dependent dephosphorylation (Tate et al., 2009).  
 
In contrast to Gln3, much less is known about the regulation of Gat1 activity. 
Modifications in Gat1 phosphorylation levels in response to nitrogen source quality 
and/or rapamycin treatment have not been demonstrated, although the Snf1-dependent 
phosphorylation of Gat1 in carbon-starved cells was easily identified. In addition, 
MSX-treatment also resulted in the opposite effects on Gln3 and Gat1 localization. In 
nearly all the cells exposed to the inhibitor, Gln3 was present in the nucleus whereas 
Gat1 concentrated in the cytoplasm. As with rapamycin, MSX-treatment had no 
influence on Gat1 phosphorylation. It is this lack of a general response of Gln3 and 
Gat1 localization to the inhibitors that supports the notion that these two 
transcriptional activators represent the branches of parallel pathways for the positive 
regulation of NCR transcription (Georis et al., 2008; Wong et al., 2008; Georis et al., 
2009). Finally, transcriptional control of GAT1 is Gln3- and Gat1-dependent, i.e. 
auto-activation of its own transcription, and demonstrates particular sensitivity to 
Dal80 inhibition.  
 
As noted before, the two negative regulators of NCR-sensitive transcription, Dal80 
and Gzf3, contain leucine-zipper motifs near their C-termini, allowing them to self-
associate. The strength with which Dal80 and Gzf3 bind DNA is, in fact, believed to 
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originate from their ability to do so as a dimer. In contrast to Gln3, which binds a 
single GATA, the Dal80 homodimer requires two GATA sequences, positioned either 
head to tail or tail to tail, but not head to head, spaced 15 to 40 bp apart, for binding. 
Gzf3, on the other hand, functions via a single GATA sequence and forms 
homodimers or heterodimers with Dal80 (Svetlov and Cooper, 1998; Distler et al., 
2001). The expression of Dal80 and Gzf3 are nitrogen source-dependent, with Gzf3 
functioning as the major inhibitor in the presence of rich sources. Therefore, when 
cells are shifted from favorable, i.e. conditions where Dal80 levels are very low, to 
poor nitrogen sources, Dal80 does not initially antagonize NCR transcription. It is 
only through the upregulation in expression, brought about by Gln3 and Gat1’s 
nuclear localization in poor nitrogen conditions that Gal80 levels are sufficient to 
regulate NCR-sensitive genes. One of the targets Gal80 downregulates is its own 
activator, Gat1, in a process commonly referred to as autogenous regulation 
(Cunningham et al., 2000; Magasanik and Kaiser, 2002). By regulating its own 
expression, Gal80 provides a negative feedback loop that allows the cell to fine-tune 
its response to the prevailing conditions. Such a mechanism is proposed to be most 
advantageous to the cell in the intermediate period when adjusting its metabolism to 
being shifted from a good to a poor nitrogen source.  
 
A recent genome-wide study identified 44 additional genes subject to NCR. The new 
targets include the GAAC transcriptional activator Gcn4, the membrane peptide 
transporter Ptr2 and the regulator of nitrogen permeases Npr2 (Godard et al., 2007). 
Interestingly, the screen also identified the anabolic glutamate dehydrogenase Gdh1 
and glutamate synthase Glt1 as NCR-sensitive. These two proteins, together with 
Gln1 (glutamine synthetase) and Gdh2 (catabolic glutamate dehydrogenase) 
constitute the main route of nitrogen utilization in S. cerevisiae. With Gln1 and Gdh2 
both well-established targets of NCR, the new data suggest that the complete set of 
enzymes forming the core of nitrogen metabolism in yeast is in fact NCR regulated.  
 
1.3.2. General Amino Acid Control (GAAC) 
 
As described in the previous section, most amino acids can serve as a source of 
nitrogen or as building blocks during protein synthesis. Intracellular amino acid 
concentrations are constantly monitored by the GAAC system. Starving cells for any 
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amino acid induces the activator protein Gcn4 which in turn activates the transcription 
of a large number of genes, many of which are involved in amino acid biosynthesis. 
Gcn4 activity is regulated at the level of translation initiation through the presence of 
four small open reading frames (ORFs) upstream of the main mRNA coding 
sequence. These upstream ORFs function as a translational barrier in nonstarvation 
conditions by preventing scanning ribosomes from reaching the GCN4 start codon. 
However, during amino acid starvation, uncharged tRNA molecules bind and activate 
the Gcn2 kinase, which in turn phosphorylates the translation initiation factor eIF2α. 
Active eIF2 inhibits the guanine nucleotide exchange factor (GEF), eIF2B, from 
recycling inactive eIF2-GDP to active eIF2-GTP. Since only the GTP-bound form of 
eIF2 can deliver charged methionyl initiator tRNA (Met-tRNAiMet) to the 40S 
ribosome in the first step of translation initiation, inhibition of eIF2B results in a 
severely reduced level of active eIF2-GTP. Under these circumstances, initiation at 
the upstream ORFs is abolished with ribosomes scanning further downstream to the 
GCN4 ORF instead (Hinnebusch and Natarajan, 2002; Wilson and Roach, 2002; 
Gárriz et al., 2009) (see Figure 1.5). 
 
Because eIF2α functions by inhibiting translation, its activity is tightly regulated to 
prevent any inhibitory effect on translation during favorable conditions. The protein 
kinase Gcn2 is at the heart of this regulation. Gcn2 itself is essentially inactive and 
depends on the binding of uncharged tRNAs to its regulatory domain for activation. 
The regulatory domain is a 500 residue region, C-terminal to the Gcn2 kinase domain, 
whose sequence resembles that of histidyl-tRNA synthetase (HisRS). Binding of any 
uncharged tRNA to HisRS permits a short N-terminal segment of the HisRS motif to 
interact with a part of the kinase domain that contains the hinge that connects the N- 
and C-terminal lobes, resulting in a conformational change that is thought to stimulate 
Gcn2 kinase activity (Hinnebusch, 2005). Similar to other kinases, 
autophosphorylation of the activation loop is a prerequisite for Gcn2 activity. Gcn2 
autophosphorylates a threonine882 and a threonine887 in the so-called activation loop of 
which the latter is essential for proper function. There is also evidence that Gcn2 
activation requires interaction between the N-terminus of Gcn2 with the Gcn1-Gcn20 
complex. The Gcn1-Gcn20 complex promotes the binding of tRNAs to the translating 
ribosome’s decoding site, or its transfer from the decoding site to the HisRS domain 
of Gcn2.  
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Figure 1.5: General amino acid control in yeast. 
The current model for GCN4 translational control. Starving cells for any amino 
acid induces Gcn4 which in turn activates the transcription of various genes 
involved in amino acid biogenesis. Gcn4 activity is regulated at the level of 
translation initiation through the presence of four small ORFs upstream of the 
main coding sequence. The circle containing the letter P denotes a 
phosphorylated amino acid residue. 
 
The domain structure and function of Gcn2 appears to be evolutionary conserved in 
other fungi and higher eukaryotes. The Drosophila and mouse Gcn2 proteins restore 
viability to yeast gcn2Δ mutants starved for amino acids. Furthermore, eIF2α 
phosphorylation in starved mammalian cells induces the translation of ATF4 mRNA 
in a similar fashion as yeast Gcn4. What makes this remarkable is that Atf4 is a 
transcriptional activator belonging to the same family as Gcn4 (Santoyo et al., 1997; 
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Sood et al., 2000; Vattem and Wek, 2004). The core elements of this nutritional 
control are thus highly conserved (see section 1.2.3.).  
 
Besides amino acid deprivation, the Gcn2-mediated synthesis of Gcn4 is also induced 
during starvation for purines, glucose limitation or growth on the non-fermentable 
carbon source ethanol, high salinity in the growth media, exposure to methyl 
methanesulfonate (MMS) and treatment with rapamycin. The requirement of Gcn2 
kinase activity in such diverse environmental stress conditions is probably due to an 
impaired synthesis of amino acids in these conditions. This results in the 
accumulation of uncharged tRNAs and the activation of Gcn2 in the same manner that 
functions in amino acid-depleted cells. New experimental evidence, however, 
demonstrated this not to be the case for purine starvation, MMS and rapamycin 
treatment or high salt concentrations (Hinnebusch, 2005). For glucose limitation, 
Yang et al. (2000b) showed that cytosolic amino acid levels dropped as cells stored 
amino acids in vacuoles instead. The levels of amino acids accumulated in the 
vacuole during glucose limitation exceeded by far the net loss measured in the 
cytosol; the difference being attributed to Gcn4 activity. It was rationalized that by 
vacuolar storage of amino acids and the accompanying translation of GCN4 mRNA 
during glucose limitation, cells would have immediate access to nitrogen once 
glucose levels are replenished.  
 
Apart from the Gcn2-mediated regulation of GCN4 translation, a Gcn2-independent 
mechanism also exists that operates as cells are shifted from amino acid-rich to 
minimal media. It requires activation of PKA and is absent in constitutively low PKA 
mutants. Accordingly, mutants with overactive PKA activity, e.g. bcy1Δ or RAS2G19V 
cells, display a constitutively derepressed translation of GCN4 that is partly 
independent of Gcn2 (Marbach et al., 2001). The role PKA activity plays in GCN4 
translation is poorly understood.  
 
In addition to stimulating its synthesis, amino acid starvation also stabilizes Gcn4. In 
a nutrient-rich environment, Gcn4 is quickly degraded, with a half-live of typically 2 
to 3 minutes, whereas degradation occurs four to five times slower in amino 
acid-deprived conditions. Degradation of Gcn4 is a complex process and requires the 
phosphorylation of both threonine105 and threonine165 in the activation loop, as well as 
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ubiquitination by the ubiquitin-conjugating enzyme Cdc34 and the associated 
ubiquitin ligase complex SCFCDC4. Phosphorylation of the threonines by the two 
multifunctional cyclin-dependent kinases (CDKs), Pho85 and Srb10, enhances 
ubiquitination. As with all CDKs, substrate specificity is ensured through the binding 
of a specific cyclin, and in the case of Pho85-mediated phosphorylation of Gcn4, the 
cyclin is Pcl5 (Shemer et al., 2002; Aviram et al., 2008). Pcl5 itself is under 
transcriptional control of Gcn4 and the negative feedback loop created ensures Gcn4 
activity is regulated according to the nutritional situation. A similar Pho85-Pcl5 
regulatory loop seems to operate in C. albicans as well (Gildor et al., 2005).  
 
A novel study employing an analog sensitive version of the Snf1 kinase, the snf1-as 
allele, identified Snf1 as a repressor of GCN4 translation in amino acid-rich media. 
Shirra et al. (2008) demonstrated snf1Δ cells to have elevated levels of Gcn4 protein 
and that the phenomenon is dependent on both Gcn2 and Gcn20, suggesting that Snf1 
regulates the translation of GCN4 and not the stability of the protein. The exact 
mechanism by which it is achieved remains unknown. An unexpected consequence of 
the research is the finding that Snf1 exhibited activity, although severely reduced, in 
the presence of high glucose, a condition normally associated with its inhibition. 
Similar contradictions for Snf1 were observed for pseudohyphal growth (Van de 
Velde and Thevelein, 2008).  
 
1.3.3. SPS amino acid-sensing  
 
Nutrients have the capacity to regulate cell function beyond their crucial role in 
metabolism. In S. cerevisiae, the sensing of extracellular amino acids is dependent on 
the amino acid permease homologue Ssy1. It is the largest member of the amino acid 
permease family and also the only member that has lost its transport capability. A 
striking feature of Ssy1 is an extended N-terminus, 276 residues in length, which 
makes it significantly larger than any of the other amino acid permeases (Andréasson 
and Ljungdahl, 2002; Kodama et al., 2002). These are characteristics similar to those 
that distinguish the glucose sensors, Rgt2 and Snf3, from the rest of the hexose 
transporter family. 
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Ssy1, together with the intracellular peripheral membrane proteins Ptr3 and Ssy5, 
form the core components of the SPS sensing pathway. Binding of amino acids to 
Ssy1 generates a signal that is transduced to Ptr3 and Ssy5 (Andréasson and 
Ljungdahl, 2004; Poulsen et al., 2005). Ssy5 is synthesized as an inactive 
chymotrypsin-like protease, consisting of an inhibitory N-terminal pro-domain and a 
C-terminal catalytic domain. In receiving the Ssy1-Ptr3-relayed signal, Ssy5 is 
autolyticly processed and consequently activated. Active Ssy5, in turn, stimulates the 
proteolytic cleavage of two related transcription factors, Stp1 and Stp2. That Ssy1, 
Ptr3 and Ssy5 function in a highly interdependent, conformationally coordinated 
fashion is supported by two important findings. First, in two-hybrid assays Ptr3 was 
shown to interact with itself and with Ssy5, while Ssy1 was found to interact with 
Ptr3 (Eckert-Boulet et al., 2004). Second, mutants containing the constitutive 
signaling forms of Ptr3 and Ssy5 are only active in the presence of the complete SPS 
sensor. Thus, in ssy1Δ or ssy5Δ cells carrying the PTR3-5 allele as well as ssy1Δ or 
ptr3Δ cells carrying the SSY5-6 allele, activation of downstream reporters were 
completely abolished (Poulsen et al., 2005). These results are consistent with the 
notion that the three proteins are not only functionally but also physically associated.  
 
The SPS-mediated processing of the transcription activators Stp1 and Stp2 (Stp1/2) 
also requires the SCFGrr1 E3 ubiquitin ligase complex and the activity of either of the 
two yeast casein kinases Yck1 or Yck2. As positive regulators of the SPS pathway, 
Yck1/2 and Grr1 were shown to hyperphosphorylate Ptr3 during conditions of amino 
acid availability. The conformational change that occurs in the Ptr3-Ssy5 complex 
due to Ptr3 hyperphosphorylation results in Ssy5 activation and the processing of 
Stp1/2 (Zaman et al., 2008). Conversely, in the absence of external amino acids, a 
phosphatase complex encompassing the PP2A regulatory subunit Rts1 
dephosphorylates Ptr3, and the SPS pathway is as a consequence inactivated. A role 
as negative regulator of the SPS pathway was confirmed for Rts1; rts1Δ cells exhibit 
an increased phosphorylation of Ptr3 that coincides with the constitutive expression of 
SPS-responsive genes. It is important to note that the constitutive signaling by 
mutants of the SPS complex always requires the presence of the wild-type copies of 
the two other components of the sensor (Ljungdahl, 2009). This suggests that the 
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presence of extracellular amino acids causes a conformational change in the SPS 
sensor from a non-signaling to a signaling conformation.  
 
Stp1/2 is synthesized as latent precursor forms that are excluded from entering the 
nucleus under non-inducing conditions. In response to amino acids, active Ssy5 
removes a 10-kDA N-terminal inhibitory fragment from Stp1/2 in a process known as 
receptor-activated proteolysis (Boban and Ljungdahl, 2007). The truncated form of 
the transcription factors enters the nucleus and activates transcription of relevant 
amino acid permeases by binding to specific upstream activating sequences (UASaa) 
within SPS-sensitive promoters. Single deletions of either STP1 or STP2 has no 
significant effect on SPS signaling, whereas in a stp1Δ stp2Δ double mutant signaling 
is completely abolished.  
 
Several eukaryotic transcription factors involved in signal transduction are 
synthesized as latent, inactive precursors restricted to the cytosol. Well-documented 
examples include Drosophila’s Cubitus interruptus transcription activator, involved in 
the Hedgehog signaling pathway, and the NF-κB family of transcription factors that 
regulate cell division and apoptosis according to nutrient cues (Wang and Price, 2008; 
Graff et al., 2009). The subcellular relocalization of activated transcription factors 
therefore provide a novel means by which nutrient-induced signals generated at the 
plasma membrane are physically transferred from the cytosol to the nucleus.  
 
The negative regulation of full-length Stp1/2 is not restricted to cytoplasmic retention 
alone. A backup system, consisting of the three amino acid sensor independent (ASI) 
proteins, Asi1, Asi2 and Asi3, prevents full-length Stp1 and Stp2 that ‘leaks’ into the 
nucleus from activating transcription. Asi1 was originally identified in a genetic 
screen designed to isolate mutations that restore leucine uptake in SPS-deficient 
strains (Forsberg et al., 2001). Cells carrying the ssy1Δ asi1Δ double mutations 
displayed constitutive activation of SPS-regulated genes and restored amino acid 
uptake to wild-type levels. Remarkably, Stp1/2 did not accumulate in the nucleus of 
ssy1Δ asi1Δ mutants as expected; the low levels of full-length Stp1/2 that enter the 
nucleus are sufficient to induce expression of SPS-responsive genes. This latter result 
clearly indicates that the Asi proteins confer their inhibitory effect on unprocessed 
Literature overview 
 
 34 
Stp1/2 in an additional, i.e. cytoplasmic retention-independent, manner. A novel study 
by Zargari et al. (2007) shed some light on the mechanism involved. The authors 
proposed a simple model whereby the Asi proteins function as a complex localized 
within the inner nuclear membrane (Figure 1.6). 
 
The model is based on the following observations. First, deletions of ASI1, ASI2 or 
ASI3 result in comparable levels of SPS gene expression. Moreover, all deletion 
mutants display the same, if not identical amino acid uptake-related phenotypes. 
Second, Asi1 and Asi3 are structurally related, but not redundant, proteins. Both 
proteins contain a C-terminal localized RING domain characteristic of ubiquitin 
ligases. Third, all three Asi proteins function to inhibit the activity of full-length 
Stp1/2 in the absence of inducing amino acids. Finally, the Asi proteins co-fractionate 
to membranes of similar density (Forsberg et al., 2001; Boban et al., 2006).  
 
The fact that the low levels of unprocessed Stp1/2 induce SPS-regulated gene 
expression in ssy1Δ asi1Δ cells to levels undistinguishable from wild-type cells, did 
not escape the attention of Boban and Ljungdahl (2007). The authors identified an 
additional layer of control exerted on SPS gene expression by the AGP1 transcription 
factor, Dal81 (Uga35) (Abdel-Sater et al., 2004). Dal81 acts as an amplifier of 
expression by facilitating the binding of Stp1/2 to the UASaa promoter region of 
amino acid permeases. It does, however, not discriminate between full-length or 
processed Stp1/2, which explains the apparent contradiction observed in ssy1Δ asi1Δ 
cells. Although important, Dal81 activity is not an absolute requirement for amino 
acid-induced SPS gene expression. During these conditions the truncated forms of 
Stp1/2 accumulate in the nucleus at levels high enough to stimulate expression 
independent of Dal81. In line with its role as an amplifier, Dal81 does not affect the 
nuclear targeting of processed Stp1/2; neither does it activate expression of 
SPS-regulated genes by itself (Ljungdahl, 2009).  
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Figure 1.6: The SPS amino acid-sensing pathway.  
Amino acid sensing is initiated by its binding to Ssy1, which relays signals 
through Ptr3 and Ssy5 to the two transcription factors Stp1 and Stp2. Once in the 
nucleus, Stp1 and Stp2 activate the expression of genes encoding amino acid 
permeases. (A). The non-induced state in the absence of amino acids. (B). The 
induced state in the presence of amino acids (adapted from Ljungdahl, 2009).  
 
SPS regulates the transcription of several amino acid permeases in response to the 
presence of all the amino acids, except proline. These include genes that code for 
AGP1, BAP2, BAP3, GNP1, DIP5, TAT1, TAT2, the arginase CAR1 and the peptide 
transporter PTR2. SPS also negatively regulates CAN1, PUT4 and GAP1 in amino 
acid-rich media. In addition to these direct effects on the amino acid permease genes, 
two independent transcription profile studies have indicated that it only represents a 
part of the full spectrum of SPS-regulated gene expression (Kodama et al., 2002; 
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Eckert-Boulet et al., 2004). For example, ssy1Δ and stp1Δ stp2Δ mutants display an 
overall upregulation of NCR-sensitive and stress-responsive gene expression.  
 
 
1.4. REGULATED TRAFFICKING OF GAP1 
 
The transport of proteins between intracellular membrane-bound compartments, or 
organelles, is common to all eukaryotic cells. It involves the selective packaging of 
newly synthesized proteins into the budding region formed of the donor compartment. 
These regions bud off as transport vesicles and are targeted to specific acceptor 
compartments to which they deliver their cargo. The general mechanism and the main 
proteins involved in these reactions appear to be conserved from yeast to humans 
(Salama and Schekman, 1995; Lupashin et al., 1996). Major stages in protein 
secretion in yeast includes: (i) synthesis of proteins on endoplasmic reticulum (ER)-
associated polysomes, (ii) release of newly synthesized proteins into the lumen of the 
ER, (iii) chaperone-assisted protein folding and glycosylation in the ER, (iv) vesicle-
mediated transport of proteins from the ER to the cis-Golgi apparatus, (v) further 
modification of the protein’s carbohydrate side-chain in the Golgi, (vi) secretory 
vesicles derived from budding of the trans-Golgi deliver proteins to the cell surface, 
which in the case of membrane proteins, are inserted into the lipid bilayer.  
 
The S. cerevisiae general amino acid permease Gap1 has long proved to be an 
extremely useful system to unravel the complex genetic and molecular events 
underpinning protein trafficking. Particularly in recent years, it has provided a wealth 
of information about new gene products and mechanisms involved in the transport 
and regulation of membrane proteins. The transcriptional regulation of Gap1 is 
absolutely intertwined with the presence of nitrogen in the extracellular environment - 
the GATA transcriptional activator Gln3 induces GAP1 transcription under 
nitrogen-deplete conditions whereas the presence of extracellular amino acids results 
in its SPS-dependent repression. The following section, however, deals with the 
post-translational control Gap1 encounters on its movement through the secretory 
pathway.  
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Earlier work on Gap1 regulation in the Σ1278b and S288c genetic backgrounds 
highlighted a crucial difference in their response to the addition of ammonia to 
starved cells. For Σ1278b strains, ammonia is a repressing nitrogen source and causes 
the rapid downregulation of Gap1; a process known as ammonium inactivation 
(Magasanik and Kaiser, 2002). The S288c strains, on the other hand, do not suffer 
from ammonia inactivation. For the sake of this section, we will refer to nitrogen-rich 
conditions in the context of a rapid decline in Gap1 activity.  
 
1.4.1. ER quality control 
 
The ER plays a critical role in the folding of newly-synthesized proteins. Although 
the proper conformation of proteins lies encoded in their amino acid sequence, the ER 
provides the optimal environment for folding. It is packed with folding enzymes and 
molecular chaperones, like Lhs1, Pbn1 and the essential Kar2, that actively monitor 
the folding state of the new protein. Misfolded or incompletely assembled proteins are 
recognized by these chaperones and retained in the ER until they are correctly folded, 
in a process known as ‘ER quality control’ (Watanabe and Riezman, 2004; Pety de 
Thozée and Ghislain, 2006). Failure to do so results in protein aggregation, which was 
shown to be the root cause of human diseases like cystic fibrosis, Alzheimer’s and 
Huntington’s. The ER quality control system also ensures proteins that are 
persistently misfolded are targeted for ER-associated degradation (ERAD) (Spear and 
Ng, 2003; Kleizen and Braakman, 2004). The ERAD pathway re-translocates the 
misfolded protein back into the cytosol where proteasomal degradation takes place.  
 
1.4.2. ER exit 
 
Once fully folded, proteins destined for secretion are segregated from ER-resident 
proteins and taken up into transport vesicles, the so-called coat protein complex II 
(COPII) vesicles. Proteins may enter the COPII vesicles at the concentration present 
in the ER, a process termed bulk-flow, or at concentrations substantially higher than 
that in the ER. The bulk-flow model is an extremely inefficient mode of transport and 
accounts for only a small volume of total protein transport. Most of the 
transmembrane proteins are specifically enriched in COPII vesicles. The selective 
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enrichment is achieved by the presence of an ER exit signal located on the exposed 
region of the cargo protein that binds directly to COPII components. Gap1, for 
example, is enriched threefold in COPII vesicles compared to membrane 
phospholipids (Watanabe et al., 2008).  
 
The ER exit signal of Gap1 was elucidated in a study by Malkus et al. (2002). The 
authors identified a short di-acidic sequence (-DxD-; residues 564-566) within the 
C-terminal cytosolic domain of Gap1 essential for the concentrative sorting of the 
permease. Interestingly, this region was shown to be highly conserved among yeast 
amino acid permeases (Figure 1.7).  
 
 
 
Figure 1.7: The C-terminal domain of Gap1. 
A ClustalW alignment of Gap1 and 13 other S. cerevisiae amino acid permeases. 
Residues shaded black are identical in more than 80% of the aligned sequences 
and residues shaded grey are similar in more than 80% of the aligned sequences.  
 
Mutations within this region severely reduced packing of the mutant Gap1 into COPII 
vesicles without affecting its folding, as demonstrated by the mutant protein’s 
stability and functionality; aspartic acid564 and isoleucine565 are apparently the most 
sensitive to amino acid substitutions. 
 
Moreover, the authors demonstrated the universality of the Gap1 ER export signal. In 
an experimental approach similar to an earlier study (Ma et al., 2001), Malkus and 
co-workers constructed an arginine permease Can1 chimeric protein in which its 
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native C-terminal localized export signal is replaced with that of Gap1. Strikingly, the 
chimeric Can1 was concentrated in COPII vesicles more efficiently than the 
wild-type. This suggests that Can1 make use of an additional export signal(s) located 
outside the C-terminal domain that may have an accumulative affect with the Gap1 
exit signal. 
 
COPII assembly on the ER membrane starts with activation of the small GTPase Sar1 
by its ER-restricted GEF Sec12. Activated Sar1-GTP binds to the ER membrane by 
inserting an N-terminal α-helix into the lipid bilayer. Once anchored to the membrane, 
Sar1-GTP recruits the cytosolic Sec23/24 heterodimer. The Sec23 subunit functions 
as the GTPase activating protein (GAP) for Sar1 whereas Sec24 is responsible for the 
majority of cargo binding. Together with cargo, the Sec23/24-Sar1 complex forms the 
inner shell of the vesicle, also known as the prebudding complex (Bi et al., 2002; Fath 
et al., 2007; Kirchausen, 2007). Finally, the prebudding complex recruits the 
Sec13/31 complex that acts as a scaffold for the outer layer of the COPII vesicle 
(Figure 1.8).  
 
A screen for secretory pathway mutants in yeast identified two additional proteins 
involved in COPII assembly, Sec16 and Sed4. Sec16 is a large hydrophobic protein 
that physically interacts with all of the COPII components, except Sec13. Deletion of 
SEC16 blocks ER to Golgi transport and is lethal in sec13Δ or sec23Δ cells; an 
indication that Sec16 probably serves as a scaffold onto which the coat subunits 
assemble. A similar function was assigned to Sed4 (Sato and Nakano, 2007). Isolated 
as a multi-copy suppressor of sec16Δ mutations, SED4 was shown to encode an 
important, but not essential, factor of the coat assembling machinery. Cells lacking 
Sed4 display a reduced rate in ER-Golgi transport and results in an exacerbated 
phenotype in combination with deletions in SEC16, SEC12, SEC13, SEC23 and 
SAR1. 
 
Accumulating evidence indicates that all amino acid permeases, including Gap1, 
depend on the membrane protein Shr3 to exit the ER. In shr3Δ mutants, amino acid 
permeases accumulate as large molecular weight complexes within the ER, and as a 
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consequence fail to enter COPII vesicles (Gilstring et al., 1999; Kota and Ljungdahl, 
2005).  
 
 
 
Figure 1.8: COPII vesicle formation and uptake of cargo protein. 
COPII assembly on the ER membrane starts with activation of the GTPase Sar1 
by its ER-bound guanine nucleotide exchange factor Sec12. Sar1-GTP binds to 
the ER and recruits the Sec23/24 complex. Together with cargo, the 
Sec23/24-Sar1 complex forms the “prebudding complex”. These prebudding 
complexes are clustered by the Sec13/31 complexes, giving rise to COPII-coated 
vesicles.  
 
These cells typically exhibit poor growth on amino acids due to the low levels of 
functional amino acid permeases present at the plasma membrane. The molecular 
mechanism underlying Shr3-dependent regulation of amino acid permease traffic was 
only recently determined (Kota et al., 2007). Using ‘split’ Gap1 constructs, it was 
demonstrated that Shr3 physically binds to the charged amino acid residues within the 
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transmembrane domains of the unfolded protein. It is believed that these charged, or 
polar, residues are the trigger for targeting misfolded proteins for ERAD. Therefore, 
by covering up the charged residues in the transmembrane domains, Shr3 prevents 
incompletely folded Gap1 from being degraded prematurely, i.e. the protein is 
allowed sufficient time for proper folding. Not surprising then, that deletions within 
the ERAD pathway partially restore amino acid uptake in shr3Δ cells. Protein folding 
and degradation are thus tightly connected processes.  
 
In a related study, Kota et al. (2007) identified additional factors that regulate the 
passage of amino acid permeases through the secretory pathway. Exploiting the shr3Δ 
mutant’s inability to import amino acids, the authors isolated three high-copy 
suppressors of the phenotype, SSH4, RCR2 and RCR1. When overexpressed, SSH4, 
RCR2 and RCR1 restores amino acid uptake to near wild-type levels in shr3Δ, ssy1Δ 
and stp1Δ stp2Δ mutant strains. Analogously, overexpression of SSH4, RCR2 and 
RCR1 in wild-type strains resulted in a threefold increase in plasma membrane-bound 
Gap1. In contrast to the ER-restricted Shr3, the suppressor proteins have been 
localized to the endosome-vacuole pathway, from where they determine the plasma 
membrane protein’s fate only after it has left the ER.  
 
1.4.3. Delivery of vesicles: Tethering and Fusion 
 
The journey of the COPII vesicle ensues with its pinching-off from the ER and 
delivery to the next compartment in the secretory pathway. Two independent 
processes ensure proper targeting of the vesicle to, and fusion with, the acceptor 
compartment: tethering and SNARE (soluble N-ethylmaleimide-sensitive factor 
attachment protein receptor) assembly.  
 
Vesicle tethering marks the first interaction between a transport vesicle and its 
acceptor compartment (Lee et al., 2004). Tethers are either long coiled-coil proteins, 
e.g. Uso1, or large multi-subunit complexes, like the transport protein particle I 
(TRAPPI) complex. In yeast, TRAPPI is thought to serve as the recognizable feature 
on the Golgi that attracts the COPII vesicles. More importantly, TRAPPI also 
Literature overview 
 
 42 
functions as a GEF for the small Rab GTPase Ypt1, facilitating its conversion from 
the inactive GDP-bound form to the active GTP-bound state. 
 
In a series of groundbreaking studies, the mechanistic detail of the process was 
recently resolved. It was shown that tethering depends on the direct interaction 
between the TRAPPI subunit Bet3 and its binding partner Sec23, a component of the 
COPII inner coat complex (Cai et al., 2007; Fromme et al., 2008; Spang, 2009). This 
initial binding activates Ypt1 to recruit Uso1, whose binding stabilizes the vesicle on 
the Golgi membrane and also promotes the formation of SNAREs on the membrane. 
These findings refute the long-held believe that tethering only occurs after the vesicle 
uncoats; instead it reveals an additional role for COPII coats in determining its own 
binding to the target membranes.  
 
The final phase of vesicular transport involves fusion of the vesicle with the acceptor 
compartment. This process is mediated by a highly conserved family of 
membrane-associated proteins called SNAREs. Generally, this family is classified in 
two categories: the v-SNAREs that reside on vesicles and t-SNAREs that are found 
on target membranes. Both v-SNAREs and t-SNAREs self-assemble into extremely 
stable four helix-bundles; three α helixes contributed by the t-SNAREs and the fourth 
by the v-SNARE (Volchuk et al., 2004; Weinberger et al., 2005). Crucially, the three 
t-SNARE helixes are always composed of one member of the syntaxin heavy chain 
family and two non-syntaxin light chains.  
 
In yeast, the cis-Golgi-localized syntaxin Sed5 plays an essential role in ER-Golgi and 
intra-Golgi transport. It forms functional SNARE complexes with Bet1, Sec22, Ykt6, 
Bos1, Sft1 and Gos1. This apparent promiscuity in binding partners has been difficult 
to reconcile with the ordered fashion in which vesicle fusion proceeds. However, 
Parlati et al. (2002) have shown that there are actually two distinct SNARE 
complexes operating in tandem in the Golgi; one, consisting of Sed5 as the heavy 
chain, Bos1 and Sec22 as the light chains and Bet1 as the v-SNARE, is required for 
entry into the Golgi, whereas Sed5, in combination with Gos1 and Ykt6 as the two 
light chains and Sft1 as the v-SNARE, is required for transport within the Golgi.  
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Gos1 is an atypical v-SNARE in that it participates in more than one transport step. In 
addition to its role in intra-Golgi transport, Gos1 is also proposed to direct vesicular 
transport from the ER to the Golgi (McNew et al., 1997). Accordingly, disruption of 
GOS1 causes clear secretory defects. The ER-restricted chaperone, Kar2 (see section 
1.4.1.), is secreted five-fold more in gos1Δ cells compared to wild-type cells, 
suggesting that gos1Δ cells display an ER-retention defective (erd) phenotype. The 
proteolytic processing of carboxypeptidase Y (CPY) also notably decreased such that 
both the p1CPY and p2CPY precursors accumulated in gos1Δ mutants (McNew et al., 
1998).  
 
1.4.4. trans-Golgi network: Finding yourself at the cross-roads 
 
The trans-Golgi network (TGN) has a central role in protein sorting. The transport of 
newly synthesized proteins along the ER and Golgi stack occurs with basically no 
diversion to alternative routes. However, once proteins reach the TGN they face 
numerous possible subcellular destinations, including the plasma membrane, 
secretory vesicles or endosomes. The TGN sorts proteins to each of these destinations 
by segregating them from Golgi complex-resident proteins, before being packaged 
into specific membrane-coated vesicles. The role of the TGN as a sorting station is 
not limited to forward-transport; it also receives protein for recycling from the late 
endosome (Seaman, 2008).  
 
Movement of Gap1 through the late secretory pathway is for the greater part regulated 
by the quality of the available nitrogen source. As mentioned before, in cells grown 
on proline or urea, i.e. poor nitrogen sources, Gap1 is directly sorted to the plasma 
membrane where it is active for amino acid uptake. In de-repressing growth 
conditions, however, newly synthesized Gap1 is sorted from the TGN to the vacuole 
without ever being delivered to the cell surface (Soetens et al., 2001; Horák, 2003). 
Ubiquitination is essential to this nitrogen source-dependent downregulation of Gap1.  
 
The mechanism of ubiquitination involves the attachment of a highly conserved, 76 
amino acid protein, ubiquitin, to specific lysine residues of the target protein. 
Ubiquitin itself contains seven lysines that can be used for the attachment of another 
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ubiquitin moiety. Hence, substrate proteins can either be monoubiquitinated (one 
ubiquitin molecule on a single lysine), multiubiquitinated (several lysines modified 
with just one ubiquitin molecule) or polyubiquitinated (several ubiquitin molecules in 
a chain on a single lysine residue) (Staub and Rotin, 2006). 
 
Previous work has shown that Gap1 is ubiquitinated on two N-terminal lysine 
residues, lysine9 and lysine16. Mutational analysis of the events leading to the loss of 
both plasma membrane-bound Gap1 and newly synthesized, TGN-localized Gap1 
revealed that both groups share the same elements: (i) Gap1 must be ubiquitinated on 
at least one of the two lysines, (ii) ubiquitination requires the essential E3 ubiquitin 
ligase Rsp5 and at least one of the two redundant ubiquitin ligase adapters, Bul1 and 
Bul2, and finally, (iii) a functional, full-length C-terminal tail of Gap1. There are, 
however, two schools of thought on the exact role of ubiquitination in the regulation 
of Gap1 trafficking.  
 
Helliwell et al. (2001) have reported that sorting of Gap1 at the TGN can be regulated 
by polyubiquitination. Therefore, overexpression of either BUL1 or BUL2 results in 
the polyubiquitination of Gap1 and sorting of it to the vacuole, irrespective of the 
nitrogen source. Conversely, in the bul1Δ bul2Δ double mutant, polyubiquitination of 
Gap1 is abolished and Gap1, in its monoubiquitinated form, reaches the plasma 
membrane more efficiently than in wild-type cells. Moreover, an rsp5-1 allele lacking 
Rsp5 catalytic activity, displays the same sorting defect for Gap1 as observed in 
bul1Δ bul2Δ cells. These observations suggest that polyubiquitination is the main 
determinant for Gap1 sorting from the TGN to the vacuole. In contrast, Soetens et al. 
(2001) observed no increase in the monoubiquitinated form of Gap1 in bul1Δ bul2Δ 
cells, neither in the polyubiquitinated form of Gap1 in response to the overexpression 
of the BUL genes. Instead, polyubiquitination of the transporter was only detected in 
proline-grown cells supplemented with ammonium. In addition, the authors failed to 
demonstrate an essential role of polyubiquitin in sorting of Gap1 to the vacuole. 
These experiments were, however, performed in cells lacking Doa4, the 
deubiquitinating enzyme, which could perhaps explain the requirement of 
polyubiquitination of Gap1 for TGN - vacuole sorting in DOA4 cells.  
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Mutations that influence Gap1 sorting can be divided into two general classes: 
mutations that cause constitutive sorting of Gap1 to the vacuole, or mutations that 
constitutively sort Gap1 to the plasma membrane. The first group includes mutations 
in SEC13, one of the components constituting the outer coat of the COPII vesicle, as 
well as LST4, LST7 and LST8; the latter being isolated on the basis of their synthetic 
lethality with sec13-1 (Roberg et al., 1997; Magasanik and Kaiser, 2002). Genetic 
analysis of sec13-1 mutants reveals no apparent defect in ER-Golgi transport, 
indicating that Sec13’s proposed function at the TGN is independent of its role in 
ER-Golgi traffic. Lst8, a subunit of TORC1, negatively regulates the GATA 
transcription factor Gln3, limiting the synthesis of α-ketoglutarate, glutamate and 
glutamine in the cell. Mutations inactivating LST8 therefore results in an increase in 
intracellular levels of glutamate and glutamine, which acts as a signal for Gap1 
sorting to the vacuole (Chen and Kaiser, 2003). The functions of Lst4 and Lst7 
remain to be determined.  
 
The second group of mutations is mainly found in the genes involved in 
ubiquitination of Gap1, namely Rsp5, Bul1, Bul2, and Doa4. As polyubiquitination of 
Gap1 is required for its sorting to the vacuole, mutations that interfere with this 
process cause high Gap1 activity and increased missorting of Gap1 to the plasma 
membrane. Importantly, combining a mutation that inhibits ubiquitination and causes 
constitutive sorting of the transporter to the plasma membrane, with a mutation that 
causes constitutive sorting to the vacuole, results in a double mutant in which Gap1 is 
constitutively sorted to the cell surface, i.e. in rsp5-1 lst4Δ cells Gap1 is constitutively 
targeted to the plasma membrane (Helliwell et al., 2001). This implies that 
ubiquitination of Gap1 occurs before its sorting to the vacuole.  
 
The degradation of plasma membrane proteins in the vacuolar/lysosomal lumen 
requires its prior sorting into the multivesicular endosome (MVE) pathway. MVEs 
originate from early endosomes, as the protein-laden endosomal membrane buds off 
into the endosome to form an internal vesicle. Proteins are eventually delivered to the 
vacuole/lysosome when the MVE fuses with it (Bowers and Stevens, 2005; Nikko and 
André, 2007a; Nikko and André, 2007b). Formation of the MVE requires the 
sequential participation of three different protein complexes: ESCRT-I is required for 
the recognition of ubiquitinated proteins targeted to the pathway and ESCRT-II and 
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ESCRT-III assist in the sorting of proteins into the MVE vesicles. ESCRT-III also 
recruits Doa4 to deubiquitinate proteins before they are sorted to the vesicles, thus 
replenishing the intracellular pools of ubiquitin. ESCRTs are encoded by the class E 
VPS genes.  
 
The endosome is, however, more than just a pit stop for plasma membrane proteins on 
the road to degradation. A study by Rubio-Texeira and Kaiser (2006) highlighted the 
importance of the bi-directional traffic between the endosome and the TGN. In a 
genome-wide screen designed to isolate novel genes involved in the intracellular 
sorting of Gap1, the authors reported that mutations in all of the class E VPS genes 
resulted in the missorting of Gap1 to the plasma membrane, possibly via the TGN. 
Thus, in conditions where the formation of inwardly budding MVE vesicles is 
compromised, e.g. dysfunctional ESCRTs, Gap1 is recycled to the plasma membrane. 
More importantly, the authors demonstrated that this recycling step is inhibited by 
high levels of internal amino acids or deletion of LST4. The vacuolar sorting of Gap1 
also occurs independently of the ubiquitin-binding GGA (Golgi-associated, γ-adaptin 
homologues, ARF-binding) proteins, as an lst4Δ gga1Δ gga2Δ triple mutant still 
exhibits constitutive sorting of the permease to the vacuole (Babst, 2004). The 
recycling of Gap1 between the endosome and plasma membrane allows for a quick 
and effective response to changes in the cell’s nutritional environment.  
 
The same group also elucidated the mechanism by which the recycling of Gap1 
between the two organelles is achieved (Gao and Kaiser, 2006). In a screen for 
mutants that display constitutively low Gap1 activity, a conserved multi-protein 
complex was identified. It consists of five different proteins, Gse1, Gse2, Ltv1, Gtr1 
and Gtr2, and was dubbed the GSE/EGO complex. Two of the components, Gtr1 and 
Gtr2, are small GTPases, and control the formation of the complex according to their 
nucleotide-bound state. Gtr2, only active in the GDP-bound state, directly interacts 
with a di-aromatic sequence KPRWYR in the C-terminal tail of Gap1; a prerequisite 
for its sorting from the endosome to the plasma membrane (Seaman, 2006).  
 
In addition to regulating transcription and intracellular sorting of Gap1, nitrogen 
source quality and quantity have been implicated in a third mechanism of regulation: 
the activity-dependent inactivation of plasma membrane-localized Gap1. In utilizing 
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the Gap1K9R,K16R mutant’s inability to be ubiquitinated, it was shown that the 
permease loses its transport activity upon the addition of amino acids while remaining 
localized in the plasma membrane. Moreover, this inactivation of Gap1 seems to be 
reversible, because the removal of exogenously-added amino acids restores transport 
activity in the Gap1K9R,K16R mutant (Risinger et al., 2006). Gap1 inactivation at the 
plasma membrane also requires active transport of the amino acids by the protein, 
indicating that the amino acid-induced inactivation of Gap1 probably involves a 
reversible conformational change that occurs during the transport cycle. The 
advantage of an additional layer of control lies in the nutritional efficiency it affords 
the cell. When internal amino acid levels are low, GAP1 expression and trafficking to 
the plasma membrane is upregulated. As internal amino acid stores are replenished, 
transport of amino acids by Gap1 causes both its inactivation at the plasma membrane 
and sorting of the newly synthesized form of the transporter to the vacuole. In the 
meantime, the cell continues making use of the nitrogen-rich conditions by inducing 
the expression of specialized, Ssy1-regulated amino acid permeases, i.e. general 
amino acid transport by Gap1 satisfies the cell’s immediate need for nitrogen after 
which it is replaced by a more controlled transport of the available nitrogen source.  
 
1.4.5. Endocytosis and degradation 
 
The loss of Gap1 activity at the plasma membrane is the result of its endocytosis and 
subsequent targeting to and degradation in the vacuole. Although is has been 
ascertained that direct sorting of Gap1 at the TGN is independent from its endocytosis 
at the plasma membrane, it is unclear what role ubiquitin-mediated endocytosis plays 
in targeting Gap1 to the vacuole. With all the available mutants affecting both sorting 
steps, it was assumed that the same cis- and trans-acting ubiquitin elements 
participate in both sorting steps of Gap1. However, a recent study has revealed 
interesting differences in the ubiquitination events occurring at the two cellular 
locations (Risinger and Kaiser, 2008) (Figure 1.9). It was demonstrated that direct 
sorting from the TGN to the MVE requires the Rsp5-Bul1-Bul2-dependent 
polyubiquitination of Gap1 on either lysine9 or lysine16; the level of 
polyubiquitination is not influenced by a single mutation of either lysine residue.  
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Figure 1.9: Proposed model for the sorting of Gap1 at the trans-Golgi network.  
 Neosynthesized Gap1 reaching the TGN has two possible fates: sorting to the 
plasma membrane where it is active for amino acid transport, or to the vacuole 
for eventual degradation. Its fate is decided by the nutritional situation both 
intracellularly and intracellularly (see text for details). 
 
In addition to the N-terminal lysines, the extreme C-terminus of Gap1 also aids in the 
identification of the transporter by the ubiquitin ligase complex, as confirmed by a 
point mutation in the C-terminal domain, Gap1E583D, that abolishes both the 
polyubiquitination of Gap1, and as a result, the direct targeting of newly synthesized 
Gap1 to the MVE. 
 
Chapter I 
 
 49 
Endocytosis, on the other hand, occurs through either the Rsp5-Bul1-Bul2-dependent 
monoubiquitination of lysine9 or lysine16, or by the Rsp5-dependent, 
Bul1-Bul2-independent monoubiquitination of specifically lysine16. These findings 
indicate a formerly unrecognized level of specificity in the ubiquitin-mediated 
trafficking of Gap1. Elaborating on their work, Lauwers et al. (2009) demonstrated 
the necessity of lysine63-inked polyubiquitination of Gap1 as a specific signal for its 
sorting into the MVE pathway. Once internalized by the monoubiquitination of either 
lysine9 or lysine16, Gap1 must undergo lysine63-linked polyubiquitination on at least 
one of the acceptor lysines. Failure to do so, e.g. in an ubiquitinK63R mutant, causes 
the recycling of internalized Gap1 to the plasma membrane via the TGN, with a small 
amount of the permease accumulating at the vacuole. The mechanism by which 
lysine63-linked ubiquitination of Gap1 bolsters its MVE sorting remains poorly 
understood. It has been proposed that the GGA proteins may recognize the 
lysine63-inked chains, since deletion of the ubiquitin-binding GAT domain of GGA 
proteins display a similar phenotype as ubiquitinK63R cells, i.e. recycling of Gap1 to 
the plasma membrane.  
 
The role of the C-terminus of Gap1 in determining its ubiquitin-mediated 
internalization and downregulation is well-established. Previous work has identified a 
di-leucine motif (residues 575-576) and a glutamate (residue 582) critical to the 
ammonium-induced inactivation of Gap1 in proline-grown cells. Replacing the 
di-leucine with di-alanine, or substituting the glutamate for a lysine, results in a 
mutant Gap1 allele fairly resistant to ammonium-induced degradation. The two motifs 
are located in a region predicted to form an α -helix (residues 571-588) (Hein and 
André, 1997; Springael and André, 1998). Deleting the 11 amino acid tail following 
the α -helix causes the same resistance to ammonium-induced downregulation as 
observed in the di-alanine and lysine582 mutants. Other then containing a high 
proportion of aromatic amino acids and ending in a highly conserved tripeptide, the 
11 amino acid tail lacks any distinct features. The exact role of the C-terminus in 
Gap1 trafficking requires further study. The assembly of the N- and C-termini of 
Gap1 into a signaling complex that is recognized by the Rsp5-Bul1-Bul2 ubiquitin 
ligase complex, as predicted by Risinger and Kaiser (2008), seems very likely (for an 
overview of the known interactions and functions of the C-terminal portion of Gap1 
in determining its fate, see Table 1.1).  
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Table 1.1: Role and function of specific residues within the C-terminal portion of Gap1.  
 
C-terminal position: Required for: Interacting partner(s): 
Residues 564-566 
(DxD) 
ER exit and concentrative sorting 
into COPII vesicles Sec23-Sec24-Sar1 
Residue 583 Polyubiquitination of Gap1 on the N-terminal lysines Rsp5-Bul1-Bul2 
Residues 590-595 
(KPRWYR) 
Sorting of Gap1 from the endosome 
to the plasma membrane Gtr2 
Residues 575-576, 
582, 589-599 NH4
+-induced inactivation of Gap1 Rsp5-Bul1-Bul2 
 
The serine/threonine kinase Npr1 is another key determinant in the nitrogen-regulated 
sorting of Gap1. The main function of Npr1 involves the stabilization of Gap1 at the 
plasma membrane. Thus, loss of Npr1 activity triggers both the rapid internalization 
of membrane-bound Gap1 and targeting of newly synthesized Gap1 from the TGN to 
the vacuole; phenotypes reminiscent of those observed in nitrogen-starved cells 
supplemented with a good nitrogen source. Intriguingly, the C-terminal mutations 
described above restore wild-type Gap1 activity to npr1Δ cells. The reduced levels of 
Gap1 phosphorylation detected in proline-grown, npr1Δ cells led to the notion that 
Gap1 stability at the plasma membrane is acquired through the Npr1-dependent 
phosphorylation of the permease (De Craene et al., 2001).  
 
However, the high levels of phosphorylation seen in npr1Δ rsp5-1 mutants suggest 
that the target of Npr1 may not be Gap1 itself. Instead, it seems more probable that 
the high levels of Gap1 phosphorylation in wild-type cells is due to the transporter 
localizing to the plasma membrane. Npr1’s own phosphorylation status, and therefore 
activity, is regulated by TORC1 in response to the nutritional conditions: it is 
phosphorylated in ammonia-grown cells and dephosphorylated in rapamycin-treated 
or nitrogen-starved cells (Tate et al., 2006b). 
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1.4.6. Role of sphingolipids in Gap1 trafficking  
 
Newly synthesized Gap1 attains detergent insolubility at the TGN, and as a 
consequence, is associated with detergent-resistant membranes (DRMs) when present 
at the cell surface. DRMs are usually enriched in sphingolipids and to some extent, in 
ergosterols, the structural component of the yeast plasma membrane (Lauwers and 
André, 2006; Pineau et al., 2008). Gap1 synthesized in the absence of de novo 
sphingolipid biosynthesis displays various anomalies. In addition to being 
immediately downregulated at the plasma membrane, the permease synthesized under 
these conditions is also completely inactive and exhibits both an increased sensitivity 
to proteolytic breakdown and an inability to fractionate with DRMs. These 
observations are consistent with a model where sphingolipids associate with newly 
synthesized Gap1 to assist the folding of the protein into a functionally active 
conformation. Furthermore, the rapid downregulation of Gap1 observed in the 
absence of sphingolipid synthesis involves the uncontrolled ubiquitination of the 
protein on lysines other than the typical lysine9 and lysine16. Lauwers et al. (2007) 
reported the Rsp5-mediated ubiquitination of N-terminal lysines at positions 76, 87 
and 91. Under wild-type conditions, i.e. conditions where Gap1 is correctly folded, 
these lysines are close to the plasma membrane and are as such protected from 
ubiquitination. This result suggests that sphingolipids, in addition to their chaperone 
activity, may also regulate the ubiquitination of Gap1.  
 
 
1.5. PROTEIN PHOSPHATASES IN NUTRIENT-INDUCED 
SIGNALING 
 
Protein phosphorylation and dephosphorylation are essential regulatory mechanisms 
in multiple, if not all, cellular processes. The importance of the phosphorylation 
networks in eukaryotic biology is emphasized by the estimated one-third of proteins 
that are reversibly phosphorylated. The phosphorylation status, and potentially, the 
activity, of any given protein is determined by both the enzymes performing the 
phosphorylation reaction, serine/threonine kinases, and the enzymes performing the 
dephosphorylation reaction, the serine/threonine phosphatases. The S. cerevisiae 
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genome is reported to contain 139 protein kinases and, in contrast, only 32 protein 
phosphatases, implying that protein phosphatases are generally promiscuous in their 
activity. However, these phosphatases are required multi-subunit enzymes, 
constructed from a limited number of catalytic subunits (C subunits) associating with 
literally hundreds of regulatory subunits (Garcia et al., 2003; Gallego and Virshup, 
2005). As a consequence, the C subunits of the main protein phosphatases are 
synthesized in excess; the C subunit of protein phosphatase 2A (PP2A), for example, 
constitutes nearly 1% of total cellular protein (Fellner et al., 2003a). It is this 
versatility of the combinatorial subunit arrangement that lends specificity and 
accuracy to the activity of protein phosphatases.  
 
Based on sequence similarities and crystal structures, the protein phosphatases can be 
divided into the PPP family, PPM family and PTP family (Table 1.2). The 
serine/threonine PPP family includes the protein phosphatase 1 (PP1), PP2A and 
PP2B (also known as calcineurin). The PPM family consists of Mg2+-dependent 
phosphatases such as PP2C and pyruvate dehydrogenase phosphatase, whereas the 
PTP family comprises both phosphotyrosine-specific and dual-specific phosphatases, 
like Cdc14, that can dephosphorylate all three phosphoresidues (Yigong, 2009).  
 
Table 1.2: Protein phosphatases from S. cerevisiae (adapted from Stark, 1996).  
 
Class Specificity Function/Gene 
PPP family serine/threonine PP1: Glc7 
  PP2A: Pph21, Pph22 
  PP2B: Cna1 (Cmp1), Cna2 (Cmp2) 
  PP2A-like: Ppg1, Sit4, Pph3 
PPM family serine/threonine Ptc1, Ptc2, Ptc3, Ptc4, Ptc5, Ptc7, ycr079w 
PTP family 
serine/threonine 
tyrosine 
Cdc14, Ptp1, Ptp2, Ltp1, Msg5, Yvh1, Sdp1 
 
PP2A and PP1 are the two most thoroughly studied protein phosphatases, and account 
for more than 80% of the total cellular serine/threonine phosphatase activity. 
Deregulation of these two phosphatases has been linked to several crippling 
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conditions such as cancer and Alzheimer’s disease. Furthermore, several viruses, e.g. 
SV40 tumor virus and polyomavirus, employ PP2A to deregulate the metabolic 
pathways in the host, highlighting the importance of phosphatases in general signal 
transduction (Janssens et al., 2005; Xing et al., 2008).  
 
1.5.1. PP2A: structure and function 
 
The yeast PP2A, like its equivalent in higher eukaryotes, is a multimeric protein 
complex consisting of three different subunits, namely the A, B and C subunit. The 
structural A subunit serves as a scaffold to receive the other two subunits. The C 
subunit, in association with the A subunits, forms the heterodimeric core enzyme. The 
B subunit is the regulatory subunit that confers substrate specificity and subcellular 
localization to the A-C core enzyme (Figure 1.10). In S. cerevisiae, the C subunit is 
encoded by two related genes, PPH21 and PPH22. Deletion of either gene has no 
observable effect on cell growth; deletion of both genes, however, eliminates 90% of 
total PP2A activity and results in mutant cells displaying a severely impaired 
growth- and temperature-sensitive phenotype, as well as cell wall and polarity defects 
(Stark, 1996; Janssens and Goris, 2001; Zabrocki et al., 2002a). The remaining 
phosphatase activity in pph21Δ pph22Δ cells is thought to originate from the 
PP2A-related PPH3 gene product. Deletion of PPH3 does not affect growth but is 
lethal in a pph21Δ pph22Δ background. Curiously, there is no evidence of Pph3 in 
association with either A or B subunit. Moreover, the Pph3 phosphatase exhibits 
enzymatic activities and subunit composition very different to that of the classic 
PP2A phosphatase. 
 
A distinguishing feature of the S. cerevisiae C subunit is the presence of an acidic 
stretch of 70 amino acids in the N-terminal regions of both Pph21 and Pph22. The 
relevance of the N-terminal extensions remains to be determined, but a report by 
Zabrocki et al. (2002a) offered a possible role for these regions in regulating the C 
subunit’s catalytic activity. Removal of the N-terminus results in a mutant Pph22 
protein responding notably different than the wild-type to protamine, polylysine and 
various reducing agents. The N-terminus of Pph22 also influences the enzyme’s 
binding of specific phospholipids and membranes. Intriguingly, the N-termini of 
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Pph21 and Pph22 show only 45% amino acid sequence identity, compared to the 87% 
overall identity of the two enzymes (Zabrocki et al., 2002b). This suggests that the 
N-terminal regions of Pph21 and Pph22 may have unique functions.  
 
In line with a role in signal transduction, overexpression of PPH22 was shown to 
trigger the induction of the cAMP-PKA pathway, even in the absence of nutrients. 
Modest overexpression of PPH22 affected all the PKA targets investigated, with 
PPH22-overexpression cells demonstrating a constitutive repression of 
STRE-regulated genes, heat sensitivity, low trehalose levels and high trehalase 
activity. A similar high PKA phenotype is observed in sch9Δ cells, and since the 
PPH22-overexpression results are dependent on the presence of a functional Sch9, it 
was proposed that Sch9 represents a novel Pph22 substrate (Sugajska et al., 2001).  
 
The A subunit in yeast is encoded by a single gene, TPD3. Like its mammalian 
homologue, Tpd3 mainly consists of 15 tandem repeats of a 39 amino acid sequence, 
termed a HEAT (Huntington/Elongation/A subunit/TOR) domain (Janssens and 
Goris, 2001). Deletion of TPD3 is not lethal, but confers both temperature sensitive 
and cold sensitive phenotypes.  
 
The B subunits of S. cerevisiae PP2A are encoded by two distinct genes, CDC55 and 
RTS1. Inactivation of CDC55 results in highly elongated, multiply budded and 
multinucleated cells, indicative of delayed cytokinesis. Deletion of CDC55 also 
allows sister chromatid segregation in the absence of a fully constructed spindle, 
which normally blocks G2/M cell cycle progression by activating the spindle 
checkpoint. The spindle assembly checkpoint ensures the accuracy of mitosis by 
hindering the onset of anaphase until the spindle has been completely assembled and 
each pair of sister chromatids are attached to it (Jiang, 2006; Pal et al., 2008). The 
morphological and cytokinetic defects of cdc55Δ mutants are largely suppressed by 
the expression of a mutant form of the S. cerevisiae cyclin-dependent kinase, 
Cdc28Y19F. Rts1 was isolated in two independent genetic screens: as a multicopy 
suppressor of the hsp60ts mutant allele, and later as a Rox three suppressor. Disruption 
of RTS1 diminishes the mRNA levels of the Hsp60 chaperone, thus impairing the 
deletion mutant’s overall stress response. Consequently, rts1Δ cells display severe 
Chapter I 
 
 55 
temperature and osmotic sensitivity. Similar to Cdc55, Rts1 is also required for the 
proper regulation of the cell cycle; the two B subunits are, however, not functionally 
interchangeable. In a screen aimed to identify downregulating components of the SPS 
amino acid-sensing pathway, Rts1 was isolated as a negative regulator of the pathway 
(Eckert-Boulet et al., 2006). Deletion of RTS1 results in the constitutive transcription 
of both Agp1 and Bap2. These results indicate that PP2A is involved in the 
SPS-dependent pathway and suggest that a dephosphorylation step is required to 
downregulate signaling in the absence of extracellular amino acids (see section 
1.3.3.).  
 
1.5.1.1. PP2A-like phosphatases 
 
Budding yeast also contains a group of phosphatases known as PP2A-like 
phosphatases, so called because they share more sequence similarity with PP2A than 
with PP1. Three different PP2A-like catalytic subunits have been identified in yeast: 
Ppg1, Sit4 and Pph3. The function of Ppg1 is unclear as inactivation of the protein 
causes a decrease in glycogen accumulation without affecting cell growth. Deletion of 
SIT4 diminishes cell growth and, depending on the strain background, is lethal. In 
ssd1-d strains such as W303, sit4Δ is lethal; in SSD1-v strains such as BY and S288c 
sit4Δ is viable, resulting in a slow-growth phenotype (Wang et al., 2003). Sit4 
normally exists in complex with the Sit4-associated proteins (Saps) Sap155, Sap185, 
Sap190, and possibly Sap4.  
 
1.5.1.2. Alternative PP2A complexes: Variety of forms and functions 
 
Most cellular PP2A corresponds to an A-C heterodimer core enzyme, able to complex 
with a variety of B subunits. A much smaller fraction of C subunit, not associated 
with the A subunit, instead exists as a complex with another yeast protein, Tap42 
(Figure 1.10). The first clue to the existence of an alternative PP2A structure came 
from higher eukaryotes. Alpha4, the mammalian homologue of Tap42, binds directly 
to the C subunit, at the exclusion of both the A and B subunits. Similar observations 
were later noted in yeast, where the deletion of TPD3 and CDC55 enhanced the 
association of Tap42 with Pph21 and Pph22. Since then, homologues of Tap42 in 
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various organisms have been found to associate with PP2A, indicating that the 
Tap42-PP2A complex is conserved during evolution. Contrary to the A subunit that 
binds only to the PP2A C subunits, Tap42 was shown to be also a binding partner of 
the PP2A-like phosphatases Sit4 and Pph3 (Di Como and Arndt, 1996; Yang et al., 
2007; Janssens et al., 2008). Nevertheless, the amount of C subunit that associates 
with Tap42 represents only about 10% of the total cellular phosphatase.  
 
 
 
Figure 1.10: Multiple forms of PP2A in yeast.  
The A subunit is the structural subunit that serves as a scaffold to accommodate 
the regulatory (B) and catalytic (C) subunits. In addition to the association with 
the A and B subunits, the C subunits can also complex with Tap42.  
 
Tap42 is an essential protein, probably due to its participation in the TOR signaling 
pathway. Inhibition of TORC1 by rapamycin, or nutrient deprivation, causes 
dissociation of Tap42 from the PP2A C subunit and subsequently inactivates the 
complex. Rapamycin, however, has no effect on the association of Tpd3 and Cdc55 
with Pph21. These findings have led to the notion that Tor elicits its function by 
inhibiting phosphatase activity via a Tap42-dependent mechanism, suggesting that 
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Tap42 functions as a phosphatase inhibitor by binding to, and restricting, phosphatase 
activity in response to signaling cues from Tor. Despite this, deletion of either SIT4 or 
the C subunits, the two Tap42-associating proteins, does not result in rapamycin 
resistance, and in the case of sit4Δ, it actually renders the cells more sensitive to the 
macrolide drug (Zheng and Jiang, 2005). Earlier work by Wang and Jiang (2003), 
however, clarified the seemingly contradictory data on the role of Tap42 in the 
regulation of phosphatase activity. The authors demonstrated that the Tap42-C 
subunit complex, rather than the PP2A heterodimer, is involved in the organization of 
the actin cytoskeleton during the cell cycle. These results were further substantiated 
by the observation that deletions of both PPH21 and PPH22 had no effect on 
cytoskeleton organization. Tap42’s essential role in this process was further 
underscored by the finding that rapamycin-resistant tap42-11-carrying cells exhibit an 
incorrectly polarized distribution of the actin cytoskeleton, a consequence of a 
modified binding between tap42-11 and the C subunit (see section 1.2.3.1.). 
 
Taken together, these findings suggest that Tap42 fulfills a function similar to that of 
the conventional regulatory subunits, i.e. by binding to the C subunit of the PP2A and 
PP2A-like phosphatases, Tap42 modifies their substrate specificity and cellular 
localization (Yang et al., 2007).  
 
1.5.1.3. Post-translational control of PP2A 
 
The essential role of PP2A in various cellular processes requires an exact and 
dynamic regulation of PP2A activity, localization, and substrate specificity. Although 
several factors, such as interacting proteins and reversible phosphorylation, have been 
linked to the regulation of PP2A activity, reversible methylation appears to be the 
main regulator of PP2A assembly. Comprehensive in vitro and in vivo studies have 
identified the target of methylation as a specific leucine, leucine369, present in a highly 
conserved C-terminal region within the catalytic subunits.  
 
In yeast, methylation of the PP2A C subunits is catalyzed by two enzymes, Ppm1 and 
Ppm2. Subsequent work showed that Ppm1 is the major methyltransferase acting on 
PP2A; methylated forms of Pph21 and Pph22 decreased from about 60% in wild-type 
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cells to less than 10% in ppm1Δ cells and to about 1% in ppm1Δ ppm2Δ mutants. 
PPM1 codes for a 37-kDa protein that displays an overall weak sequence similarity to 
other eukaryotic methyltransferases, other than the trademark S-adenosylmethionine 
domain. Removal of the methyl group is catalyzed by the PP2A-specific 
methylesterase, Ppe1 (Wei et al., 2001; Leulliot et al., 2004). Interestingly, 
overexpression of PPE1 yields phenotypes similar to those observed in ppm1Δ cells 
or cells lacking either B subunit. To date, no clear phenotype has been identified 
following deletion of PPE1 in yeast.  
 
Methylation of PP2A has been shown to affect the affinity of the A-C core enzyme 
for the various B subunits. The regulatory machinery, however, appears to be quite 
complex, as some regulatory subunits bind more efficiently to an A-C core when the 
C subunit has been methylated, while other regulatory subunits are not influenced by 
the C subunit methylation state.  
 
PP2A activity is also regulated by a set of evolutionary-conserved proteins known as 
Rrd1 and Rrd2 (Rrd1/2), the yeast homologs of the mammalian phosphotyrosyl 
phosphatase activator (PTPA) (Van Hoof et al., 2001; Van Hoof et al., 2005). 
Deletion of both RRD genes causes resistance to rapamycin and an increased 
sensitivity to spindle depolymerizing drugs. Both are phenotypes normally associated 
with strains lacking the B subunits of PP2A and, more importantly, are indicative of a 
functional relationship between PP2A and Rrd1/2. Detailed analysis of the 
rrd1Δ rrd2Δ double deletion mutants indeed revealed a previously unknown role for 
Rrd1/2 in the generation of catalytically active PP2A. Cells deficient for Rrd1/2 
typically produce C subunits with conformationally altered active sites, as 
substantiated by its severely reduced catalytic activity towards 
phosphoserine/phosphothreonine residues and its metal dependence. The lack of 
Rrd1/2, however, did not influence the assembly of the PP2A complex, as the mutant 
C subunit can still associate with the A en B subunits (Fellner et al., 2003a; Douville 
et al., 2006).  
 
Recent work by Hombauer et al. (2007) has uncovered a novel mechanism of PP2A 
assembly in which a highly-regulated series of events protect the cell from unspecific 
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dephosphorylation reactions. It was demonstrated that the A subunit, Tpd3, physically 
associates with Rrd2 and that this Tpd3-Rrd2 interaction is an essential prerequisite 
for optimal binding of the C subunit. The Tpd3-Rrd2 complex interacts exclusively 
with the demethylated, i.e. inactive, form of the C subunit, by specifically targeting 
the Pph21/Pph22-Ppe1 complex. By monitoring the Tpd3-Rrd2 association and 
ensuing targeting of the demethylated C subunit, Ppe1 prevents the premature 
methylation and concomitant activation of the C subunits in the absence of the 
scaffolding subunit.  
 
1.5.2. PP1 
 
S. cerevisiae is unique in that it has only one PP1 gene, GLC7, compared to the 
multiple forms found in all other eukaryotes. As in mammalian cells, Glc7 regulates 
numerous processes in yeast, including glucose and glycogen metabolism, 
sporulation, transcriptional responses and amino acid biosynthesis. The catalytic 
activity of Glc7 is controlled by its association with a broad range of regulatory 
subunits, some of which have been identified in a recent two-hybrid screen (Walsh et 
al., 2002). These include proteins like Reg1 and Reg2, Gac1, Pig1 (and possibly 
Pig2), and Sds22; all of which will be discussed in further detail. In an attempt to 
isolate additional interacting partners of Glc7, Logan et al. (2008) identified 245 
genes in a synthetic suppressor screen required for viability of yeast cells carrying a 
glc7 mutant. The majority of these genes are implicated in nutrient-sensing, stress 
response and mitochondrial activity, suggesting additional, previously unknown, 
functions for the catalytic subunit of PP1 (Virshup and Shenolikar, 2009).  
 
1.5.2.1. Regulation of Snf1 activity: Reg1 and Reg2 
 
The Snf1 protein kinase of S. cerevisiae is the founding member of a family of 
serine/threonine protein kinases that include the mammalian AMP-activated protein 
kinase (AMPK). Like its mammalian counterpart, yeast Snf1 is required for metabolic 
control and energy homeostasis. In glucose-grown cells, the Snf1 kinase complex 
exists primarily in an inactive conformation. When glucose is depleted, Snf1 is 
rapidly activated through the phosphorylation of a conserved threonine, threonine210, 
in the activation loop segment of the protein (Hong and Carlson, 2007). Three highly 
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similar and redundant upstream kinases, Sak1, Elm1, and Tos3 carry out the 
phosphorylation.  
 
The Reg1-Glc7 phosphatase complex counteracts Snf1’s activation by the upstream 
kinases. Reg1 interacts with activated Snf1 and directs Glc7 to the activation loop of 
the kinase, resulting in Snf1’s dephosphorylation and subsequent inactivation. Snf1, 
in turn, phosphorylates and restricts Reg1-Glc7 activity, thereby creating a positive 
feedback loop governing its own activity. Consistent with its role as a targeting 
protein, reg1Δ cells exhibit both a constitutive activation of Snf1 and a 
hyperphosphorylation of its activation loop (Orlova et al., 2008; Hedbacker and 
Carlson, 2009). Localization and expression of Reg1, as well as its association with 
Glc7, do not appear to be regulated by the carbon source, but the activity of the 
Reg1-Glc7 complex may be regulated by a posttranslational phosphorylation event; 
direct biochemical evidence of such a mechanism is, however, still lacking. 
 
Recent work by Rubenstein et al. (2008) has uncovered part of the mechanistic detail 
of the Snf1 dephosphorylation event. It was shown that both the upstream kinases and 
Glc7 are catalytically active, in spite of glucose availability. However, under 
conditions of glucose limitation, the phosphorylated activation loop of Snf1 is 
protected from Reg1-Glc7-dependent dephosphorylation by an as-yet unknown 
protein, allowing the accumulation of phosphorylated and active Snf1. The identity of 
the protein shielding threonine210 from dephosphorylation remains to be determined, 
but a likely candidate is Reg1. It is an important component of the Snf1 complex and 
requires direct interaction with the activation loop threonine, an interaction which is 
stronger in low glucose. Reg1 may therefore have a dual function in regulating Snf1 
activity: as a recruiter of Glc7 phosphatase activity during high glucose levels or 
safeguarding the Snf1 activation loop during glucose-depleted conditions.  
 
In line with its role in maintaining energy homeostasis, the Reg1-Glc7 complex also 
participates in the downregulation and degradation of certain gluconeogenic enzymes, 
like fructose-1,6-bisphosphate (FBPase), when they are no longer required. These 
enzymes are essential when cells are grown on non-fermentable carbon sources, but 
as cells are replenished with glucose, they necessitate rapid inactivation to prevent 
any unnecessary loss of energy (Cui et al., 2004; Gancedo, 2008). The Reg1-Glc7 
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complex ensures validity of the degradation process by promoting the import of 
FBPase into intermediate transport vesicles, before it is delivered to the vacuole for 
degradation. Hence, conditions that affect the binding of Glc7 to Reg1 also negatively 
affect FBPase degradation, e.g. reg1Δ mutants or cells carrying the glc7T152K point 
mutation that decreases the interaction between Glc7 and Reg1 display a severely 
impaired degradation of FBPase.  
 
REG2 encodes a homologue of Reg1 that, like Reg1, also associates with Glc7. While 
deletion of REG2 is without a clear phenotype, deletion of both REG1 and REG2 
results in a strong growth defect. This defect is suppressed either by the loss of Snf1 
or the overexpression of REG2, suggesting that Reg1 and Reg2 are also functionally 
related (Frederick and Tatchell, 1996; Jiang et al., 2000). Reg2 is, however, not 
involved in glucose repression, as concluded from a fully-functional, Snf1-dependent 
glucose repression pathway operating in reg2Δ cells. Instead, the Reg2-Glc7 
phosphatase complex is involved in stimulating the glucose-induced proteolytic 
breakdown of the maltose permease.  
 
1.5.2.2. Glycogen synthesis: Gac1, Pig 1 and Pig2 
 
In S. cerevisiae, as in higher eukaryotes, Glc7 is thought to dephosphorylate, and as a 
result, activate, glycogen synthase. Glc7 activity towards glycogen synthase is 
controlled by the regulatory subunit Gac1. Yeast cells deficient for Gac1 fail to 
accumulate glycogen and glycogen synthase in these strains remains in a 
hyperphoshorylated, inactive form. Similarly, cells harboring the glc7R73C mutation 
that is unable to bind Gac1, also fails to accumulate normal levels of glycogen 
(François and Parrou, 2001; Williams-Hart et al., 2002). The glycogen deficiencies of 
both mutant strains can, however, be alleviated by either mutating the three putative 
C-terminally-located phosphorylation sites of Gsy2, the main glycogen synthase in 
yeast, or by truncation of the C-terminal tail of the enzyme.  
 
GAC1 encodes an 88-kDa protein that shares 30% identity with its mammalian 
equivalent RGL. It contains two separate functional domains required for binding Glc7 
and Gsy2: an N-terminally-located valine71-X-phenylalanine73 motif (where X 
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denotes any amino acid), also known as the VXF motif, is crucial for Glc7 binding, 
whereas asparagine356 and tyrosine357 are the essential residues for Gsy2 binding. Two 
additional Gac1-related genes, PIG1 and PIG2, were identified in a two-hybrid screen 
with Gsy2 as bait. Disruption of PIG1 causes a minor reduction in glycogen levels; 
combining it with a gac1Δ mutation, however, results in a severe glycogen 
accumulation defect, even stronger than that of the gac1Δ single mutant (Cheng et al., 
1997; Wu et al., 2001). Together, these data suggest that Gac1 and Pig1 are 
functionally redundant glycogen targeting subunits for Glc7. The role of Pig2 in 
glycogen metabolism remains unknown. One intriguing characteristic of these three 
proteins is that they share a common 25 residue region, designated ‘GVNK’. The 
yeast genome encodes only four examples of the GVNK motif; the fourth being the 
product of YER054. The GVNK motif is also present in mammalian RGL and may 
regulate its interaction with either PP1 catalytic subunits or glycogen molecules.  
 
1.5.2.3. Cell division: Sds22 
 
Accurate chromosome segregation is at the core of mitosis – failure causes both 
genetic disorders and cancer in mammals. An essential innovation that makes 
chromosome segregation possible is the kinetochore, a protein-like structure on the 
chromosome that binds to spindle microtubules. Once both kinetochores of an 
individual chromosome have secured a proper microtubular attachment, anaphase is 
initiated. The identification of a mitotic requirement for Glc7 in yeast came from the 
observation that the temperature-sensitive glc7-12 mutant displays the so-called 
‘dumb-bell’ phenotype at the nonpermissive temperature – large-budded cells with 
the nucleus stretched across the bud neck (Hong et al., 2000; Peggie et al., 2002).  
 
In S. cerevisiae, the mitosis-specific functions of Glc7 are regulated by the nuclear 
targeting subunit Sds22. The essential gene SDS22 encodes a 40-kDa protein found 
mainly in the nucleus, despite lacking a NLS. Sds22 also lacks the VXF motif found 
in other Glc7 targeting subunits. Rather, interaction between Sds22 and Glc7 seems to 
be mediated by the 11 imperfect leucine-rich repeats present in Sds22’s central 
domain, and occurs at a site in Glc7 distinct from the one used to bind the VXF motif 
(Pedelini et al., 2007). Overexpression of SDS22 suppresses the ‘dumb-bell’ 
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phenotype of a glc7-12 mutant; extra copies of GLC7 can in turn suppress the deletion 
of SDS22. Sds22 also plays a role in ensuring the typical nuclear localization of Glc7, 
as evident from the accelerated loss of nuclear Glc7 in sds22 mutant cells (Stark, 
1996).  
 
A recent study by Pedelini et al. (2007) identified the first inhibitory subunit of Glc7 
in S. cerevisiae. The 155 amino acid, heat-stable protein was dubbed Ypi1, for yeast 
phosphatase inhibitor 1. Absence of YPI1 results in phenotypes similar to those 
observed in sds22Δ cells, i.e. mislocalization of nuclear Glc7 and a mitotic arrest of 
all mutant cells. This suggests that Sds22 and Ypi1 may be functionally related. In 
support of this notion, it was shown that overexpression of YPI1 increases the 
interaction between Sds22 and Glc7, while overexpression of SDS22 increases the 
interaction between Ypi1 and Glc7 (Bharucha et al., 2008). These effects may be due 
to the stabilization of the interaction between two components, which is brought about 
by the overexpression of the third component. Curiously, the combination of equal 
amounts of Ypi1 and Sds22 leads to a nearly complete inactivation of Glc7. 
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AIM OF THIS STUDY 
 
 
Adaptation to a constantly-changing nutritional environment is of critical importance 
to the survival of all organisms. The unicellular fungus S. cerevisiae has evolved 
numerous signaling pathways that ensure the optimal use of all available nutrients, 
thus maximizing the yeast cell’s potential for survival under the existing conditions. 
Depriving yeast cells of an essential nutrient, like nitrogen, phosphor or sulfur, causes 
growth arrest and entry into the G0 state of the cell cycle. The latter is characterized 
by an increase in levels of the storage carbohydrates trehalose and glycogen, and the 
transcriptional repression of ribosomal protein genes.  
 
The general amino acid permease Gap1 was recently shown to act as a nutrient 
receptor, signaling the availability of its substrate to the interior of the cell. The dual 
function of Gap1 as amino acid transporter/receptor, or transceptor, was supported by 
the isolation of constitutively signaling alleles. These Gap1 mutants contain short 
truncations of the extreme C-terminus of the protein, with their expression resulting in 
a high PKA phenotype that affected all the downstream targets investigated, even in 
the absence of any nitrogen source. The high PKA phenotype was shown to be 
independent of the carbon source in the growth medium, and is also observed in the 
presence of ammonium as sole nitrogen source.  
 
In Chapter II and Chapter III, we further characterized the underlying mechanism 
involved in the constitutive signaling of truncated Gap1 alleles. To determine the 
(possible) contribution of known nutrient signaling pathways to the overactive PKA 
phenotype observed in these mutants, we studied the effect that blocking of these 
pathways may have on PKA activity. We also evaluated different C-terminal 
truncations of Gap1 for their influence on the PKA phenotype. 
 
Chapter IV deals with the molecular underpinnings of the mechanism by which 
glucose addition to carbon-deprived cells cause rapid activation of the 
serine/threonine-specific protein phosphatases PP2A and PP1. We assessed the roles 
that the different regulatory, catalytic and structural subunits of the respective 
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phosphatase enzymes may play in the process. We also studied the effect glucose 
addition may have on methylation of the PP2A catalytic subunits.  
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SIGNALING ALLELES OF GAP1 
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2.1. ABSTRACT 
 
The cAMP-PKA pathway in budding yeast controls an array of characteristics that 
depend on the nutrient composition of the growth medium. Rapid activation of the 
pathway by amino acids is triggered by the general amino acid permease Gap1. 
Expression of short, C-terminal truncations of the transporter results in cells that 
display a constitutively high PKA phenotype, even when starved for nitrogen. We 
show here that this phenomenon is not caused by the overactivation of either Tor1 or 
Stt4, or by the inhibition of the protein kinase Sch9. We provide evidence that the 
mutant alleles mediate the overactive PKA phenotype in a cAMP-independent, but 
PKA-dependent manner. Our results also show that the PKA phenotype is dependent 
on a background mutation in the specific gap1Δ strain used. The seg1-1 mutation, an 
acronym for “Suppressor of ER exit-deficient Gap1”, causes the secretion of truncated 
Gap1 alleles that would otherwise be retained in the ER by the organelle’s quality 
control system. Finally, we show that the overactive Gap1ΔC6(14aa) phenotype is 
synergistically dependent on both the truncated allele and the seg1-1 mutation.  
 
_________________________________________________ 
 
2.2. INTRODUCTION  
 
Yeast contains a series of transport proteins entrusted with the uptake of nitrogenous 
compounds from the medium, some of which also acts as receptors signaling the 
availability of their substrate to the interior of the cell. The first indication of such a 
dual function for some transporters came from the observation that low levels of 
L-citrulline, exclusively transported by Gap1, can activate the PKA pathway in vivo. 
In contrast, higher levels of L-citrulline, transported by additional amino acid 
permeases, were unable to activate the pathway. Further evidence highlighting Gap1’s 
additional regulatory function is observed in gap1Δ cells where both amino acid 
transport and signaling are absent, suggesting that S. cerevisiae lacks a 
transport-independent receptor for sensing extracellular amino acids (Thevelein et al., 
2008). Moreover, metabolization of the transported amino acid as possible activator 
of the PKA pathway can be excluded, as deletion of ARG1, the gene encoding 
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arginosuccinate synthase, had no affect on the rapid L-citrulline-induced activation of 
the PKA pathway through Gap1.  
 
The dual function of Gap1 as an amino acid transporter/receptor (transceptor) is 
further supported by the isolation of constitutively active alleles. These Gap1 mutants 
contain short truncations of the extreme C-terminus of the protein, resulting in a high 
PKA phenotype that affects all the downstream targets investigated, even in the 
absence of a nitrogen source (Donaton et al., 2003) (Figure 2.1). The high PKA 
phenotype is independent of the carbon source in the growth medium and is also 
observed in the presence of ammonium as sole nitrogen source. Cells carrying these 
Gap1 alleles typically have a low trehalose and glycogen content, while expression of 
STRE-regulated genes is severely reduced, causing very high stress sensitivity. 
Amino acid-induced trehalase activation, however, is slightly reduced compared to 
the wild-type, probably due to an increased feedback inhibition of the enzyme. 
Transport activity of Gap1 is unaffected by the short truncations. These mutants 
represent the first case of an active nutrient transporter that causes permanent 
activation of a signaling pathway in eukaryotic cells.  
 
 
 
Figure 2.1: Amino acid sequence of the C-terminal region of Gap1 (amino acids 533 –
602) and the various truncations thereof.  
Residues shaded green represent the last transmembrane domain; those in brown 
constitute the predicted α -helix. The ER exit signal of Gap1 is shaded in red. 
Underlined sequences are involved in NH4+-induced inactivation and degradation 
of Gap1. The names of the various Gap1 truncated alleles do not refer to the 
actual number of amino acids removed, but rather to the order in which they were 
constructed. 
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The role of the C-terminus of Gap1 in determining the transporter’s fate is 
well-established. The ubiquitin-mediated internalization and downregulation of Gap1, 
as well as its concentrative sorting into COPII vesicles, are both dependent on the 
presence of a complete and functional C-terminal tail. Previous work has identified a 
di-leucine motif and a glutamate residue essential for ammonium-induced inactivation 
of Gap1 in proline-grown cells. Moreover, deleting the 11 amino acid tail following 
the predicted α -helix causes complete resistance to ammonium-induced 
downregulation (Springael and André, 1998; Malkus et al., 2002).  
 
In this chapter, we have further characterized the underlying mechanism involved in 
the constitutive signaling of truncated Gap1 alleles. To determine the possible 
contribution of known nutrient signaling pathways to the high PKA phenotype 
observed in these mutants, we studied the effect of blocking these pathways, either 
through the inactivation of an activating protein or through the use of specific 
inhibitors. 
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2.3. RESULTS AND DISCUSSION  
 
2.3.1. Role of components known to be involved in nutrient signaling 
 
2.3.1.1. Gap1ΔC6(14aa) does not genetically interact with Sch9 
 
The serine/threonine protein kinase Sch9 is a functional yeast homologue of 
mammalian PKB/Akt, both of which are involved in the regulation of growth in 
response to nutrient availability. More recently, Sch9 has been assigned to the FGM 
pathway as a nitrogen- and glucose-sensitive regulator that acts independently of 
cellular cAMP to control PKA targets (Crauwels et al., 1997; Thevelein and de 
Winde, 1999). Moreover, the authors also demonstrated that deletion of SCH9 results 
in a partial increase in PKA activity and, as a consequence, sch9Δ cells display an 
inability to properly enter stationary phase when starved for nitrogen. These are all 
phenotypic properties it shares with the Gap1ΔC6(14aa)-carrying cells.  
 
We checked whether the overexpression of SCH9 can suppress the overactive 
signaling phenotype of Gap1ΔC6(14aa). Cloned under transcriptional control of its 
native promoter and on a multicopy plasmid, various SCH9-overexpression strains 
were monitored for their L-citrulline-induced mobilization of trehalose. The 
overexpression of SCH9, however, had no influence on the phenotype of 
Gap1ΔC6(14aa)-carrying cells, as evident from the levels of trehalose accumulated by 
the various overexpression strains during nitrogen starvation (Figure 2.2). Similar 
unchanged phenotypes were observed for the wild-type and gap1Δ strains carrying 
the SCH9-overexpression constructs, i.e. PKA status is apparently unaffected.  
 
The efficacy of our overexpression construct was determined by examining growth of 
a wild-type strain in the presence of the potent immunosuppressive drug, wortmannin. 
The overexpression of SCH9 was previously shown to restore growth of cells exposed 
to this toxic compound (Geyskens, 2004; see section 2.3.1.5.). Similar results were 
obtained with our constructs, indicating functionality (data not shown).  
 
Chapter II 
 
73 
 
 
Figure 2.2: Overexpression of SCH9 does not suppress the overactive signaling 
phenotype of Gap1∆C6(14aa). (In collaboration with Ole Lagatie) 
 Mobilization of trehalose after the addition of 10 mM L-citrulline to 
nitrogen-starved cells of the wild-type + pYX212 (J), wild-type + 
pYX212-SCH9 (E), gap1∆ + pYX212 (H), gap1∆ + pYX212-SCH9 (C), 
Gap1∆C6(14aa) + pYX212 (B), and Gap1∆C6(14aa) + pYX212-SCH9 (G).  
 
Consistent with the overexpression studies, deletion of SCH9 was also shown to be 
ineffective in reversing the high PKA phenotype of Gap1ΔC6(14aa) cells (Figure 2.3). 
Deletion strains of sch9∆ carrying the wild-type- or Gap1ΔC6(14aa) alleles accumulate 
similar levels of trehalose when starved for nitrogen on a glucose-containing medium. 
Although the amount of trehalose accumulated by the sch9∆ mutants is somewhat 
reduced compared to the wild-type, it is still significantly higher than the trehalose 
levels obtained in the Gap1ΔC6(14aa)-carrying cells. The reduction in trehalose levels 
may be attributed to the higher basal activity of the trehalose-degrading enzyme, 
trehalase, in the sch9∆ cells (Crauwels et al., 1997). 
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Figure 2.3: The deletion of SCH9 does not suppress the overactive signaling phenotype 
of Gap1∆C6(14aa).  
 Mobilization of trehalose after the addition of 10 mM L-citrulline to 
nitrogen-starved cells of the wild-type + pFL38 (J), sch9∆ + pFL38-GAP1 (E), 
sch9∆ + pFL38-GAP1∆C6(14aa) (H), and Gap1∆C6(14aa) + pFL38 (C). 
 
2.3.1.2. PKA-dependency of the overactive Gap1ΔC6(14aa) phenotype 
 
Earlier studies have shown that both the glucose- and nitrogen-induced activation of 
the FGM pathway depends on the activity of the free catalytic subunits of PKA, and 
that the regulatory subunit, encoded by BCY1, is not required and may even be 
inhibitory to the process. Moreover, the activity levels of individual TPK genes differ 
according to the nutrient used, with glucose-induced activation of trehalase pointing 
to an order of TPK2 > TPK1 > TPK3, whereas nitrogen-induced activation of the 
enzyme is more effective in the order TPK1 > TPK2 = TPK3 (Toda et al., 1987a; 
Durnez et al., 1994).  
 
To establish if PKA, and more specifically its catalytic subunits, are involved in the 
constitutive activation of PKA targets in the Gap1ΔC6(14aa) mutant, we investigated 
whether mutations that alter PKA activity also influenced the overactive phenotype. 
To this end, we created a PKA mutant with attenuated activity in which both TPK1 
and TPK3 genes are deleted and cell viability is ensured through the expression of a 
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temperature-sensitive tpk2ts mutant allele. The tpk1Δ tpk2ts tpk3Δ GAP1ΔC6(14aa) and 
tpk1Δ tpk2ts tpk3Δ GAP1 strains were spotted in serial dilutions on nutrient plates and 
incubated at both the permissive (23°C) and restrictive (35°C) temperatures 
(Figure 2.4). Strains carrying wild-type TPK2 were included as a control. As 
expected, growth at 23°C was unaffected for all the strains evaluated, as the tpk2ts 
allele active at this temperature is sufficient to rescue growth.  
 
 
 
Figure 2.4: The overactive Gap1ΔC6(14aa) allele is unable to rescue a strain with inactive 
PKA. 
 The tpk1Δ tpk2ts tpk3Δ GAP1 (A), tpk1Δ TPK2 tpk3Δ GAP1 (B), tpk1Δ tpk2ts 
tpk3Δ GAP1ΔC6(14aa) (C), and tpk1Δ TPK2 tpk3Δ GAP1ΔC6(14aa) (D) strains were 
serially diluted onto YPD plates and incubated for 3 days at 23°C or 35°C, 
respectively (The colonies observed in panels A and C at 35°C are likely due to 
suppressor mutations in tpk2ts). 
 
In contrast, at the restrictive temperature both the tpk1Δ tpk2ts tpk3Δ GAP1ΔC6(14aa) 
and tpk1Δ tpk2ts tpk3Δ GAP1 strains displayed a severe growth defect. These data 
suggest that the overactive Gap1ΔC6(14aa) allele is unable to rescue a strain with 
inactive PKA; indicative of the fact that the overactive effect on the PKA targets is 
likely due to an interference with a component(s) upstream of PKA or PKA itself, and 
not with one or more of the components downstream of the kinase. This is supported 
by earlier findings which showed that the characteristically low trehalose levels of 
Gap1ΔC6(14aa) mutants are restored to near wild-type levels in tpk1Δ tpk2Δ TPK3 
GAP1ΔC6(14aa) cells (Holsbeeks, 2004).  
Characterization of constitutively signaling alleles of Gap1 
 
76 
2.3.1.3. Gap1ΔC6(14aa) exerts its effect downstream of CYR1-encoded adenylate 
cyclase 
 
As demonstrated in the previous section, the overactive phenotype of Gap1ΔC6(14aa) 
depends on the catalytic subunits of PKA. PKA, in turn, is regulated by cAMP which 
is synthesized from ATP by the CYR1/CDC35-encoded adenylate cyclase. Deletion of 
CYR1 is lethal. Viability of a cyr1Δ mutant, however, can be restored by the 
additional deletion of the high-affinity phosphodiesterase, PDE2, and the culturing of 
the double deletion mutant on medium supplemented with at least 3 mM cAMP 
(Mitsuzawa, 1993). In addition, earlier work by Matsumoto et al. (1983) demonstrated 
that if PKA activity is stimulated in an additional, cAMP-independent manner, e.g. 
through the deletion of BCY1 in cyr1Δ cells, the requirement of exogenously-added 
cAMP to such cells becomes unnecessary.  
 
To determine the cAMP-dependency nature of the Gap1ΔC6(14aa) phenotype, we 
evaluated growth of the mutant in the absence of adenylate cyclase. CYR1 and PDE2 
were deleted in a diploid Gap1ΔC6(14aa) background, and, after sporulation, the 
progeny was recovered on media enriched with 3 mM cAMP. We selected the 
cyr1Δ pde2Δ double deletion spores containing the Gap1ΔC6(14aa) allele, and spotted 
dilution series of this strain on nutrient plates with decreasing concentrations of 
cAMP (Figure 2.5). A similar, adenylate cyclase-deficient strain containing wild-type 
Gap1, was included as experimental control.  
 
Strikingly, the expression of GAP1ΔC6(14aa) clearly suppressed the growth deficiency 
of the cyr1Δ pde2Δ mutant, even in the complete absence of cAMP, whereas the 
adenylate cyclase-deficient control strain carrying wild-type Gap1, requires at least 
2 mM cAMP for viability. This result convincingly demonstrates that the overactive 
phenotype of Gap1ΔC6(14aa) does not require the presence of cAMP and as such 
cannot be caused by either an increase in activity of the adenylate cyclase enzyme 
itself, or by enhanced stimulation of its enzymatic activity by an upstream activator, 
such as Cdc25 or Ras.  
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Figure 2.5: The expression of GAP1ΔC6(14aa) abolishes the cAMP requirement for growth 
of an adenylate cyclase mutant.  
The cyr1∆ pde2∆ GAP1 (A) and cyr1∆ pde2∆ GAP1∆C6(14aa) (B) strains were 
cultured on YPD supplemented with 3 mM cAMP to mid-exponential phase, 
spotted in serial 10-fold dilutions on YPD plates with the indicated cAMP 
concentrations, and incubated at 30°C for 3 days. 
 
2.3.1.4. The overactive Gap1ΔC6(14aa) phenotype is not suppressed by inhibition 
of TORC1  
 
Like Sch9, the serine/threonine TORC1 kinase has been implicated in carbon- and 
nitrogen source-dependent control of cell growth, mainly through its positive 
regulation of various anabolic processes, including transcription, translation and 
nutrient transport. Inhibition of TORC1 by rapamycin elicits many of the cellular 
responses that are associated with nutrient starvation, such as downregulation of 
amino acid permeases, inhibition of protein synthesis and a rapid accumulation of 
storage carbohydrates (Jacinto and Lorberg, 2008).  
 
To gain insight into the molecular mechanisms that underlie the overactive phenotype 
of Gap1ΔC6, we considered the hypothesis that the mutant allele causes constitutive 
activation of the TORC1 complex. If this would indeed be the case, then the treatment 
of GapΔC6 cells with rapamycin should result in abolishment of the high PKA 
phenotype. We tested this hypothesis by adding rapamycin to both 
exponentially-growing and nitrogen-starved Gap1ΔC6(14aa) cells (Figure 2.6).  
 
Characterization of constitutively signaling alleles of Gap1 
 
78 
In wild-type cells, exposure to rapamycin or transfer to nitrogen-starvation medium 
led to rapid accumulation of trehalose; a phenomenon that was more pronounced with 
the latter treatment. Combination of the two treatments led to faster accumulation of 
trehalose. 
 
 
 
Figure 2.6: Rapamycin treatment, or the transfer to nitrogen-starvation medium, does 
not interfere with the overactive signaling phenotype of Gap1∆C6-carrying 
cells. (In collaboration with Ole Lagatie) 
Accumulation of trehalose as measured in wild-type (J, E) and Gap1∆C6(14aa) 
(H, C) cells, respectively. (A). Cells were cultured to mid-exponential phase and 
at time zero transferred to either synthetic medium containing the drug vehicle 
alone (J, H), or to synthetic medium supplemented with 200 ng/ml rapamycin 
(E, C). (B). Cells were cultured to mid-exponential phase and at time zero 
transferred to either nitrogen-starvation medium containing the drug vehicle 
alone (J, H), or to nitrogen-starvation medium supplemented with 200 ng/ml 
rapamycin (E, C). 
 
Similar treatment of the Gap1ΔC6(14aa)-carrying cells, however, had no such effect, 
and trehalose levels remained low throughout the time-course. More intriguing, is the 
observation that even the addition of rapamycin to nitrogen-starved cells had no 
influence on the amount of trehalose accumulated. These data suggest that the 
Gap1ΔC6(14aa) mutant allele functions independently of TORC1, which allows it to 
overcome the rapamycin-induced inhibition of the complex. We suspect that 
Gap1ΔC6(14aa) may affect components downstream or parallel of TORC1. 
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We reasoned that if the mutant allele controls a component downstream (or parallel) 
of TORC1, the expression of GAP1ΔC6(14aa) would render cells 
rapamycin-insensitive, which would correlate with their ability to grow in the 
presence of rapamycin. We spotted a dilution series of a Gap1ΔC6(14aa)-carrying strain 
on nutrient plates supplemented with 50 ng/ml rapamycin. The expression of 
GAP1ΔC6(14aa) could indeed compensate for the growth inhibitory properties of 
rapamycin (Figure 2.7). The wild-type strain was clearly more inhibited by the 
rapamycin than the Gap1ΔC6(14aa) mutant. This is in agreement with previous studies 
which demonstrated that mutants with constitutively high PKA activity, like RAS2G19V 
or bcy1Δ cells, can overcome rapamycin sensitivity (Stanhill et al., 1999; 
Zurita-Martinez and Cardenas, 2005). It is known that under normal growth 
conditions, the Σ1278b strain has a hyperactive PKA pathway, which may explain, at 
least in part, why the Σ1278b genetic background is more resistant to rapamycin than 
for example the W303-1A and BY backgrounds.  
 
 
 
Figure 2.7: The expression of GAP1∆C6(14aa) overcomes rapamycin sensitivity. 
The ∑1278b wild-type (A) and Gap1∆C6(14aa) (B) strains were cultured on YPD 
to mid-exponential phase, spotted in serial 10-fold dilutions on YPD plates 
supplemented with rapamycin at the indicated concentration, and incubated at 
30°C for 3 days.  
 
We sought to test if this rapamycin-insensitivity of the Σ1278B wild-type strain is 
indeed linked to its higher PKA activity. Exponentially growing cultures of the 
cyr1Δ pde2Δ GAP1 and cyr1Δ pde2Δ GAP1ΔC6(14aa) strains, in which 
cAMP-dependent PKA activity is severely reduced, were serially diluted and spotted 
on nutrient plates (see section 2.3.1.3.). When supplemented with cAMP, the 
cyr1Δ pde2Δ GAP1 strain remains viable (Figure 2.8). However, in the absence of 
exogenously-added cAMP, the cyr1Δ pde2Δ GAP1 strain failed to grow, indicating 
that our previous hypothesis is correct: the hyperactivation of one pathway (PKA 
pathway) can compensate for the block in another (TORC1 pathway).  
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In accord with the trehalose accumulation results, the growth of the 
cyr1Δ pde2Δ GAP1ΔC6(14aa) mutant is unaffected by rapamycin. We attribute this 
apparent rapamycin-insensitivity of the Gap1ΔC6(14aa) strain to its cAMP-independent 
hyperactivation of the PKA pathway (Figure 2.8). Collectively, these results indicate 
that TORC1 is dispensable for the overactive phenotype of Gap1ΔC6(14aa), and that the 
mutant allele, in line with the PKA-dependency results, is acting through PKA. 
 
 
 
Figure 2.8: TORC1 is dispensable for the overactive signaling phenotype of 
Gap1ΔC6(14aa). 
The cyr1∆ pde2∆ GAP1 (A) and cyr1∆ pde2∆ GAP1∆C6(14aa) (B) strains were 
cultured on YPD supplemented with 3 mM cAMP to mid-exponential phase, 
spotted in serial 10-fold dilutions on YPD plates with the indicated cAMP and/or 
rapamycin concentrations, and incubated at 30°C for 3 days. 
 
2.3.1.5. Gap1ΔC6(14aa) does not genetically interact with Stt4 
 
Phosphoinositide second messengers, generated by the well-conserved type III 
phosphoinositide 4-kinase Stt4, mediate a variety of signaling pathways through the 
activation of downstream proteins. Phosphoinositides have been implicated in the 
regulation of processes as diverse as cell proliferation, membrane trafficking and 
cytoskeleton organization. The STT4 gene was originally identified in a screen for 
mutants that showed increased sensitivity to staurosporine, an inhibitor of protein 
kinase C (Audhya and Emr, 2002). In addition, work by Bergsma et al. (2001) has 
defined a unique function for Stt4 in FGM signaling. The authors demonstrated that 
addition of the Stt4 inhibitor, wortmannin, to nitrogen-starved glucose-repressed cells, 
inhibited the activation of trehalase and concomitant mobilization of trehalose, which 
normally occurs in response to the addition of a nitrogen source to such cells. 
Moreover, wortmannin-treatment also results in cell cycle arrest and the acquisition of 
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stationary-phase characteristics. The overexpression of SCH9, however, can alleviate 
the growth cessation imposed by the inhibitor, indicating that Stt4 may function as an 
upstream regulator of Sch9. To address whether Stt4 is involved in the 
constitutively-active phenotype of the Gap1ΔC6(14aa) mutant, we determined trehalose 
content of both exponentially-growing and nitrogen-starved cells exposed to 
300 ng/ml wortmannin (Figure 2.9).  
 
 
 
Figure 2.9: Wortmannin-induced inhibition of Stt4 does not block the overactive 
signaling phenotype of Gap1∆C6(14aa)-carrying cells. (In collaboration with 
Ole Lagatie) 
Accumulation of trehalose as measured in wild-type (J, E) and Gap1∆C6(14aa) 
(H, C) cells, respectively. (A). Cells were cultured to mid-exponential phase and 
at time zero transferred to either synthetic media containing the drug vehicle 
alone (J, H), or to synthetic media supplemented with 300 ng/ml wortmannin 
(E, C). (B). Cells were cultured to mid-exponential phase and at time zero 
transferred to either nitrogen-starvation media containing the drug vehicle alone 
(J, H), or to nitrogen-starvation media supplemented with 300 ng/ml 
wortmannin (E, C). 
 
Similar to the rapamycin data, we found that treating wild-type cells with 
wortmannin, or transferring it to nitrogen-depleted media, elicit the rapid 
accumulation of trehalose. The two effects proved to be cumulative. In contrast, the 
Gap1ΔC6(14aa) cells did not exhibit any change in trehalose levels, which remained 
consistently low throughout the experiments. Thus, blocking Stt4 activity with 
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wortmannin has no effect on the constitutive signaling phenotype of Gap1ΔC6(14aa), 
suggesting that the mutant allele acts independently of Stt4.  
 
2.3.1.6. Possible role of the Krh proteins in the Gap1ΔC6(14aa) phenotype 
 
Concerted research efforts over the last few years have identified an additional 
mechanism by which the Gα protein Gpa2 activates PKA through two kelch-repeat 
proteins, bypassing adenylate cyclase stimulation in the process (Lu and Hirsch, 2005; 
Peeters et al., 2007). The discovery of such a bypass pathway naturally raises the 
question as to why Gpa2 utilizes both a cAMP-dependent and – independent route for 
activation of PKA. The authors propose a simple model whereby Krh1/2 serve as 
integrators of different nutrient cues. As opposed to fermentable sugars that activate 
PKA by increasing cellular cAMP levels, other nutrients, like nitrogen or phosphate, 
accomplish activation of the PKA pathway without causing an increase in cAMP. The 
Krh proteins could therefore integrate nutrient signal(s) with the fermentable 
sugar-induced cAMP signal for a coordinated activation of PKA.  
 
Cells lacking both KRH genes display phenotypes reminiscent of that observed in 
Gap1ΔC6(14aa) mutants: trehalose and glycogen levels remain low in krh1Δ krh2Δ 
mutants, even when starved for an essential nutrient. Moreover, the deletion of KRH1 
and KRH2 reduces the requirement of cAMP for growth in the absence of CYR1, a 
phenotype that is similar (although not identical) to that seen in Gap1ΔC6(14aa) cells 
(Peeters et al., 2006).  
 
To investigate the possible functional importance of the Krh proteins in Gap1ΔC6(14aa) 
signaling, we deleted these genes in both the original gap1Δ strain (which contains the 
seg1-1 background mutation; see section 2.3.2.), and in a gap1Δ strain without the 
mutation; both gap1Δ mutants are in the Σ1278b genetic background. We measured 
trehalose mobilization in the respective single and double krhΔ mutants when starved 
for nitrogen (Figure 2.10). To our surprise, deletion of the KRH genes led to a clear 
increase in the amount of trehalose accumulated during the starvation period for the 
Gap1∆C6(14aa)-carrying cells, suggesting a reversal in the PKA phenotype of the 
constitutive signaling strains. The increase in trehalose levels is most pronounced in 
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the krh1∆ single deletion mutant, whereas the krh2∆ mutant shows only a slight 
increase in the initial level of the storage carbohydrate. This result fits with the data 
presented by Batlle et al. (2003) that showed the krh2∆ mutant to demonstrate PKA 
phenotypes less pronounced than krh1∆ cells. Although there are no differences in 
initial trehalose levels between similar deletion strains carrying either Gap1 allele, e.g. 
krh1∆ KRH2 GAP1 vs. krh1∆ KRH2 GAP1∆C6(14aa), mobilization of trehalose, 
however, occurred faster in the strains carrying the wild-type permease than those 
with the truncated allele. These data indicate that the krh deletions counteract the 
effect of the overactive Gap1∆C6(14aa) allele, causing it to be even less active than the 
wild-type allele. As a result, trehalose mobilization by the truncated permease occurs 
at a slower rate than in the wild-type.  
 
 
 
Figure 2.10: Deletion of KRH1 and/or KRH2 abrogates the overactive signaling 
phenotype of Gap1∆C6(14aa) cells. 
Mobilization of trehalose after the addition of 10 mM L-citrulline to 
nitrogen-starved cells of the seg1-1 gap1Δ  background: krh1∆ KRH2 + 
pFL38-GAP1 (J), krh1∆ KRH2 + pFL38-GAP1∆C6(14aa) (E), krh1∆ krh2∆ + 
pFL38-GAP1 (H), krh1∆ krh2∆ + pFL38-GAP1∆C6(14aa) (C), KRH1 KRH2 + 
pFL38-Gap1∆C6(14aa) (S), KRH1 krh2∆ + pFL38-GAP1 (F), and KRH1 krh2∆ 
+ pFL38-GAP1∆C6(14aa) (A); and the SEG1 gap1Δ  background: krh1∆ KRH2 
+ pFL38-GAP1 (B), and krh1∆ krh2∆ + pFL38-GAP1 (G).  
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Taken together, these results indicate a possible role for the Krh proteins in the 
overactive signaling phenotype, but require further investigation.  
 
 
2.3.2. The overactive phenotype of Gap1ΔC6(14aa) is dominant in a specific 
gap1Δ  background 
 
As a first step in assessing the dominant or recessive nature of the overactive 
phenotype, we introduced the Gap1ΔC6(14aa) allele into a wild-type GAP1 strain. 
Curiously, the trehalose levels of this hybrid strain after nitrogen starvation was equal 
to that of the wild-type experimental control, indicating an apparent reversal in the 
PKA phenotype of the diploid strain. This normally suggests that Gap1ΔC6(14aa) is 
recessive (Figure 2.11A).  
 
 
 
Figure 2.11: The dominant Gap1ΔC6(14aa) phenotype is restricted to a specific 
background.  
Mobilization of trehalose after the addition of 10 mM L-citrulline to 
nitrogen-starved cells. (A). wild-type + pFL38-GAP1 (J), wild-type + 
pFL38-GAP1∆C6(14aa) (E), Gap1∆C6(14aa) + pFL38 (H), and Gap1∆C6(14aa) + 
pFL38-GAP1 (C). (B). wild-type + pFL38-GAP1 (J), BY gap1∆ + 
pFL38-GAP1∆C6(14aa) (E), W303-1A gap1∆ + pFL38-GAP1∆C6(14aa) (H), 
∑1278b gap1∆ + pFL38-GAP1∆C6(14aa) (C), and Gap1∆C6(14aa) + pFL38 (B).  
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In a similar approach, we introduced wild-type GAP1 into a Gap1ΔC6(14aa) 
(genomically-integrated) strain. However, contrary to the previous results, the latter 
strain did show the low trehalose levels that have become the hallmark of the 
overactive phenotype (Figure 2.11A). This indicates that Gap1ΔC6(14aa) is dominant. 
 
These findings are significant as they demonstrate that the Gap1ΔC6(14aa) allele is only 
dominant in a specific gap1Δ strain in the Σ1278b genetic background. The gap1Δ 
strain concerned was employed in all our characterization experiments (section 2.3.1.) 
and is the same strain used by Donaton et al. (2003). It was originally a gift from B. 
André (Brussels). 
 
These results raise the question as to why the overactive signaling phenotype of 
Gap1ΔC6(14aa) is restricted to a specific genetic background. We entertained the notion 
that the gap1Δ strain in which we obtain the overactive phenotype, may contain an 
additional genomic mutation(s) that proves essential for the overactive Gap1ΔC6(14aa) 
signaling. To examine the importance of the genetic background on this phenotype, 
we constructed Gap1ΔC6(14aa) mutants in various genetic backgrounds, including BY, 
W303-1A and wild-type Σ1278b strains, and measured the trehalose accumulated by 
these strains after nitrogen starvation. As shown in Figure 2.11B, all the new 
Gap1ΔC6(14aa) strains constructed, including the new Σ1278b Gap1ΔC6(14aa) mutant, 
exhibited trehalose levels comparable to that of the wild-type, and are as such 
indicative of a wild-type PKA phenotype. These results indicate that the overactive 
signaling phenotype depends on both the truncated allele and a genomic mutation(s) 
present in the original gap1Δ strain.  
 
 
2.3.3.  The background mutation(s) also has profound effects on the 
phenotype caused by other Gap1 truncated alleles 
 
In light of the importance of the genetic background for the high PKA phenotype 
caused by Gap1ΔC6(14aa), we decided to re-evaluate the previous data obtained with 
the other Gap1 truncated alleles as presented in Donaton et al. (2003). All these 
results were obtained in the presence of the background mutation(s). Hence, when 
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expressed in wild-type strains, their effect may also disappear, as found for the 
Gap1ΔC6(14aa) allele. For this purpose, we monitored L-citrulline-induced 
mobilization of trehalose and glycogen in the new Σ1278b gap1Δ strain 
complemented with various truncated Gap1 alleles (see Figure 2.1). As shown in 
Figure 2.12, three different classes of truncated alleles can be identified based on their 
phenotypic properties in the original (mutant) and new gap1Δ (wild-type) genetic 
backgrounds.  
 
 
 
Figure 2.12: The background mutation(s) has profound effects on the phenotype caused 
by other Gap1 truncations.  
Mobilization of trehalose (A and B) and glycogen (C and D) after the addition 
of 10 mM L-citrulline to nitrogen-starved cells. (A and C). Gap1∆C6(14aa) (J), 
Gap1∆C7(3aa) (E), Gap1∆C11(15aa) (H), Gap1∆C12(20aa) (C), and Gap1∆C14(42aa) 
(B). (B and D). ∑1278b gap1∆ + pFL38-GAP1∆C6(14aa) (J), ∑1278b gap1∆ + 
pFL38-GAP1∆C7(3aa) (E), ∑1278b gap1∆ + pFL38-GAP1∆C11(15aa) (H), 
∑1278b gap1∆ + pFL38-GAP1∆C12(20aa) (C), and ∑1278b gap1∆ + 
pFL38-GAP1∆C14(42aa) (B).  
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The first type of alleles, consisting only of Gap1ΔC7(3aa), causes a wild-type PKA 
phenotype both in the presence and absence of the background mutation(s): trehalose 
and glycogen levels are similar in the mutant and wild-type strain when starved for 
nitrogen. A second type of truncated alleles, represented only by Gap1ΔC14(42aa), 
functions as wild-type allele only in the presence of the background mutation(s); in its 
absence, this allele displays an interesting phenotype in that it does not show 
L-citrulline-induced mobilization of trehalose or glycogen. The third type of alleles, 
comprising Gap1ΔC6(14aa), Gap1ΔC11(15aa) and Gap1ΔC12(20aa), demonstrates an 
overactive signaling phenotype in the mutant background, but a wild-type phenotype 
when expressed in a strain lacking the background mutation(s). 
 
We also performed western analysis on extracts of wild-type- and mutant gap1Δ cells 
expressing the GAP1ΔC6(14aa) and GAP1ΔC14(42aa) alleles. The results of this analysis 
are shown in Figure 2.13. The Gap1ΔC6(14aa) allele shows a significant increase in 
expression, compared to the wild-type, when expressed in the mutant background. 
Based on this result, it is tempting to hypothesize that the increased expression of 
GAP1ΔC6(14aa) also increases the truncated permease’s basal signaling capacity, 
which in turn would result in the constitutive activation of the cAMP-PKA pathway. 
Furthermore, as evident from Figure 2.13, the Gap1ΔC14(42aa) allele only reaches the 
plasma membrane when expressed in the mutant background.  
 
 
 
Figure 2.13: A Gap1 allele lacking an ER exit signal reaches the plasma membrane 
when expressed in the mutant gap1Δ  background. (In collaboration with 
Ole Lagatie) 
Western analysis of Gap1 expression in cell extracts of mutant (A) and 
wild-type (B) cells expressing the wild-type GAP1, GAP1ΔC6(14aa) and 
GAP1ΔC14(42aa) alleles, respectively.  
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Strikingly, in a background lacking the genomic mutation(s), the presence of 
Gap1ΔC14(42aa) in the plasma membrane is undetectable. This indicates that the 
background mutation(s) causes certain truncated alleles to be secreted to the plasma 
membrane, whereas in wild-type cells these truncated alleles are unable to reach the 
plasma membrane. These results also lend further support to the beforementioned data 
on storage carbohydrate mobilization. 
 
Consistent with our localization data, Malkus et al. (2002) demonstrated the 
requirement of a short di-acidic sequence within the C-terminal tail of Gap1 essential 
for the permease’s concentrative sorting to the plasma membrane. Mutations within 
this region, known as the ER exit signal, severely reduce the permease’s packaging 
into COPII transport vesicles, culminating in Gap1’s retention in the ER, and eventual 
degradation by the organelle’s quality control system (see Figure 2.1 and “Chapter I”, 
section 1.4.1.). The background mutation(s), on the other hand, seems to overcome 
the requirement for an ER exit signal for Gap1 and was therefore named ‘suppressor 
of ER-exit deficient Gap1’, or seg1-1, accordingly.  
 
We next analyzed whether the overactive signaling phenotype of Gap1∆C6(14aa) in the 
seg1-1 mutant strain is correlated with its overaccumulation at the plasma membrane. 
We tested this hypothesis by overexpressing GAP1∆C6(14aa) on a multi-copy plasmid. 
As the expression of GAP1 is tightly regulated, both at the transcriptional- and 
post-translational level, we performed the overexpression of GAP1∆C6(14aa) both in a 
wild-type- and npi1-1 strain (Figure 2.14). The npi1-1 mutation inhibits the Rsp5 
ubiquitin ligase-dependent downregulation of Gap1, which allows the permease to be 
present en masse at the plasma membrane during nutritional conditions in which it is 
normally rapidly downregulated (De Craene et al., 2001). Hence, overexpression of 
GAP1∆C6(14aa) in the npi1-1 mutant should result in strong expression of the truncated 
allele in the plasma membrane.  
 
Contrary to expectation, the overexpression of GAP1∆C6(14aa) in the npi1-1 mutant did 
not result in a constitutive signaling phenotype. Initial trehalose levels in the 
overexpression strains are identical to that of the wild-type strain. The rate of 
L-citrulline-induced mobilization of trehalose, however, is increased in the npi1-1 
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strains overexpressing wild-type GAP1, compared to the overexpressing NPI1 
wild-type strains. This increased signaling capacity also correlates with an increase in 
transport activity in the npi1-1 strains (personal communication, Ole Lagatie). 
 
 
 
Figure 2.14: Overexpression of GAP1∆C6(14aa) does not confer a constitutive signaling 
phenotype in the absence of seg1-1.  
Mobilization of trehalose after the addition of 10 mM L-citrulline to 
nitrogen-starved cells of ∑1278b gap1∆ + pFL44L-GAP1 (J), npi1-1 + 
pFL44L-GAP1 (E), ∑1278b gap1∆ + pFL44L-GAP1∆C6(14aa) (H), npi1-1 + 
pFL44L-GAP1∆C6(14aa) (C), ∑1278b gap1∆ + pFL44L (B), and Gap1∆C6(14aa) 
+ pFL44L (G). 
 
This fits with the previous observations that the npi1-1 mutation causes a higher 
expression of GAP1 at the plasma membrane. Hence, the quicker mobilization of 
trehalose may be due to the stronger signaling capacity of the overexpressed GAP1 at 
the plasma membrane. The mobilization is also more pronounced which may be due 
to the absence of Gap1 internalization and breakdown at the vacuole.  
 
The fact that the overexpression of GAP1∆C6(14aa) failed to mimic the 
seg1-1 Gap1∆C6(14aa) phenotype, suggests that the overaccumulation of Gap1∆C6(14aa) 
at the plasma membrane is not (exclusively) responsible for the constitutive signaling. 
It has to be noted that overexpression studies were performed in strains lacking the 
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seg1-1 mutation, which in itself is an indication that the background mutation(s) 
contributes more to the overactive signaling phenotype than merely ensuring the 
overaccumulation of the truncated Gap1 allele at the plasma membrane. 
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IDENTIFICATION OF THE BACKGROUND MUTATION 
REQUIRED FOR CONSTITUTIVE SIGNALING BY 
TRUNCATED GAP1 ALLELES IN YEAST 
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3.1. ABSTRACT 
 
We have previously shown that the constitutively high PKA phenotype observed in 
Gap1∆C6(14aa) cells depend on both the truncated permease and an unknown 
background mutation. Here, we show that seg1-1 mutation is both a single and a 
recessive mutation. Single-copy suppressor analysis of the mutation identifies a role 
for the retromer in the constitutively signaling phenotype. We subsequently 
performed genetic mapping of the mutation and identified a 40 kb region on 
chromosome VIII most likely linked to the mutation. We focused first on a 
Golgi-localized v-SNARE, Gos1, which was previously shown to cause clear 
secretory defects upon disruption. Biochemical analyses of the gos1∆ mutant support 
a role for Gos1 in the overactive signaling phenotype.  
 
_________________________________________________ 
 
3.2. INTRODUCTION 
 
Allelic variation is quite common in different strains and in different individuals in a 
population. The frequency of genetic variation between common laboratory strains of 
yeast is believed to be as high as 1% (Nelson et al., 1993). A fundamental challenge 
in genetics therefore, is to understand how different genetic loci contribute to specific 
traits. In model organisms such as yeast, genetic interactions are typically identified 
using reverse genetic approaches, in which different genes are systematically knocked 
out to create a collection of deletion mutants. Deletion strains are then subjected to 
various forms of phenotypical characterization, and the outcome of these tests is 
usually assigned as a (putative) function(s) of the gene product concerned.  
 
Here, we describe the identification of a genomic mutation, dubbed seg1-1, present in 
a specific Σ1278b gap1Δ strain, 25.969b (stocked as JT 4505), employed in our 
studies. The mutation is not present in any other strain tested. The background 
mutation, in combination with a C-terminally truncated allele of Gap1, Gap1ΔC6(14aa), 
results in cells that display a constitutively high PKA phenotype, even in the absence 
of any nitrogen source (Donaton et al., 2003). The high PKA phenotype is 
independent of the carbon source in the growth medium, and is also observed in the 
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presence of ammonium as sole nitrogen source. seg1-1 cells harboring Gap1ΔC6(14aa) 
typically have a low trehalose and glycogen content and a severely reduced 
expression of STRE-regulated genes, causing very high stress sensitivity. Amino 
acid-induced trehalase activation, however, is slightly reduced.  
 
As opposed to Gap1ΔC6(14aa), the Gap1ΔC14(42aa) allele, which has a slightly longer 
truncation of 42 amino acids, does not cause a high PKA phenotype in the seg1-1 
strain. It is, however, only in the seg1-1 background that Gap1ΔC14(42aa) reaches the 
plasma membrane where it functions as a wild-type allele for both transport and 
signaling; a wild-type SEG1 strain carrying only Gap1ΔC14(42aa) displays a 
“gap1Δ-phenotype”.  
 
In this chapter, we made use of several approaches to identify the gene with the 
seg1-1 mutation. First, we utilized Gap1’s unique ability to transport toxic D-amino 
acids as a basis for a suppressor screen in which we tried to identify the SEG1 gene by 
complementation of the seg1-1 mutant. We next employed a novel genetic mapping 
technology in the screening process, which pointed to a specific v-SNARE protein as 
a likely candidate for the mutation. We show that the constitutively high PKA 
phenotype is synergistically dependent on both the Gap1∆C6(14aa) allele and disruption 
of the v-SNARE; an attribute reminiscent to that of the seg1-1 mutation. 
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3.3. RESULTS AND DISCUSSION  
 
3.3.1. The seg1-1 mutation is both single and recessive 
 
Having determined that the overactive signaling phenotype of the 
Gap1ΔC6(14aa)-carrying cells depends both on the truncated form of the permease and 
a background mutation(s), provisionally called seg1-1, present in a specific Σ1278b 
gap1Δ strain, we next tested whether the seg1-1 mutation(s) itself is dominant or 
recessive. We crossed the seg1-1 strain with a Σ1278b gap1Δ strain lacking the 
mutation(s) and transformed the resulting heterozygous seg1-1/SEG1 diploid strain 
with plasmid-borne copies of either the GAP1ΔC6(14aa) or GAP1ΔC14(42aa) allele. As 
depicted in Figure 3.1A, the phenotypes of the respective diploid strains bear 
resemblance to that of the haploid strain without the mutation, i.e. seg1-1 is a 
recessive mutation. 
 
 
 
Figure 3.1: The seg1-1 mutation is a single and recessive mutation. 
Mobilization of trehalose after the addition of 10 mM L-citrulline to 
nitrogen-starved cells. (A). Σ1278b wild-type (J), Σ1278b gap1Δ (E), 
seg1-1/SEG1 GAP1ΔC6(14aa) (H), seg1-1/SEG1 GAP1ΔC14(42aa) (C), and seg1-1 
GAP1ΔC6(14aa) (B). (B). SEG1 GAP1ΔC6(14aa) segregant 1 (J), SEG1 
GAP1ΔC6(14aa) segregant 2 (E), seg1-1 GAP1ΔC6(14aa) segregant 3 (H), and 
seg1-1 GAP1ΔC6(14aa) segregant 4 (C). A representative experiment is shown.  
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In addition, the haploid meiotic progeny of the seg1-1/SEG1 GAP1ΔC6(14aa) diploid 
strain exhibits a segregation ratio of 2:2, with respect to the levels of trehalose 
accumulated after starvation for nitrogen, suggesting that seg1-1 is a mutation in a 
single gene (Figure 3.1B). As the results of this experiment have a considerable 
bearing on any future strategy for identification of the SEG1 gene, we confirmed the 
original results several times with independent meiotic segregants and transformants.  
 
 
3.3.2. Identification of the cognate gene for seg1-1 
 
3.3.2.1. Screening strategy 
 
As seg1-1 is both a single and recessive mutation, we sought to identify the mutant 
locus by cloning the cognate gene from a yeast genomic DNA library. Our strategy 
for the screening process exploited the unique properties of both the Gap1 permease, 
in general, and the seg1-1 GAP1ΔC14(42aa) strain specifically. The latter strain 
contains a transport-competent Gap1 allele and is, as a consequence, inviable on a 
medium supplemented with toxic D-histidine, an amino acid of which the uptake is 
solely mediated by Gap1 (Regenberg and Hansen, 2000). Complementing the seg1-1 
mutation with the corresponding wild-type SEG1 gene would therefore result in a 
strain lacking a functional Gap1 allele, i.e. a gap1Δ mutant, which in turn would allow 
the latter strain to grow in the presence of D-histidine.  
 
3.3.2.2. Screening results 
 
We transformed the seg1-1 GAP1ΔC14(42aa) strain with a single-copy yeast genomic 
library in YCp50, and recovered an estimated 30,000 transformants. The 
transformants were plated out on minimal L-proline plus D-histidine (MPDHis) 
medium. The plasmids from viable clones were isolated and the genomic DNA inserts 
were identified by sequence analysis. We verified that the D-histidine-insensitivity of 
the viable clones is due to the single-copy plasmids, by counter-selecting for the loss 
of the URA3-based YCp50 plasmid on 5-fluoro-orotic acid (5-FOA) plates (Boeke et 
al., 1987). The 5-FOA growers, i.e. ura3 cells lacking the YCp50 library, were 
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evaluated for growth on MPDHis medium, and were found to be non-viable (results 
not shown). We also re-introduced the plasmids isolated from the viable clones into 
the original seg1-1 GAP1ΔC14(42aa) strain, which bestowed the same 
D-histidine-insensitivity on the transformants as witnessed in our screen (results not 
shown). The genes identified in this screen are listed in Table 3.1.  
 
Table 3.1: Genes identified as single-copy suppressors of the seg1-1 mutation.  
 
Gene General function Description 
Erp2 Secretory pathway 
Member of the highly-conserved p24 family of proteins 
that are involved in ER to Golgi transport; localized to 
COPII vesicles (Marzioch et al., 1999) 
Erp4 Secretory pathway Functionally redundant member of the p24 family of proteins; closely related to Erp2 (Springer et al., 2000) 
Vps26 Secretory pathway 
Vacuolar protein sorting protein that, together with 
Vps29, Vps35, Vps5 and Vps17 form a multimeric 
complex, mainly on vesicular and tubulovesicular 
membranes. The complex, called the retromer complex, 
assembles onto the membrane from two distinct 
subcomplexes, comprising (a) Vps35, Vps29, and Vps26; 
and (b) Vps5 and Vps17. Essential for endosome-to-
Golgi retrograde transport (Seaman et al., 1998) 
Vps29 Secretory pathway 
Endosomal protein that is a subunit of the retromer 
complex; essential for endosome-to-Golgi retrograde 
transport (Reddy and Seaman, 2001) 
Vps35 Secretory pathway 
Vps35 acts as a “receptor” protein for recognition of the 
retrieval signals of cargo proteins during their recruitment 
into retrograde vesicles (Nothwehr et al., 2000) 
Stp2 Transcription factor 
Stp2 is a transcription factor that binds to specific 
sequences within the promoters of SPS-regulated amino 
acid permease genes (Andréasson and Ljungdahl, 2002) 
Dia4 Translation initiation 
Probable mitochondrial seryl-tRNA synthetase; deletion 
mutant displays increased invasive and pseudohyphal 
growth (Arnez and Moras, 1997) 
Caj1 Protein folding and chaperone activity 
A type II heat shock protein of the bacterial dnaJ family, 
which facilitates the molecular chaperone Hsp70’s 
interaction with polypeptide substrates (Walsh et al., 
2004) 
 
The most abundant class of proteins we isolated as potential wild-type counterparts of 
the seg1-1 mutation, all function within the early secretory pathway, i.e. transport 
between the ER and the Golgi apparatus, or vice versa. The Vps26, Vps29 and Vps35 
proteins, for example, constitute the cargo-selection subcomplex of the retromer 
complex; the latter being a conserved cytoplasmic coat that functions in 
endosome-to-Golgi retrieval. Loss of the retromer function results in a protein 
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missorting defect to the vacuole, and subsequent mislocalization of the vacuolar 
hydrolase carboxypepetidase Y to the plasma membrane (Seaman, 2004; Gokool et 
al., 2007).  
 
The Erp2 and Erp4 (for Emp24- and Erv25-related proteins) proteins are the founding 
members of the evolutionary-conserved p24 family of proteins. This family of 
transmembrane proteins has been suggested to limit the entry of specifically unfolded 
proteins into COPII vesicles. Given their ability to strongly interact with the COPII 
coat proteins, p24 complexes may act as ‘placeholders’ to prevent other proteins with 
a lower affinity to COPII proteins from entering COPII vesicles. Cargo proteins that 
efficiently interact with COPII components could then displace p24 complexes from 
COPII budding sites, and as such secure a space for themselves in a COPII vesicle 
(see “Chapter I”, section 1.4.2.). A similar mechanism is proposed to act in the 
COPI-dependent, endosome-to-Golgi retrieval pathway (Springer et al., 2000; 
Caldwell et al., 2001).  
 
In addition to the single-copy suppressor screen, we also performed a multi-copy 
suppressor analysis that functioned on the same principle as the single-copy screen 
(see section 3.3.2.1.). We isolated 26 suppressors, which represented 11 different 
genes (Table 3.2). 
 
Table 3.2: Genes identified as multi-copy suppressors of the seg1-1 mutation.  
 
Gene General function Description 
Isolated 13 times 
Put4 Amino acid transport 
Proline permease required for high-affinity 
transport of proline; also transports the toxic 
proline analog azetidine-2-carboxylate (AzC); 
PUT4 transcription is repressed in ammonia-
grown cells (Andréasson et al., 2004) 
Isolated 4 times 
Stp2 Transcription factor 
Stp2 is a transcription factor that binds to specific 
sequences within the promoters of SPS-regulated 
amino acid permease genes (Andréasson and 
Ljungdahl, 2002) 
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Isolated once 
Gcd14 Translation/transcription 
One of the subunits of tRNA methyltransferase, 
and is required for the modification of the adenine 
at position 58 in tRNAs, especially tRNAi-Met; 
was first identified as a negative regulator of 
GCN4 expression (Cuesta et al., 1998) 
Agp1 Amino acid transport 
Low-affinity amino acid permease with broad 
substrate range; involved in uptake of most 
uncharged amino acids, including asparagine, 
glutamine and leucine; expression is under control 
of the SPS amino acid sensor system (Abdel-Sater 
et al., 2004) 
Bdf1 Transcription factor 
BDF1 encodes a bromodomain-containing 
transcription factor involved in transcription 
initiation at TATA-containing promoters; 
corresponds to the C-terminal region of 
mammalian TAF1 (Liu et al., 2009) 
Kar4 Transcription factor 
Putative transcription factor required for the 
induction of CIK1 and KAR3 during mating and 
meiosis, and for the efficient transit from the G1 
phase during mitosis (Lahav et al., 2006) 
Hsp82 Protein folding and chaperone activity 
Hsp90 molecular chaperone required for 
pheromone signaling and negative regulation of 
Hsf1; chaperone activity of Hsp82 is unique in 
that it acts on partially folded proteins that are 
recruited by the sequential activity of Hsp40 and 
Hsp70 (Tapia and Morano, 2010) 
Exo84 Exocyst 
Essential protein which mediates polarized 
targeting of secretory vesicles to active sites of 
exocytosis; specifically localizes to the bud tip or 
the mother/daughter connection (Guo et al., 1999) 
Ssb2 Translation 
Ribosome-associated chaperone that may be 
involved in the folding of newly-synthesized 
polypeptide chains; member of Hsp70 family 
associated with ribosomes (Pfund et al., 1998) 
Sec16 (N-
term.) Secretion 
COPII vesicle coat protein required for ER 
transport vesicle formation and physically 
interacts with all of the COPII components, except 
Sec13; deletion of SEC16 blocks ER to Golgi 
transport (Connerly et al., 2005) 
Mth1 (N-
term.) Other 
Negative regulator of the glucose-sensing signal 
transduction pathway, required for repression of 
transcription by Rgt1; interacts with both the Snf3 
and Rgt2 glucose sensors; phosphorylated by 
Yck1 (Lakshmanan et al., 2003) 
 
Remarkably, this set of suppressor clones was comprised of mainly two distinct 
clusters of genes: one group of genes that codes for amino acid permeases (e.g. the 
proline permease-encoding PUT4 and the low-affinity amino acid permease-encoding 
AGP1), and another that includes transcription factors specific for the expression of 
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amino acid permease genes, like Stp2 and the Gcn4-specific regulator Gcd14. It is 
important to note that only amino acid permeases, and no other nutrient carriers, were 
isolated as multi-copy suppressors of the seg1-1 mutation. Based on this observation, 
it is tempting to hypothesize that seg1-1 specifically modulates the ER-to-Golgi 
transit of amino acid transporters. Moreover, overexpression of the amino acid 
transporters apparently strengthens the ER quality control system (and/or saturates the 
recruitment of the secreted proteins into the COPII transport vesicles) in such a 
manner that the Gap1∆C14(42aa) allele apparently no longer is able to reach the plasma 
membrane.  
 
3.3.2.3. Is one of the single-copy suppressors SEG1? 
 
To determine whether one of the single-copy suppressors is the SEG1 gene, we mated 
a Σ1278b gap1Δ strain with the corresponding deletion mutants in the genes we 
picked up as suppressors. After sporulation and tetrad analysis, the appropriate 
haploid double deletion strains were transformed with the plasmid-borne 
Gap1ΔC6(14aa) allele, and the resulting mutants were monitored for 
L-citrulline-induced mobilization of trehalose.  
 
However, contrary to expectation, none of the deletions had any impact on the PKA 
phenotype of the respective mutant strains, as evident from the high levels of 
trehalose accumulated by the various strains during nitrogen starvation (Figure 3.2). It 
therefore appears that none of the single-copy suppressor genes, as listed in Table 3.1, 
is actually identical to the SEG1 gene. The remaining explanation that the point 
mutant would give a different phenotype compared to the deletion mutant appears 
unlikely, because of the recessive character of the seg1-1 mutation. Hence, seg1-1 is 
probably a (partial) inactivation mutation.  
 
Although not relevant to our study, it is interesting to note that the vps29Δ mutant 
displays a “gap1Δ-phenotype”, despite carrying a copy of the truncated permease. 
This may be in part due to a defect in retromer-dependent trafficking (Seaman, 2008). 
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Figure 3.2: None of the deletion strains in the single-copy suppressors could support the 
high PKA phenotype caused by Gap1∆C6(14aa) in the seg1-1 mutant.  
Mobilization of trehalose after the addition of 10 mM L-citrulline to nitrogen-
starved cells. (A). Σ1278b gap1Δ + pFL38-GAP1∆C6(14aa) (J), erp2Δ + 
pFL38-GAP1∆C6(14aa) (E), erp4Δ + pFL38-GAP1∆C6(14aa) (H), vps26Δ + 
pFL38-GAP1∆C6(14aa) (C), vps29Δ + pFL38-GAP1∆C6(14aa) (B), vps35Δ + 
pFL38-GAP1∆C6(14aa) (G), and seg1-1 + pFL38-GAP1∆C6(14aa) (F). (B). Σ1278b 
gap1Δ + pFL38-GAP1∆C6(14aa) (J), stp2Δ + pFL38-GAP1∆C6(14aa) (E), dia4Δ + 
pFL38-GAP1∆C6(14aa) (H), caj1Δ + pFL38-GAP1∆C6(14aa) (C), and seg1-1 + 
pFL38-GAP1∆C6(14aa) (B). 
 
Albeit a major advantage as a genetic system, identifying a mutant locus in yeast by 
cloning the cognate gene from a plasmid library may sometimes prove difficult. A 
gene may, for example, be underrepresented in a library or toxic in E. coli, gene 
dosage effects may result in unexpected phenotypes, or false positives may be more 
easily recovered than the gene of interest (Agnan et al., 1997; Wiatrowski and 
Carlson, 2001). However, the advent of new technologies, like genome-wide mapping 
and single nucleotide polymorphism (SNP) genotyping, and its application in the 
identification of mutant loci by linkage analysis, has circumvented many of the 
above-mentioned problems associated with the conventional cloning system.  
 
Here we describe a novel, alternative approach, named ‘Artificial Marker Track 
Exclusion Mapping’ (AMTEM), with which we proceeded for the identification of the 
mutation.  
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3.3.3. Identifying the genomic locus of seg1-1 using AMTEM 
 
3.3.3.1. Screening strategy 
 
The AMTEM technology was developed in our laboratory, and makes use of a 
standard artificially-marked yeast strain (AMS; S288c genetic background) that 
contains approximately 600 different markers in its genome. The artificial markers are 
specific 20 bp oligonucleotides introduced at predefined, neutral (intergenic) positions 
in the genome, at a distance of roughly 20 kb from one another. They cover the whole 
yeast genome genetically. Mapping is performed by crossing the AMS with any other 
strain displaying a trait of interest; in our case the high PKA phenotype caused by the 
seg1-1 mutation in a strain expressing GAP1∆C6(14aa) or the D-histidine sensitivity 
caused by seg1-1 in a strain expressing GAP1∆C14(42aa). The segregants of this cross 
are phenotyped and those with the desired trait are selected. About 20 of these 
segregants are pooled, their genomic DNA extracted and the artificial markers are 
scored using a custom-made micro-array carrying oligonucleotides that match the 
artificial markers (Figure 3.3).  
 
Because all loci that are required for the trait of interest in the segregants, have to 
originate from the unmarked parent strain carrying the desired trait, the positions of 
these loci are indicated by the different gaps in the track of markers. Moreover, due to 
crossing-over events in the mapped locus (at a rate of about 1 in every 12 segregants), 
the markers are not necessarily completely absent but may have a strongly reduced 
signal intensity. This is true for genetic elements that are essential for the trait of 
interest. When they are only important, and not truly essential, the markers will be 
reduced in intensity to some extent depending on the importance of the genetic 
element. When the markers are scored in the individual segregants, loci that are not 
linked with the trait of interest will show about 50% marker presence, whereas in the 
loci linked to the desired trait the presence of the marker drops well below 50% - the 
lower the percentage, the stronger the linkage with the trait of interest. 
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Figure 3.3: Schematic depiction of the principle of the AMTEM technology.  
Black squares represent the markers detected by micro-array; red crosses denote 
the mutations responsible for the trait of interest; pink-filled squares constitute the 
trait of interest. Meiotic segregants of a cross between the AMS and a strain of 
interest each contain approximately 50% of the markers. About 20 segregants 
with the desired phenotype are selected and their genomic DNA pooled. In a pool 
of 20 segregants, all unlinked markers are detected, while the markers adjacent to 
the genetic element(s) required for the trait of interest are either absent or have 
very low signal intensity. Hence, the gap(s) in the marker track will indicate the 
genomic location of the responsible mutation(s). The very low signal intensity 
can be due to the presence of interval recombinants (strains with a crossing-over 
in the mapped locus between the mutation and the adjacent marker). As there are 
approximately 50 crossing-overs in one meiotic event and there are 600 markers 
in the genome, the mean frequency of interval recombinants between two 
markers is roughly 1 in 12.  
 
During the course of this study, the completely marked strain was not available yet, 
which meant that we had to cross with several AMS strains covering most of the 
genome genetically. The first strain we used had 61 markers.  
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3.3.3.2. Screening results 
 
We crossed the seg1-1 mutant strain with an AMS containing 61 markers, and 
subjected the diploid to tetrad analysis. We transformed the meiotic progeny with a 
plasmid-borne copy of the GAP1ΔC6(14aa) allele, and measured the amount of 
trehalose accumulated by each transformed segregant after nitrogen starvation. We 
isolated 11 segregants that displayed the high-PKA phenotype, i.e. low levels of 
trehalose. The genomic DNA from these strains was isolated, pooled and used in our 
marker-detection micro-array (see “Materials and Methods”, section 6.2.7.). 
Segregants that displayed the wild-type PKA phenotype, i.e. high levels of trehalose, 
were included as control.  
 
Application of the marker-detection methodology resulted in negative signals for 
three adjacent markers (no. 249 – 251). They were absent in the genomic DNA of all 
11 low-trehalose segregants. In contrast, all of the markers were present in the 
genomic DNA of the high-trehalose segregants selected. We confirmed the 
micro-array data by scoring the presence, or absence, of each marker in each 
individual low-trehalose segregant. We employed a standard PCR protocol in the 
process, in which we used the specific marker as one primer, and an appropriate 
downstream sequence of the same length as the second primer. The PCR confirmation 
results are shown in Table 3.3.  
 
Table 3.3: Confirmation of the micro-array data by marker-specific PCR detection. 
The “+” sign denotes the presence of a marker, whereas a “-” sign indicates its  
absence.  
 
Chromosome VIII  Marker 249 Marker 250 Marker 251 
Low-trehalose segregant 1 - - + 
2 - - - 
3 + - - 
4 - - - 
5 - - - 
6 - - - 
7 - - - 
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8 - - - 
9 + - + 
10 - - - 
11 + - - 
PCR controls 
Marker strain  + + + 
S288c wild-type (unmarked) - - - 
 
The area covered by markers 249 to 251 comprises of a 40 kb region between bp 
18,226 and 58,935 near the beginning of chromosome VIII. The probability (P value) 
of this region being relevant to the seg1-1 phenotype was calculated at 4.338 × 10-4 
(see “Materials and Methods”, section 6.2.8.). Given that the mathematical cut-off for 
the significance of a specific gene or chromosomal region contributing to a 
phenotype, has been specified at 0.005, our data suggest a high true-positive-to-false 
discovery ratio, i.e. there is a very good mathematical probability that the seg1-1 
mutation is contained within the 40 kb region (Steinmetz et al., 2002; Segrè et al., 
2006). Table 3.4 lists all the genes of chromosome VIII within this specific region. 
 
Table 3.4: Genes within the 18,226 to 58,935 bp region of chromosome VIII. 
 
Gene General function Description 
Arn1 Transport 
Member of the ARN family of transporters that 
specifically recognize siderophore-iron chelates 
(Heymann et al., 2000) 
Yhl039w Unknown Putative protein of unknown function; localizes to the cytoplasm 
Cbp2 Transcription 
Mitochondrial protein required for splicing of the 
group I intron aI5 of the COB pre-mRNA by binding 
to the RNA to promote its splicing (Tirupati et al., 
1999) 
Yhl037c Unknown Dubious open reading frame unlikely to encode a functional protein 
Mup3 Transport Low-affinity methionine permease, similar to Mup1 (Menant et al., 2006) 
Vmr1 Transport 
Member of the ATP-binding cassette (ABC) 
superfamily of multi-drug transporters (Paumi et al., 
2009) 
Yhl034w-a Unknown Dubious open reading frame unlikely to encode a functional protein 
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Sbp1 Translation Putative RNA binding protein involved in translational repression (Segal et al., 2006) 
Rpl8a Translation 
Ribosomal protein L4 of the large (60S) ribosomal 
subunit; mutation results in decreased amounts of 
free 60S subunits (Zhao et al., 2006) 
Gut1 Glycerol utilization 
Glycerol kinase that converts glycerol to 
glycerol-3-phosphate; glucose repression of 
expression is mediated by Adr1 and Ino2-Ino4 
(Grauslund et al., 1999) 
Yhl030w-a Unknown Dubious open reading frame unlikely to encode a functional protein 
Gos1 
Secretion pathway 
(ER-Golgi and 
intra-Golgi) 
v-SNARE protein localized to the Golgi 
compartment and likely homolog of the mammalian 
protein GOS-28/GS28; may play a role in multiple 
transport steps (McNew et al., 1998) 
Ecm29 Proteasome function 
Major component of the proteasome; tethers the 
proteasome core particle to the regulatory particle, 
and enhances the stability of the proteasome 
(Leggett et al., 2002) 
Oca5 Unknown 
Cytoplasmic protein required for replication of the 
Brome mosaic virus in S. cerevisiae (Kushner et al., 
2003) 
Wsc4 Cell wall integrity / protein targeting to ER 
ER-localized protein involved in the translocation of 
soluble secretory proteins and insertion of membrane 
proteins into the ER membrane; may also have a role 
in the stress response (Zu et al., 2001) 
Rim101 Cell wall biogenesis 
Transcriptional repressor involved in response to pH 
and in cell wall construction; required for alkaline 
pH-stimulated haploid invasive growth and 
sporulation, and is activated by proteolytic 
processing (Castrejon et al., 2006) 
Yhl026c Unknown Putative protein of unknown function 
Snf6 Chromatin remodeling 
Subunit of the SWI/SNF chromatin remodeling 
complex involved in transcriptional regulation 
(Smith et al., 2003) 
Rim4 Meiosis 
Putative RNA-binding protein required for the 
expression of early and middle sporulation genes 
(Deng and Saunders, 2001) 
 
Based on our previous data (see “Chapter II”), we focused our study first on the two 
candidate genes functioning within the yeast’s secretion pathway, namely the 
v-SNARE GOS1 and the ER membrane protein WSC4. Gos1 has been localized 
primarily to the Golgi complex and likely participates in ER-Golgi and / or 
intra-Golgi transport. It is thus not surprising then that the deletion of GOS1 causes 
clear secretory defects. The ER chaperone, Kar2 (see “Chapter I”, section 1.4.1.), is 
secreted five-fold more in gos1Δ mutants than in wild-type cells, indicative of the 
ER-retention defective (erd) phenotype that gos1Δ cells suffer from. It was also 
reported that the proteolytic processing of carboxypeptidase Y (CPY) significantly 
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decreased in gos1Δ mutants, such that both the p1CPY and p2CPY precursors 
accumulated in these cells (McNew et al., 1998). Moreover, during the course of this 
study, Gos1 was identified in a split-ubiquitin screen as an interacting partner of 
wild-type Gap1 (Griet Van Zeebroeck, personal communication).  
 
Wsc4, on the other hand, is an essential component of the signal recognition 
particle (srp) - dependent translocation of secretory proteins through, or into, the ER. 
Deletion of WSC4 causes significant defects in the translocation of both soluble and 
membrane secretory proteins, resulting in the accumulation of pre-CPY, 
prepro-α-factor, preinvertase as well as the integral membrane protein 
dipeptidyl-aminopeptidase B (Mamoun et al., 1999). The role of Wsc4 in the yeast 
cell’s response to environmental stress, however, is far less clear, with earlier data 
suggesting that the function of Wsc4 may partially overlap with that of the other WSC 
family members (Zu et al., 2001).  
 
 
3.3.4. Is GOS1 or WSC4 identical to SEG1?  
 
We next sought to test whether the GOS1 or the WSC4 genes could be identical to 
SEG1. We deleted GOS1, or WSC4, in a Σ1278b gap1Δ strain, transformed the double 
deletion mutant with plasmid-borne Gap1ΔC6(14aa), and determined the trehalose 
levels in the respective strains when starved for nitrogen (Figures 3.4A and B, 
respectively). In contrast to the GOS1 wild-type strain, trehalose levels in the gos1Δ 
mutant were significantly reduced. Initial trehalose levels in the deletion strain were 
in fact very similar to that of the seg1-1 Gap1ΔC6(14aa) mutant, suggesting that GOS1 
may be identical to SEG1. Additional trehalose experiments with independent 
transformants confirmed the original result, which justified taking a closer look at 
GOS1 as the potential wild-type counterpart of seg1-1.  
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Figure 3.4: Deletion of GOS1 in a strain expressing GAP1ΔC6(14aa) results in a low 
trehalose level. 
Mobilization of trehalose after the addition of 10 mM L-citrulline to 
nitrogen-starved cells. (A). Σ1278b gap1Δ + pFL38-GAP1∆C6(14aa) (J), 
Σ1278b gap1Δ gos1∆ + pFL38-GAP1∆C6(14aa) (E), and seg1-1 + 
pFL38-GAP1∆C6(14aa) (H). (B). Σ1278b gap1Δ + pFL38-GAP1∆C6(14aa) (J), 
Σ1278b gap1Δ wsc4∆ + pFL38-GAP1∆C6(14aa) (E), and seg1-1 + 
pFL38-GAP1∆C6(14aa) (H). 
 
Contrary to the gos1Δ results, the disruption of WSC4 did not result in a high PKA 
phenotype. The trehalose levels in the wsc4Δ strain expressing GAP1ΔC6(14aa) was 
even higher than in the WSC4 wild-type strain carrying Gap1ΔC6(14aa) (Figure 3.4B). 
This actually suggests a further decrease in PKA activity in wsc4Δ cells, and is as 
such not relevant to our study. The remainder of this particular study therefore focuses 
on understanding the role of Gos1 in the overactive signaling phenotype of the seg1-1 
mutant.  
 
3.3.4.1. Deletion of GOS1 in combination with Gap1ΔC6(14aa) mimics the 
overactive phenotype 
 
We also mated the gos1Δ Gap1ΔC6(14aa) strain with the seg1-1 Gap1ΔC6(14aa) mutant 
and measured trehalose mobilization in the diploid after starvation for nitrogen 
(Figure 3.5).  
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Figure 3.5: The seg1-1/gos1Δ  diploid displays phenotypes identical to the seg1-1/seg1-1 
diploid strain.  
Mobilization of trehalose after the addition of 10 mM L-citrulline to 
nitrogen-starved cells of the seg1-1/seg1-1 diploid + pFL38-GAP1 (J), Σ1278b 
gap1Δ + pFL38-GAP1∆C6(14aa) (E), seg1-1/gos1∆ diploid + pFL38-GAP1 (H), 
seg1-1/gos1Δ diploid + pFL38-GAP1∆C6(14aa) (C), and seg1-1/seg1-1 diploid + 
pFL38-GAP1∆C6(14aa) (B). 
 
We included a seg1-1/gos1Δ diploid strain carrying a plasmid-borne wild-type copy 
of Gap1 as control. Similar to the individual haploid stains, the seg1-1/gos1Δ 
Gap1ΔC6(14aa) diploid displayed the characteristically low levels of trehalose that has 
become the hallmark of the overactive PKA phenotype. More importantly, the 
seg1-1/gos1Δ diploid harboring the plasmid-borne Gap1 exhibited trehalose levels 
identical to that of the seg1-1 homozygous diploid carrying wild-type Gap1. This 
suggests that, analogous to the seg1-1 mutant strain, the high PKA phenotype of a 
gos1Δ strain is only observed in combination with the Gap1ΔC6(14aa) allele.  
 
This is an important finding since it corroborates the synergistic nature of the 
overactive phenotype – both the background mutation and Gap1 truncated allele is 
required for the constitutive signaling phenotype (see “Chapter II”, section 2.3.3.). 
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These results also show that the gos1Δ and seg1-1 mutations do not complement each 
other, which strongly suggests that GOS1 and SEG1 is the same gene.  
 
We confirmed the mobilization data by sporulating the respective diploid strains and 
measuring the accumulation of trehalose in all four of the meiotic progeny 
(Figure 3.6).  
 
 
 
Figure 3.6: Trehalose levels of the individual segregants confirm the original mobilization 
data.  
Trehalose levels as accumulated by the haploid meiotic progeny of the respective 
strains when starved overnight for nitrogen on a glucose-containing medium. 
 
Consistent with the data on trehalose mobilization, the gos1Δ Gap1ΔC6(14aa) 
segregants (as confirmed by PCR analysis) accumulated very little trehalose during 
the starvation period. The gos1Δ Gap1 segregants, on the other hand, accumulated 
wild-type levels of the storage carbohydrate, which essentially underscores our earlier 
findings. Taken together, these data provide a strong argument for GOS1 being the 
wild-type equivalent of the seg1-1 mutation. 
 
3.3.4.2. Sequence analysis of the GOS1 ORF, promoter and terminator regions 
in the seg1-1 background does not reveal any mutation 
 
Because the previous results strongly suggested that GOS1 was identical to SEG1, we 
searched for the presence of mutations in the GOS1 ORF, promoter and terminator in 
the seg1-1 background. We sequenced the 672 bp GOS1 ORF, and about 1,000 bp 
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upstream and downstream thereof, in both the seg1-1 and Σ1278b wild-type parental 
strain. We employed the conventional dideoxynucleotide PCR-based method, and 
compared the sequence data to that of the S288c reference strain 
(Saccharomyces Genome Database; http://www.yeastgenome.org). However, to our 
surprise, no loss-of-function (missense, frameshift, or nonsense) mutations were 
detected in the GOS1 coding sequence, promoter or terminator regions originating 
from the seg1-1 mutant; the sequence data of all three strains were in complete 
agreement. This is practically in contrast to our previous data suggesting that GOS1 is 
identical to SEG1. 
 
We argued that the expression of GOS1 in the seg1-1 background may be severely 
compromised, to the extent that the seg1-1 strain symbolizes a “gos1Δ” strain, i.e. a 
strain lacking functional Gos1 protein. This seems reasonable, as several recent 
studies have shown that sequence variation, i.e. polymorphism, in DNA sequences 
upstream and downstream of coding sequences have profound effects on gene 
expression and, as a result, on phenotype (Yvert et al., 2003; Wang et al., 2007). 
Ronald and colleagues (2005) for example found that up to a quarter of all yeast genes 
are affected by polymorphisms in both their promoter regions and upstream 
transcription factor binding sites. Similar findings in mouse suggest that polymorphic 
variation is probably an evolutionary conserved phenomenon (Doss et al., 2005).  
 
To test our hypothesis, we determined by real-time quantitative PCR (qPCR) the 
expression levels of GOS1 mRNA in nitrogen-starved, seg1-1 Gap1ΔC6(14aa) cells, 
including relevant control strains for this experiment (Figure 3.7).  
 
However, contrary to expectation, the expression of GOS1 mRNA in the 
seg1-1 Gap1ΔC6(14aa) strain increased significantly, compared to the mutant carrying 
wild-type Gap1. This discrepancy in expression can only be attributed to the 
Gap1ΔC6(14aa) allele, although the exact mechanism by which the truncated permease 
could influence the expression of the v-SNARE is not clear. Important to note is that 
the mRNA levels do not necessarily equate to the amount of Gos1 protein found in 
the seg1-1 Gap1ΔC6(14aa) strain. Translational efficiency, i.e. GOS1 mRNA to Gos1 
protein, should therefore be determined by western analysis. 
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Figure 3.7: The Gap1ΔC6(14aa) allele causes a dramatic increase in GOS1 mRNA levels.  
Relative expression of GOS1 mRNA in the individual strains after overnight 
starvation for nitrogen. Expression of 18S mRNA was used for normalization. 
Cells were grown to mid-exponential phase before their transfer to nitrogen-
starvation medium supplemented with 4% glucose.  
 
If the level of Gos1 protein is also strongly elevated, we have to conclude that both 
the disruption and overexpression of GOS1 support the overactive Gap1 allele, or at 
least that both are correlated with the overactive effect. This may be possible as the 
overexpression of GOS1 may also disrupt its normal interaction with the t-SNARE 
proteins (see “Chapter I”, section 1.4.3.).  
 
3.3.4.3. Sequence analysis of the regions around GOS1 identifies a 
polymorphism in the ECM29 gene of the seg1-1 strain 
 
We proceeded by sequencing 20 kb upstream and downstream of the GOS1 ORF, 
thereby covering the whole locus previously identified by genetic mapping. We 
employed the recently developed Illumina GAIITM Next-Generation sequencing 
technology (Cofactor Genomics, St. Louis, MO) in the process, and recovered 227 
potential SNPs in total for the 40 kb sequenced region. However, analysis of the raw 
data indicated that most (approximately 200) were actually sequencing errors, and that 
of the remaining SNPs, only one exhibited a very high ‘confidence rate’. Table 3.5 
summarizes this result. 
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Table 3.5: A high confidence filtered list of the total SNPs.  
The most important values for defining a high ‘confidence rate’ of SNP candidates 
are those of the Total Count, Count Ratio and the Quality Base. In a 20× coverage 
sequencing project, like ours, one would expect a minimum coverage of 3×, a 
Count Ratio of 0.4, and a Quality Base value of at least 30.  
 
Reference 
Sequence ID 
 
Pos.a Baseb 
Base 
Countc 
Total 
Countd 
Count 
Ratioe 
Qual. 
Basef 
Qual. 
Totalg 
Qual. 
Ratioh 
NODE 71 
length 115 bp 
coverage 3.7 
 
19 G 3 3 1 180 180 1 
aposition of the SNP / insertion/deletion (indel) in the reference sequence; bbase or indel observed at 
this position; cnumber of times this polymorphism is observed; dcoverage at this base, counting all 
matches and mismatches; e(polymorphism count) / (total count); fsum of qualities for this 
polymorphism; gsum of qualities for ALL bases at this position; h(polymorphism quality value sum) / 
(total quality value sum at this position) 
 
The SNP is located within the ECM29 ORF, with ECM29 being the next gene on the 
chromosome but on the opposite strand, i.e. the Watson strand, to GOS1 (Figure 3.8). 
The nucleotide at bp 5524, an adenine in both the S288c and the Σ1278b wild-type 
strains, is changed to a guanine in the seg1-1 mutant. This leads to an amino acid 
change where the amino acid residue at position 1842, an asparagine (N), is 
substituted for aspartic acid (D). 
 
 
 
Figure 3.8: The SNP is located within the ECM29 ORF of the seg1-1 strain.  
Chromosome VIII features that span coordinates bp 35,000 to 55,000. The 
specified map is indicated by the region between the two vertical red dashed lines 
(coordinates bp 45,479 to bp 45,593). 
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The role that Ecm29 may play in the overactive signaling phenotype is not clear yet, 
and requires further investigation. First, the point mutation identified has to be 
introduced into a wild-type strain expressing GAP1ΔC6(14aa), to evaluate whether it 
truly is the same as the seg1-1 mutation that supports the high PKA phenotype. In 
addition, it should be investigated whether ecm29Δ also supports the high PKA 
phenotype and whether gos1Δ affects the expression of ECM29.  
 
Ecm29 enhances the stability of the proteasome by tethering the organelle’s core 
catalytic particle to its regulatory particle, which in turn stimulates the in vivo activity 
of the proteasome’s de-ubiquitinating enzyme, Ubp6. Curiously, the inactivation of 
UBP6 causes a two-fold reduction in the internalization of Gap1 present at the plasma 
membrane (Nikko and André, 2007a). The internalization of Gap1 in ubp6Δ mutants 
relies on the regular Gap1 ubiquitination, thus ubiquitination of lysine9 and lysine16. 
The function of Ecm29 may also explain the secretion of the truncated Gap1ΔC14(42aa) 
protein and the oversecretion of Gap1ΔC6(14aa) to the plasma membrane in the seg1-1 
mutant, since the proteasome is involved in the degradation of incorrect ER-produced 
proteins that do not pass the organelle’s quality control system (see “Chapter II”, 
section 2.3.3.) 
 
We are also considering the possibility that a polymorphism in one gene, e.g. ECM29, 
can affect the expression of the GOS1 gene. Such trans-regulatory variation is known 
to affect the timing, level, or activity of the transcription factors or other regulators 
that control the expression of specific genes. The question that begs an answer, 
though, is what role the Gap1ΔC6(14aa) allele plays in the regulation of GOS1 
expression in the ecm29Δ mutant, since the increased expression of GOS1 is only 
observed in a seg1-1 strain carrying Gap1ΔC6(14aa). It would be interesting to also 
check whether the Gap1ΔC14(42aa) allele, which does not cause a high PKA 
phenotype, also causes elevated expression of GOS1.  
 
Finally, it remains unclear why the gos1Δ mutation fails to complement the seg1-1 
mutation if seg1-1 is the same as the ecm29N1842D mutation. A gos1Δ strain should 
have a wild-type ECM29 gene that should complement the ecm29N1842D mutation if it 
is seg1-1, since we showed that seg1-1 is a recessive mutation. In addition, the seg1-1 
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mutant should have a wild-type GOS1 gene that in principle should be able to 
complement the gos1Δ mutation.  
 
  
 
 
 
 
 
 
 
 
 
Chapter IV 
 
 
 
 
 
GLUCOSE-INDUCED ACTIVATION OF PROTEIN 
PHOSPHATASES PP2A AND PP1 IN YEAST 
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4.1. ABSTRACT 
 
Reversible protein phosphorylation regulates practically every signaling pathway in 
the eukaryotic cell. Here, we reveal that both protein phosphatases PP2A and PP1 are 
under direct control of glucose sensing. We show that glucose addition to glucose-
deprived yeast cells triggers rapid activation of both PP2A and PP1 phosphatase 
activity. The glucose-induced activation of PP2A requires the catalytic subunits 
Pph21 and Pph22. Of the regulatory subunits, only Rts1 is involved; the Tpd3 
structural subunit is dispensable for this activity. Cells deficient in Ppm1-directed 
carboxymethylation of the catalytic subunits exhibit a slight decrease in PP2A 
activation upon glucose addition. Moreover, methylation of PP2A’s catalytic subunits 
increased in response to glucose re-addition. We also identify four different regulatory 
subunits required for glucose-dependent activation of PP1.  
 
_________________________________________________ 
 
4.2. INTRODUCTION 
 
The serine/threonine-specific protein phosphatases PP2A and PP1 are major 
regulators of numerous cellular processes in yeast and other eukaryotes. Distinct 
functions of PP2A and PP1 are generated through the association of their catalytic 
subunit(s) with a broad range of regulatory subunits. In yeast, two related genes, 
PPH21 and PPH22, encode the catalytic (C) subunits of PP2A. The TPD3 gene codes 
for the only structural (A) subunit in S. cerevisiae, which serves as a scaffolding 
protein to accommodate one catalytic subunit and one of the two mutually exclusive 
regulatory (B) subunits, encoded by RTS1 and CDC55 respectively (Jiang, 2006). 
Interestingly, the lack of a structural subunit in a PP2A complex has been reported for 
yeast (Koren et al., 2004). Formation of the PP2A holoenzyme is regulated by the 
reversible methylation of the carboxyl terminus of the catalytic subunits. Inhibition of 
methylation, e.g. through the inactivation of the PPM1-encoded methyltransferase, 
reduces the interaction of the catalytic subunits with the regulatory subunits.  
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The catalytic subunit of PP1 in yeast is encoded by a single gene, GLC7. Yeast Glc7 
is essential for viability and critically regulates processes as diverse as glucose and 
glycogen metabolism, sporulation, chromosome segregation, meiosis and protein 
synthesis. As for PP2A, the activity of PP1 is controlled by specific association with a 
wide variety of subunits. These include proteins such as Pig1 (and possibly Pig2), 
Reg1 and Reg2, Red1, Gip1 and Gip2, Gac1, Shp1, Bni4, Bud14 and Glc8; each of 
which has a well-characterized role as a modulator of Glc7 function (Walsh et al., 
2002; Logan et al., 2008). The subunits target Glc7 to the appropriate subcellular 
location, determine the substrate specificity, and modulate the enzymatic activity 
accordingly. Thus, rather than being a promiscuous phosphatase, the yeast PP1 
represents a large family of diverse enzymes that have individual specificity but share 
a common catalytic subunit.  
 
In line with a proposed role in nutrient-induced signaling, moderate overexpression of 
PPH22 was shown to trigger activation of the cAMP-PKA pathway, even in the 
absence of nutrients. Overexpression of PPH22 affected all the PKA targets 
investigated, with the PPH22-overexpressing mutants demonstrating an increased 
trehalase activity, low trehalose levels, heat sensitivity and a constitutive repression of 
STRE-controlled genes; a phenotype commonly referred to as a ‘high PKA 
phenotype’. Deletion of SCH9 in the PPH22-overexpressing cells restores the 
glucose-induced activation of trehalase, suggesting that Sch9 is required to mediate 
the nutrient-induced signaling effects of Pph22 and may as such represent a novel 
Pph22 target (Sugajska et al., 2001). The kinase-phosphatase relationship in yeast 
therefore appears to be more intimate than previously thought. Similar signal 
transduction ‘cassettes’ have been described for higher eukaryotes in which a protein 
kinase and phosphatase interact directly or via a common scaffolding protein 
(Millward et al., 1999; Takahashi et al., 1999).  
 
Previous work by Somers (2006) revealed, for the first time, the rapid activation of 
the protein phosphatases upon addition of glucose to glycerol-grown cells, i.e. 
glucose-starved cells. This activation is not inhibited by cycloheximide, which 
together with the rapidity of the response (within one minute) suggests a 
post-translational mechanism. In addition, it was demonstrated that glucose activation 
of PP2A requires only one of the known glucose-sensing mechanisms for activation 
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of the cAMP-PKA pathway: either the glucose- and sucrose-sensing GPCR, Gpr1, or 
the glucose phosphorylation-dependent system. Such a rapid change in phosphatase 
activity in response to an environmental stimulus has not been reported in yeast.  
 
In this chapter, we focus on the mechanism by which glucose stimulates the activation 
of protein phosphatases in glucose-deprived cells. We demonstrate the requirement of 
specific regulatory and catalytic subunits for the activation of both PP2A and PP1. In 
addition, we provide evidence of the increase in methylation of PP2A brought about 
by glucose re-addition. This suggests a role for the nutrient in PP2A enzyme 
assembly.  
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4.3. RESULTS AND DISCUSSION  
 
4.3.1. Glucose triggers rapid activation of PP2A and PP1 in derepressed 
cells 
 
The addition of glucose to glucose-starved cells of S. cerevisiae triggers rapid 
stimulation of phosphatase activity (Figure 4.1). We have determined this increase in 
phosphoserine/phosphothreonine-specific catalytic activity by employing a 
routinely-used phosphatase activity assay (see “Materials and Methods”, 
section 6.2.14.3.). Briefly, crude cell extracts are incubated with the 32P-labeled 
glycogen phosphorylase a substrate. The reaction is terminated by addition of 
trichloroacetic acid, at which point the 32Pi liberated by the phosphatase activity in the 
cell extract, is counted in a scintillation counter. The cpm values serve as indication of 
the protein phosphatase activity present in the cell extract. In all experiments, equal 
amounts of cells were extracted. The assay values were normalized to the amount of 
protein, as determined by Bradford analysis (Bradford, 1976). 
 
The basal level of phosphatase activity in the cell extracts, as well as the profile of the 
glucose-induced increase in activity, varied to some extent between experiments. The 
exact reason for this is unclear, but it may reflect the complexity of the process, or 
possibly the sensitivity of the activity assay to the prevailing experimental conditions. 
However, despite some experimental variability, the rapid increase in activity after 
addition of glucose remained clearly recognizable throughout the course of this study.  
 
The use of different glucose concentrations revealed that 20 mM led to maximum 
activation of phosphatase activity; both lower and higher concentrations of the carbon 
source reduced the magnitude of activation (Figure 4.1). This may be due to stronger 
feedback inhibition of the mechanism at higher glucose concentrations. Addition of 
other easily-fermentable sugars, like fructose and sucrose, at concentrations of 20 mM 
activated the phosphatases to the same extent as glucose; the non-metabolizable 
carbon sources sorbitol and 6-deoxyglucose had no effect on phosphatase activity 
(Somers, 2006).  
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Figure 4.1: Glucose elicits the rapid activation of protein phosphatases in 
glucose-deprived cells. (In collaboration with Ils Somers) 
Different glucose concentrations were added to glucose-starved wild-type cells at 
time zero. 1 mM (J), 5 mM (E), 20 mM (H), 60 mM (C), and 100 mM (B).  
 
To distinguish between PP2A activity and PP1 activity in vitro, we employed two 
highly selective phosphatase inhibitors: the naturally occurring inhibitor-2 and the 
tumor-inducing toxin okadaic acid (Foulkes and Cohen, 1980; MacKintosh et al., 
1990). Inhibitor-2 inhibits PP1 specifically, whereas okadaic acid inhibits PP2A in the 
concentration range of 1-5 nM and also PP1 at higher concentrations. We therefore 
used inhibitor-2 and okadaic acid at concentrations of 0.2 µM and 2 nM, respectively, 
unless stated otherwise. As shown in Figure 4.2, both PP2A and PP1 are rapidly 
activated by addition of glucose to cells starved for the carbon source. The 
contribution of PP1 to the overall glucose-induced phosphatase activity, however, is 
slightly lower than that of PP2A. Moreover, the combined addition of both inhibitors 
completely suppressed activation of the phosphatases, which in itself underlines the 
specificity of the inhibitors at the concentrations used. In an additional control 
experiment, we showed that the glucose-induced activation of PP1 was not influenced 
by deletion of the PP2A or PP2A-like (e.g. PPG1, SIT4, and PPH3) 
phosphatase-encoding genes (Somers, 2006).  
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Figure 4.2: Glucose causes the rapid activation of both PP2A and PP1 in derepressed 
cells.  
At time zero, 20 mM glucose was added to glucose-starved wild-type cells. 
Protein phosphatase activity was measured in cell extracts in the absence of an 
inhibitor (J), in the presence of 0.2 µM inhibitor-2 (E), 2 nM okadaic acid (H), 
or 0.2 µM inhibitor-2 and 2 nM okadaic acid (C).  
 
4.3.1.1. Glucose activation of PP2A requires Pph21 and Pph22 
 
In yeast, as in higher eukaryotes, PP2A often exists as a multiprotein complex, 
composed of a catalytic subunit, a scaffolding subunit, and a variable regulatory 
subunit. To analyze the subunit makeup of the PP2A heterotrimer activated by 
glucose, we measured glucose-induced activation of PP2A in strains lacking either 
Pph21 or Pph22, or both. Disruption of PPH21 reduced the extent of activation, and 
this was the case for deletion of PPH22 as well, although to a lesser degree. Deletion 
of both catalytic subunits completely abolished the glucose stimulation of PP2A 
activity (Figure 4.3). The increased reduction observed for the pph21Δ cells is in 
agreement with previous data indicating that the individual loss of PPH21 and PPH22 
reduced measurable PP2A activity by 51% and 33%, respectively (Wei et al., 2001). 
Deletion of the other PP2A-related catalytic subunits, PPG1, SIT4, and PPH3, had no 
impact on the glucose-induced stimulation of PP2A activity (results not shown). 
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Figure 4.3: PP2A catalytic subunits Pph21 and Pph22 are required for glucose-induced 
activation of PP2A. (In collaboration with Ils Somers) 
At time zero, 20 mM glucose was added to glucose-starved cells. Protein 
phosphatase activity was measured in cell extracts of the wild-type (J), pph21Δ 
(E), pph22Δ (H), and pph21Δ pph22Δ (C) strains in the presence of 0.2 µM 
inhibitor-2.  
 
Additional evidence that the catalytic subunits of PP2A are responsible for 
glucose-induced activation of the enzyme came from subsequent experiments with 
immunoprecipitated Pph21. We expressed hemagglutinin (HA)-tagged Pph21 in cells 
lacking both PP2A catalytic subunits, and tested the anti-HA-tag immunoprecipitates 
(one for each time point of the assay) for catalytic activity towards phosphorylase a. 
Pph21 activity was also measured in cell extracts (Figure 4.4B).  
 
As shown in Figure 4.4A, a clear increase in phosphatase activity was observed for 
the immunoprecipitated Pph21, whereas for the pph21Δ pph22Δ mutant carrying the 
empty vector, no glucose-induced activation could be measured. This correlates well 
with the fact that no detectable Pph21 protein was immunoprecipitated in the latter 
strain. Similarly, we found that Pph21 restored phosphatase activity to the double 
deletion strain (in the cell extracts); reinforcing the idea that activation of PP2A by 
glucose is apparently due to the enzyme’s catalytic subunits (Figure. 4.4B).  
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Figure 4.4: Pph21 restores glucose-inducible phosphatase activity to a strain lacking all 
PP2A catalytic subunits.  
At time zero, 20 mM glucose was added to glucose-starved cells. Protein 
phosphatase activity was measured in immunoprecipitates (A) and cell extracts 
(B) in the presence of 0.2 µM inhibitor-2. (A). Anti-HA immunoprecipitates from 
lysates of pph21Δ pph22Δ cells expressing pYX142 (J), or pYX142-HA-PPH21 
(E).  
(B). Cell extracts of the pph21Δ pph22Δ cells expressing pYX142 (J), or 
pYX142-HA-PPH21 (E).  
 
An unexpected result of the immunoprecipitation experiment is the subtle but 
reproducible increase in the basal level activity of the PPH21-expressing strain 
(Figure 4.4A). We ruled out the involvement of another (co-immunoprecipitated) 
phosphatase by performing the assay on immunoprecipitated Pph21 in the presence of 
either inhibitor-2 or okadaic acid. Addition of inhibitor-2 neither affected the high 
basal level nor the increase in PP2A activity, thus excluding PP1’s participation in the 
non-induced phosphatase activity (see Figure 4.4A). Moreover, addition of okadaic 
acid completely blocked all immunoprecipitated Pph21 activity, suggesting that both 
the high basal level and the increase in activity are solely due to PP2A (results not 
shown).  
 
Whereas PP2A usually exists as a heterotrimeric protein in vivo, cell extracts mostly 
contain catalytically-active AC dimers and free catalytic subunits (Cohen, 1989; Wu 
et al., 2000). It is thus tempting to speculate that the high basal level seen in the 
Chapter IV 
 
 127 
immunoprecipitation experiments may simply derive from unspecific phosphatase 
activity by the ABC heterotrimeric complex as a whole, or perhaps from the binding 
of an unknown activator to immunoprecipitated Pph21.  
 
To test this possibility, we measured glucose-inducible catalytic activity of 
immunoprecipitated Pph21 that was stripped of all associated proteins. Disruption of 
Pph21 complexes, and the concomitant isolation of monomeric Pph21 by 
immunoprecipitation, is achieved by treating cell lysates with an alkaline pH shift to 
disturb protein complexes, followed by neutralization (see “Materials and Methods”, 
section 6.2.15.).  
 
Surprisingly, activity from the monomeric Pph21 was largely abolished, as shown in 
Figure 4.5. This result suggests that there is an additional component(s) critical to the 
glucose-inducible PP2A phenomenon, most likely the regulatory and/or structural 
subunits of the enzyme.  
 
 
 
Figure 4.5: Monomeric Pph21 exhibits a severe defect in glucose-induced stimulation of 
PP2A activity.  
At time zero, 20 mM glucose was added to glucose-starved wild-type cells 
expressing pYX142-HA-PPH21. Protein phosphatase activity was measured in 
anti-HA immunoprecipitates from untreated lysates (J), and from pH-treated 
lysates (E) in the presence of 0.2 µM inhibitor-2.  
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The overall basal activity of the treated lysates also dropped by about three-fold to 
levels seen with cell extracts, thus corroborating our earlier hypothesis that the high 
basal level is in part due to unspecific, i.e. non-induced, activity of the PP2A 
heterotrimeric enzyme. 
 
4.3.1.2. Glucose activation of PP2A is dependent on Rts1 but not on Cdc55 and 
Tpd3  
 
Work from several laboratories has demonstrated the importance of the PP2A 
regulatory and scaffolding subunits in many cellular processes. Deletion of CDC55 or 
TPD3, for example, renders growth cold sensitive and causes clear morphological and 
cytokinetic defects (Healy et al., 1991; Yang et al., 2000a; Janssens and Goris, 2001). 
Disruption of RTS1, on the other hand, results in temperature-sensitive growth and, 
more importantly, diminishes the mRNA levels of the Hsp60 chaperone, thus 
impairing the deletion mutant’s overall stress response (Shu et al., 1997; Wu et al., 
2000).  
 
Based on our earlier findings, we asked whether the A and/or B subunits may have an 
additional, previously unknown, role in glucose-induced activation of PP2A. To this 
end, we constructed mutants deleted for the regulatory subunits RTS1 and CDC55, 
and the scaffolding subunit TPD3.  
 
As shown in Figure 4.6A, inactivation of RTS1 completely abrogated glucose-induced 
activation of PP2A. In contrast, cells lacking either CDC55 (Figure 4.6A) or TPD3 
(Figure 4.6B) exhibited no such defects and, as in the case of tpd3Δ cells, caused a 
somewhat stronger glucose-induced stimulation of PP2A activity. The rts1Δ cdc55Δ 
double deletion mutant, however, lost all PP2A-specific activity (Figure 4.6A).  
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Figure 4.6: The regulatory subunit Rts1 is required for glucose activation of PP2A, as 
opposed to Cdc55 and Tpd3 which are both dispensable for this activity.  
At time zero, 20 mM glucose was added to glucose-starved cells. Protein 
phosphatase activity was measured in cell extracts in the presence of 0.2 µM 
inhibitor-2. (A). wild-type (J), cdc55Δ (E), rts1Δ (H), and rts1Δ cdc55Δ (C). 
(B). wild-type (J), and tpd3Δ (E). 
 
Also, it has recently been reported that Rts1 is a key component of the pathways that 
integrate nutrient availability, cell size, and eventual entry into the cell cycle (Artiles 
et al., 2009). Cells deficient in Rts1 fail to undergo nutrient-based modulation of cell 
size.  
 
In addition to the association with the A and B subunits, PP2A catalytic subunits also 
exist in complex with the essential protein Tap42, a downstream target of TORC1 
(see “Chapter I”, section 1.5.1.2.). Deletion of CDC55 or TPD3 enhances this 
association, which also correlates with the increased rapamycin resistance observed in 
cdc55Δ or tpd3Δ cells. Inhibition of TORC1 activity by rapamycin treatment or 
nutrient deprivation causes dissociation of Tap42 from the PP2A C subunit and 
subsequently inactivates the complex (Jiang and Broach, 1999; Wang et al., 2003).  
 
To assess whether glucose-induced activation of phosphatases functions via TORC1, 
we pre-incubated glucose-starved wild-type cells with 300 ng/ml rapamycin for 3 
hours. Evaluation of growth confirmed that TORC1 activity was completely blocked 
under these conditions. Addition of rapamycin, however, had no effect on the 
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stimulation of PP2A activity by glucose, suggesting that both TORC1 and Tap42 are 
apparently not involved in this process (Somers, 2006).  
 
4.3.1.3. Addition of glucose to carbon-starved cells leads to carboxymethylation 
of Pph21 
 
During the course of our study, the Ogris group published a series of reports on the 
biogenesis of catalytically-active PP2A heterotrimers. The authors proposed a model 
whereby the generation of catalytic subunits and assembly of the enzyme require a 
series of highly-regulated steps that occur under scrutiny of both Ppe1 and Ppm1 
(Fellner et al., 2003a; Fellner et al., 2003b; Hombauer et al., 2007).  
 
Although carboxymethylation of the catalytic subunits is not an absolute requirement 
for phosphatase activity, it plays a major, if not indispensable, role in the assembly of 
the PP2A heterotrimeric enzyme. Accordingly, we investigated the methylation status 
of immunoprecipitated Pph21 with the methylation-specific monoclonal antibody 
2A10 (Fellner et al., 2003a).  
 
As shown in Figure 4.7, the addition of glucose to glycerol-grown cells causes a clear 
increase in carboxymethylation of the Pph21 protein, a phenomenon that was 
cumulative over the first 90 min.  
 
 
 
Figure 4.7: Glucose re-addition stimulates PP2A catalytic subunit methylation.  
At time zero, 20 mM glucose was added to glucose-starved wild-type cells 
expressing pYX142-HA-PPH21. Anti-HA immunoprecipitates were subjected to 
western analysis with the indicated antibody.  
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To confirm the beforementioned data, we also employed a methylation-sensitive 
mouse monoclonal antibody (1d6) to evaluate PP2A’s methylation status during 
carbon source re-addition (Figure 4.8). 1d6 specifically detects only unmethylated 
Pph21 and Pph22, since its binding to the catalytic subunits is strongly inhibited by 
methylation of the C-terminal leucine (Ogris et al., 1999; Wei et al., 2001).  
 
 
 
Figure 4.8: Unmethylated catalytic subunit levels decrease upon glucose re-addition.  
At time zero, 20 mM glucose was added to glucose-starved wild-type cells 
expressing pYX142-HA-PPH21. Anti-HA immunoprecipitates were subjected to 
western analysis with the indicated antibody.  
 
Figure 4.8 shows a clear decrease over time in 1d6 signal intensity upon glucose 
addition, which indicates the generation of a predominantly methylated form of Pph21 
after glucose re-supplementation, and essentially, underscores our earlier finding. 
Taken together, our data suggest that glucose stimulates methylation of the catalytic 
subunits, and as such contributes to the biogenesis of active catalytic subunits and, 
moreover, to the generation of stable PP2A heterotrimeric enzymes.  
 
We next analyzed the glucose-induced activation of PP2A in strains deficient for 
Ppm1. In yeast, PPM1 encodes the carboxymethyltransferase solely responsible for 
PP2A methylation (Leulliot et al., 2004). Deletion of PPM1 reduced PP2A activation 
with about 40% compared to the wild-type, as evident from Figure 4.9. This result is 
consistent with previous data highlighting Ppm1’s minimal effect on PP2A 
phosphatase activity. Blocking methylation in yeast results in phenotypes typically 
associated with impaired PP2A enzyme formation (Ikehara et al., 2007). 
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Figure 4.9: Loss of PPM1-encoded carboxymethyltransferase activity has only a limited 
effect on glucose-induced activation of PP2A.  
At time zero, 20 mM glucose was added to glucose-starved cells. Protein 
phosphatase activity was measured in cell extracts of the wild-type (J), and 
ppm1Δ (E) strains in the presence of 0.2 µM inhibitor-2.  
 
As expected, methylation of Pph21 in ppm1Δ cells, as measured with the 
methylation-specific antibody, was completely abolished (results not shown). 
 
The methylated state of PP2A is in a dynamic equilibrium between the opposing 
actions of Ppm1 and the methylesterase Ppe1 that catalyzes the removal of the methyl 
group from the enzyme. Recent experimental evidence identified an additional role 
for the methylesterase. It was shown that Ppe1 regulates PP2A assembly by 
preventing the premature methylation of the catalytic subunit(s) that has not been 
activated by binding to the structural subunit, thus preventing the potential risk of 
unspecific dephosphorylation events in vivo (Hombauer et al., 2007).  
 
We next determined whether the loss of Ppe1 affects glucose-induced stimulation of 
PP2A activity. As shown in Figure 4.10, loss of Ppe1 function resulted in a strong 
increase in glucose-stimulated PP2A activity, albeit at a slower rate than the 
wild-type. We attribute this increase in phosphatase activity to the fact that the 
catalytic subunits in ppe1Δ cells are all in a hypermethylated state (due to the 
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unregulated activity of Ppm1), which may contribute to an increase in uncontrolled 
C-subunit catalytic activity, especially when stimulated by glucose 
re-supplementation (also see Figure 4.11).  
 
 
 
Figure 4.10: Disruption of PPE1 causes a significant increase in glucose-dependent 
PP2A activity.  
At time zero, 20 mM glucose was added to glucose-starved cells. Protein 
phosphatase activity was measured in cell extracts of the wild-type (J), ppe1Δ 
(E), and ppm1Δ ppe1Δ (H) strains in the presence of 0.2 µM inhibitor-2.  
 
We also evaluated ppe1Δ ppm1Δ cells for their glucose-induced activation of PP2A 
and found that the extent of activation was severely reduced in the double deletion 
mutant when compared to either the wild-type or ppe1Δ cells, which in effect 
highlights the requirement of both Ppm1 and Ppe1 in the generation of a 
catalytically-active and stable PP2A enzyme (Figure 4.10).  
 
Immunoblot analysis of Pph21 protein from ppe1Δ cells revealed a large drop in the 
unmethylation level, and therefore a strong increase in methylation of the catalytic 
subunit, as judged from the strong signal intensity with the methylation-sensitive 
antibody 1d6 present in all the samples (Figure 4.11).  
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We confirmed this result via a different approach (see “Materials and Methods”, 
section 6.2.16.). Because alkali treatment was shown to demethylate the catalytic 
subunit, a cell lysate containing predominantly methylated C subunits will exhibit a 
clear increase in 1d6 signal intensity upon alkali treatment, whereas a lysate with only 
unmethylated C subunits will have no such increase (Favre et al., 1994; Wei et al., 
2001).  
 
As shown in Figure 4.11, NaOH-treatment of one of the samples, sample “0”, reveals 
a large increase in immunoreactivity compared to the untreated samples; suggestive of 
Pph21’s strongly methylated state in ppe1Δ cells prior to alkali treatment.  
 
 
 
Figure 4.11: Strains lacking PPE1-encoded methylesterase activity display increased 
catalytic subunit methylation; a phenomenon independent of the carbon 
source in the growth medium. 
At time zero, 20 mM glucose was added to glucose-starved ppe1Δ cells 
expressing pYX142-HA-PPH21. Anti-HA immunoprecipitates were subjected 
to western analysis with the indicated antibody. NaOH stripping of the C 
subunit methyl groups confirmed the reactivity of the antibody. 
 
4.3.1.4. The Rrd proteins are required for glucose-induced stimulation of PP2A 
activity 
 
As in mammalian cells, yeast PP2A is regulated by a set of evolutionary-conserved 
proteins known as Rrd1 and Rrd2 (Rrd1/2), the yeast homologs of the mammalian 
phosphotyrosyl phosphatase activator (PTPA) (Van Hoof et al., 2005). The loss of 
Rrd1/2 results in the generation of C subunits with severely impaired 
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phosphoserine/phosphothreonine-specific catalytic activity, indicating an essential 
function for Rrd1/2 in the formation of native PP2A (Fellner et al., 2003a). To 
investigate whether the Rrd proteins may also play a role in the glucose-induced 
activation, we determined activity of PP2A in cells deleted for RRD1 and/or RRD2 
after addition of glucose. Deletion of both RRD genes is synthetically lethal, but can 
be rescued by expression of the SSD1 gene (see “Chapter I”, section 1.5.1.1.). Cells 
deficient for Rrd1 showed a distinct drop in glucose activation compared to the 
wild-type, with the loss of Rrd2 imposing an even bigger reduction on the stimulation 
of PP2A activity by glucose (Figure 4.12).  
 
 
 
Figure 4.12: Loss of Rrd function abolishes the activation of PP2A by glucose.  
At time zero, 20 mM glucose was added to glucose-starved cells. Protein 
phosphatase activity was measured in cell extracts of the wild-type (J), rrd1Δ 
(E), rrd2Δ (H), and rrd1Δ rrd2Δ (C) strains in the presence of 0.2 µM 
inhibitor-2.  
 
Moreover, the double deletion mutant showed no glucose-stimulated PP2A activity. 
We ascribe the reduction in catalytic activity, or lack thereof, observed in these 
mutants to an unstable PP2A enzyme comprised of a biochemically altered C-subunit 
(Hombauer et al., 2007).  
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The PP2A C subunits of strains deleted for the RRD genes typically exhibit an 
increase in phosphotyrosine catalytic activity, as opposed to the loss in 
phosphoserine/phosphothreonine activity. It would therefore be interesting to also 
evaluate rrdΔ cells for their glucose-induced PP2A activity towards a 
phosphotyrosine substrate, like para-nitrophenyl phosphate (pNPP). Fellner and 
colleagues (2003a), for example, reported a dramatic increase (about six-fold) in 
phosphotyrosine-specific catalytic activity in rrd1Δ rrd2Δ mutants compared to the 
wild-type.  
 
 
4.3.2. Structure of PP1 activated by glucose 
 
Unlike all eukaryotes, yeast only contains one gene encoding a PP1 catalytic subunit, 
termed GLC7. As in higher eukaryotes, Glc7 regulates numerous processes in yeast, 
including glucose and glycogen metabolism, sporulation and transcriptional 
responses. One hallmark of PP1 enzymes is the association of the catalytic subunit 
with a variety of regulatory subunits – at least 100 putative PP1 regulatory subunits 
have been identified in mammalian cells (Moorhead et al., 2007; Shi, 2009).  
 
In yeast, PP1 regulatory subunits are encoded by REG1 and REG2, GIP1 and GIP2, 
PIG1 and PIG2, GAC1, SHP1, RED1, BNI4, BUD14 and GLC8, amongst others (for 
a detailed overview on the functions of the respective subunits, see “Chapter I”, 
section 1.5.2.). To investigate the possible involvement of these regulatory subunits in 
the glucose-induced stimulation of PP1 activity, we measured phosphatase activity in 
a strain deleted for a particular subunit. We ensured specificity of the assay by 
performing the phosphatase activity measurements in the presence of the PP2A 
inhibitor okadaic acid, thus focusing only on the contribution of PP1 to the 
phosphatase activity observed. With the exception of Shp1, Glc8, Gac1, and Red1, 
none of the remaining regulatory subunits are required for stimulation of PP1 activity 
by glucose (results not shown).  
 
However, deletion of SHP1, or the yeast homolog of mammalian inhibitor-2, GLC8, 
completely abolished PP1 activation, as shown in Figure 4.13A and Figure 4.13B, 
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respectively. Strains deficient for Gac1 or Red1 show only a partial decrease in 
glucose-induced activation of PP1 compared to the wild-type (Figure 4.13C and 
Figure 4.13D, respectively). The partial reduction in PP1 activity observed for the 
gac1Δ mutant may be a consequence of the weak association between Glc7 and Gac1 
that exists in the presence of glucose (Stark, 1996). This is consistent with the fact 
that glycogen synthesis, regulated by Gac1, only commences once glucose becomes 
limiting. Hence, the loss of Gac1 in cells supplemented with glucose may have only a 
limited effect on Glc7 catalytic activity.  
 
 
 
Figure 4.13: The PP1 regulatory subunits Shp1, Glc8, Gac1, and Red1 are all required 
for maximum activation of PP1 upon glucose re-supplementation.  
At time zero, 20 mM glucose was added to glucose-starved cells. Protein 
phosphatase activity was measured in cell extracts in the presence of 2 nM 
okadaic acid. (A). wild-type (J), and shp1Δ (E); (B). wild-type (J), and glc8Δ 
(E); (C). wild-type (J), and gac1Δ (E); and (D). wild-type (J), and 
red1Δ (E).  
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Both Red1 and Gip1 are required for early meiosis, and it is this (partial) overlap in 
function between the two proteins that perhaps masks the effect losing only one of 
them may have on glucose-induced stimulation of PP1 activity (Tu et al., 1996). It 
may therefore prove useful to test the red1∆ gip1∆ double mutant for its PP1 activity.  
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To grow and proliferate, all microorganisms must sense and respond to the 
availability of nutrients in their immediate surroundings. The unicellular eukaryote 
S. cerevisiae has therefore evolved numerous developmental options that ensure its 
quick adaptation to the prevailing growth conditions. Thus, when sufficient levels of 
carbon, nitrogen, phosphor and sulfur are detected, yeast cells embark on a period of 
rapid growth, characterized by, amongst others, the preferential use of glucose and the 
repression of genes required for utilization of other sugars. Starving yeast cells for 
any of these essential nutrients results in a dramatic restructuring of the cell’s 
transcriptional profile. For instance, transcription of ribosomal protein genes is largely 
repressed, whereas expression of STRE-regulated genes, like TPS1 and NTH1, is 
induced; the latter culminating in the starved cells acquiring a so-called ‘stress 
resistance’ phenotype (Rubio-Texeira et al., 2010).  
 
The response of S. cerevisiae to the quality and quantity of nutrients in its 
environment is mediated by numerous signaling pathways, among which two are 
prominent: the well-studied cAMP-PKA pathway and the FGM pathway. Whereas the 
cAMP-PKA pathway is activated by addition of glucose to non-fermenting or 
stationary phase cells, activation of the FGM pathway requires a complete growth 
medium in which all essential nutrients are present. 
 
Several nutrient-related sensors mediating nutrient-induced activation of the 
cAMP-PKA and FGM pathways have been identified. Detection of extracellular 
glucose and sucrose, for example, occurs through a GPCR system that is comprised of 
the receptor Gpr1 and its G protein Gpa2 (Lemaire et al., 2004). External amino acids 
are sensed and transported by Gap1, inorganic phosphate is sensed by Pho84 and 
Pho87, and Mep1 and Mep2 sense ammonium (Thevelein and Voordeckers, 2009; 
Popova et al., 2010). Interestingly, activation of the FGM pathway by the transported 
nutrient does not require its metabolization.  
 
The intracellular part of the pathway that connects the signal generated by the nutrient 
transporter/receptor, or transceptor, to its downstream effector, PKA, remains poorly 
understood. Strong experimental evidence, however, suggests that the protein kinase 
Sch9 acts downstream of the nitrogen (but not phosphate) sensors (Crauwels et al., 
1997; Giots et al., 2003).  
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In an attempt to identify domains of Gap1 specifically involved in signaling, short 
truncations of the extreme N- and C-termini of the permease were constructed. Partial 
removal of the Gap1 C terminal domain (14 amino acids; Gap1ΔC6(14aa)), however, 
transformed the permease into a constitutive signaling form that caused permanent 
activation of the PKA pathway under all nutrient conditions tested (Donaton et al., 
2003). To our knowledge, these mutant proteins represent the first example of an 
active nutrient transporter that causes permanent activation of a signaling pathway in 
eukaryotic cells. Further investigation revealed that this phenotype is dependent on a 
background mutation in the specific gap1Δ strain employed in our studies. The first 
part of the study therefore focused on additional characterization of the constitutive 
signaling phenotype, as well as identification of the background mutation.  
 
Characterization of the constitutive signaling Gap1 transceptor 
 
The constitutive signaling Gap1ΔC6(14aa) phenotype is characterized by low levels of 
the storage carbohydrates trehalose and glycogen, no repression of ribosomal protein 
genes, reduced expression of STRE-regulated genes, and an overall weak resistance to 
environmental stresses. In fact, of all the known PKA targets tested, only the activity 
of the trehalase enzyme remained unaffected by expression of the Gap1ΔC6(14aa) 
allele. The reason for this remains unclear, but may be due to additional inhibition of 
trehalase activity during nitrogen starvation in Gap1ΔC6(14aa)-carrying cells. 
Consequently, we employed mostly L-citrulline-induced mobilization of trehalose and 
glycogen as a more reliable read-out of overactive PKA activity in this study.  
 
We studied the contribution of known nutrient signaling pathways to the overactive 
signaling phenotype by, for example, blocking these pathways through the use of 
specific inhibitors. Inhibition of TORC1 activity by addition of the 
immunosuppressive drug, rapamycin, to yeast cells elicits profound physiological 
changes that include trehalose accumulation and the downregulation of amino acid 
transporters. However, exposing Gap1ΔC6(14aa)-expressing cells to rapamycin had no 
effect on the amount of trehalose accumulated by these mutants; levels of the storage 
carbohydrate remained consistently low throughout the treatment. Growth in the 
presence of rapamycin of an adenylate cyclase mutant carrying Gap1ΔC6(14aa) was 
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also unaffected, suggesting that Tor Complex 1 is dispensable for the overactive 
signaling phenotype. Similar observations were also made for the phosphoinositide 
4-kinase, Stt4. Blocking Stt4 activity with the antifungal antibiotic, wortmannin, left 
the Gap1ΔC6(14aa) cells unaffected, whereas similar treatment of the wild-type Gap1 
cells elicited the rapid accumulation of trehalose. Thus, as for TORC1, Stt4 activity 
seems to be obsolete for the constitutive signaling phenotype.  
 
Another serine/threonine protein kinase with a well-documented role in 
nutrient-sensing is the yeast PKB/S6K ortholog Sch9. Not only does the 
overexpression of SCH9 mitigate the growth-inhibitory properties of wortmannin, 
deletion of the kinase also renders the cells incapable of properly entering the G0 
phase when starved for nitrogen. Overexpression of SCH9 in Gap1ΔC6(14aa) cells, 
however, did not suppress the high PKA phenotype, as judged from the low levels of 
trehalose accumulated by the Gap1ΔC6(14aa) strain after starvation. This would suggest 
that Gap1ΔC6(14aa) does not signal through Sch9.  
 
As all PKA targets, with the exception of trehalase, are affected by expression of 
GAP1ΔC6(14aa), we next investigated the role of PKA itself in this phenomenon. We 
considered the possibility that Gap1ΔC6(14aa) enhances adenylate cyclase activity, 
which in turn could lead to the hyperactivation of PKA and, as a result, to the “high 
PKA” phenotype observed in the mutant cells. This seems reasonable, as earlier work 
by Amitrano et al. (1997) demonstrated a clear link between cAMP levels and Gap1 
activity: L-citrulline uptake in cyr1-1 mutant increased as the exogenously-added 
cAMP levels were increased from 0.25 to 1.0 mM. Deletion of CYR1 is lethal, but can 
be rescued through the additional deletion of PDE2 and culturing of the double 
deletion strain on cAMP-supplemented media. Remarkably, expression of 
GAP1ΔC6(14aa) in the cyr1Δ pde2Δ strain completely abolishes the requirement for 
exogenously-added cAMP, suggesting that the truncated permease functions 
downstream of the signaling pathways known to affect cAMP synthesis. This result 
also excludes the possibility that the constitutive signaling phenotype is mediated 
through either an increased affinity of the BCY1-encoded regulatory subunit (of PKA) 
for cAMP, or through a decreased affinity of Bcy1 for the PKA catalytic subunits. For 
the latter, one would still expect the requirement of cAMP for growth, although at a 
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reduced concentration compared to, for example, the cyr1Δ pde2Δ Gap1 strain. 
However, as no cAMP is required for growth, the most plausible explanation is that 
Gap1ΔC6(14aa) functions either directly through PKA, or by overactivation of a 
downstream effector of PKA involved in growth control, and/or by constitutively 
blocking a downstream inhibitor with a similar function. Interesting to note, is the 
recent discovery of an adenylate cyclase-independent regulatory mechanism 
controlling activity of PKA in the human pathogenic fungus 
Cryptococcus neoformans (Palmer et al., 2006).  
 
Subsequently, by inactivating all the PKA catalytic subunits, we could demonstrate 
the requirement of PKA for the overactive Gap1ΔC6(14aa) signaling phenotype. Hence, 
Gap1ΔC6(14aa) apparently acts at the level of PKA itself. These results probably also 
rule out the involvement of any additional component downstream of PKA as target 
of Gap1ΔC6(14aa). 
 
Of particular relevance is the connection made between PKA and TORC1 in this 
work. Previous work by Schmelzle et al. (2004) showed that constitutive activation of 
the cAMP-PKA pathway prevented several of the typical rapamycin-induced 
responses, i.e. the accumulation of glycogen or the down-regulation of ribosomal 
protein gene expression. These data are in line with our own observations, and was 
further supported by the finding that we could restore rapamycin-sensitivity to the 
Σ1278b genetic background, known for its hyperactive PKA pathway, by lowering its 
PKA activity. We could therefore employ the Gap1ΔC6(14aa) strain in a suppressor 
screen, in which suppressors of the overactive signaling phenotype may well provide 
new information on the link between these two nutrient-sensing pathways.  
 
Apart from the well-established adenylate cyclase-controlled stimulation of PKA 
activity, an alternative cAMP-independent bypass pathway for the activation of PKA 
was identified. Surprisingly, deletion of the KRH genes in the Gap1ΔC6(14aa) strain 
caused a clear reversal of the high PKA phenotype, with the single krh1Δ strain 
demonstrating the most pronounced turnaround in PKA activity, as deduced from the 
massive increase in trehalose levels in this strain. Moreover, the typical phenotypic 
differences between the wild-type Gap1 and Gap1ΔC6(14aa) strains, i.e. high trehalose 
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vs. low trehalose levels after nitrogen deprivation, are completely absent upon 
deletion of the KRH genes. In contrast, the Σ1278b krh1Δ KRH2 strain carrying a 
plasmid-borne copy of GAP1 continued to exhibit the high PKA phenotype that is 
typical of krhΔ strains.  
 
These results ofcourse raise the question as to why two seemingly similar krh1Δ 
strains in the same genetic background carrying the same copy of wild-type Gap1 can 
display such opposite PKA phenotypes. We entertained the notion that the original 
Σ1278b gap1Δ strain in which we obtain the overactive phenotype, may contain a 
genomic mutation that proves crucial for Gap1ΔC6(14aa) signaling. Furthermore, the 
fact that deletion of the KRH genes in this (mutant) background abolishes the high 
PKA phenotype, suggests that both Gap1ΔC6(14aa) and the Krh proteins converge on 
the same component additionally required for the constitutive signaling. Since 
deletion of the KRH genes enhance PKA activity, the Krh proteins are normally 
considered as inhibitors of PKA. If the Krh proteins are a target of Gap1ΔC6(14aa), one 
possibility could be that Gap1ΔC6(14aa) switches the Krh proteins from inhibitors to 
activators. This would explain why deletion of the KRH genes in the Gap1ΔC6(14aa) 
strain reduces or abolishes the high PKA phenotype. Together, these results indicate a 
potential role for the Krh proteins in the Gap1ΔC6(14aa) phenotype, but clearly require 
more investigation.  
 
Through various biochemical assays we confirmed the presence of a single and 
recessive genomic mutation, named seg1-1, present only in the original 
Σ1278b gap1Δ strain we employed in our Gap1ΔC6(14aa) characterization experiments. 
Our data also demonstrates the synergistic nature of the overactive signaling 
phenotype – both the truncated permease and seg1-1 is required for the high PKA 
phenotype; the absence of either results in wild-type PKA activity. When expressed in 
the seg1-1 strain, Gap1 alleles lacking a functional ER-exit domain, e.g. 
Gap1ΔC14(42aa), are not retained in the ER but instead show normal plasma membrane 
localization. Also, expression of GAP1ΔC6(14aa) in the seg1-1 strain results in its 
strong overaccumulation at the plasma membrane. Notably, the latter truncation of 
Gap1 lacks the last 11 amino acids essential for its NH4+-induced inactivation and 
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internalization, thus resulting in a far less efficient ubiquitination and downregulation 
of the permease (Hein and André, 1997; Springael and André, 1998).  
 
Based on these observations, we hypothesized that the overactive signaling phenotype 
of Gap1∆C6(14aa) in the seg1-1 strain is correlated with both its poor ubiquitination 
and concomitant overaccumulation at the plasma membrane. However, when tested in 
an npi1-1 SEG1 strain deficient for Rsp5-mediated ubiquitination, overexpression of 
GAP1∆C6(14aa) on a multi-copy plasmid did not result in an overactive signaling 
phenotype. This would suggest that seg1-1 contributes more to the overactive 
signaling phenotype than only ensuring the overaccumulation of Gap1∆C6(14aa) at the 
plasma membrane.  
 
It may prove worthwhile to evaluate other amino acid transporters lacking an ER 
export signal for their subcellular localization in seg1-1 cells. The di-acidic sequence 
(-DxD-; residues 564-566) of Gap1 essential for its sorting to the plasma membrane, 
is highly conserved among yeast amino acid permeases. In addition, Malkus and 
colleagues (2002) demonstrated the apparent universality of the permease export 
signal by creating an arginine permease molecule that contained the Gap1 ER exit 
signal. Appending Gap1’s ER exit signal to Can1 resulted in a chimeric molecule that 
was packaged into COPII transport vesicles even more efficiently than full-length 
Can1.  
 
Identification of the cognate gene for seg1-1 
 
We employed several approaches to identify the gene containing the seg1-1 mutation. 
In our single- and multi-copy suppressor screens, we made use of the unique 
properties of both the Gap1 transporter, in general, and the seg1-1 GAP1ΔC14(42aa) 
strain specifically. Keeping in mind that the Gap1ΔC14(42aa) allele is only properly 
localized to the plasma membrane in the seg1-1 strain, we set out to complement the 
mutation by virtue of growth on a medium supplemented with D-histidine; a toxic 
amino acid transported only by Gap1. We isolated eight different single-copy 
suppressors, most of which functions within the yeast’s early secretory pathway. In 
the multi-copy suppressor analysis, we isolated only amino acid carriers and no other 
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nutrient transporters, suggesting that seg1-1 specifically modulates the ER exit of 
amino acid permeases. Subsequent genetic analysis showed that also none of the 
single-copy suppressors were identical to the SEG1 gene.  
 
We ascribe the failure to isolate SEG1 by the conventional 
‘cloning-by-complementation’ procedure, to the typical shortcomings associated with 
this method. For instance, a gene may be underrepresented in a library or toxic in 
E. coli, or false positives may be more readily isolated than the gene of interest. Also, 
SEG1 may well be a large gene, which could make isolating the full-length SEG1 
from a 5-10 kb gDNA library, such as the one we used, more difficult.  
 
We therefore switched to a genetic mapping strategy, AMTEM, for the purpose of 
identifying SEG1. As a first step in the AMTEM methodology, we crossed the seg1-1 
mutant strain with several artificially-marked strains carrying 20 bp oligonucleotide 
markers inserted all over the genome. We isolated 11 segregants that displayed the 
overactive signaling phenotype, i.e. low levels of trehalose. Although recommended 
to take about 20 segregants carrying the desired trait, we took extreme care to only 
select those segregants which showed a clearly reduced level of the reserve 
carbohydrate (0.6-0.8% of trehalose per wet weight) after overnight nitrogen 
deprivation. Segregants with trehalose levels of 1% or more were excluded from the 
experiment. Similarly, for the segregants we selected as a negative control, i.e. those 
with wild-type PKA activity, we only focused on the segregants with a clearly 
increased level of trehalose after nitrogen starvation (2% or more).  
 
Application of the marker-detection micro-array resulted in negative signals for three 
adjacent markers located in a 40 kb region near the beginning of chromosome VIII. 
Further investigation revealed that, in addition to a variety of other genes, this region 
also contained a v-SNARE protein, Gos1, known to participate in multiple transport 
steps, most notably in the ER-Golgi transit. Deletion of GOS1 is characterized by the 
uncontrolled secretion of the ER-resident chaperone Kar2, indicative of an 
ER-retention defective (erd) phenotype.  
 
The critical role of Gos1 in the secretory pathway was further highlighted by the 
discovery that some SNARE proteins, like Gos1, not only ensure the efficient fusion 
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of a transport vesicle with an acceptor compartment, but also contribute to the 
specificity of intracellular transport. This was based on the finding that certain 
combinations of v- and t-SNAREs that actually inhibits vesicle fusion, e.g. 
Sed5-Sec22-Gos1-Bet1, are still found to assemble into non-fusogenic complexes in 
vivo. Originally, this was interpreted as evidence of SNARE proteins’ promiscuous 
nature. However, a study by Varlamov et al. (2004) demonstrated that these 
non-fusogenic complexes indeed have a biological function: that of 
inhibitory-SNARE (i-SNARE) complexes. i-SNARE proteins are thought to fine-tune 
the movement of transport vesicles through the secretory pathway by ‘removing’ 
fusogenic-competent SNARE complexes from the transport process and replacing 
them with non-fusogenic complexes, which in effect blocks vesicular traffic.  
 
Strikingly, when complemented with the Gap1ΔC6(14aa) allele, gos1Δ cells exhibited 
the same constitutive signaling phenotype as the seg1-1 Gap1ΔC6(14aa) mutant strain. 
Moreover, gos1Δ cells carrying wild-type Gap1 exhibited trehalose levels similar to 
that of the seg1-1 Gap1 strain, indicative of the wild-type PKA phenotype of the 
gos1Δ Gap1 strain. More importantly, though, is the fact that the high PKA phenotype 
of a gos1Δ strain is only observed in combination with the Gap1ΔC6(14aa) allele, 
which essentially corroborates our earlier findings on the synergistic character of the 
constitutive signaling phenotype.  
 
Sequence analysis of the GOS1 ORF, promoter and terminator regions in the seg1-1 
background, however, revealed no missense or any other potentially relevant 
mutations. This contrasts with the earlier data suggesting that GOS1 is identical to 
SEG1. The exact reason for this seemingly contradictory observation is not yet clear. 
We hypothesized that the expression of GOS1 may be affected by sequence variation 
in DNA sequences upstream and downstream of the GOS1 coding sequences. 
Surprisingly, qPCR analysis of the expression of GOS1 mRNA in the 
seg1-1 Gap1ΔC6(14aa) strain revealed a dramatic increase in GOS1 mRNA levels, 
whereas the levels of GOS1 mRNA in the seg1-1 Gap1 strain were unaffected. Hence, 
the differences in expression can only be attributed to the Gap1ΔC6(14aa) allele. The 
exact mechanism by which Gap1ΔC6(14aa) can influence the expression of Gos1 is not 
clear. We should, however, confirm the overexpression data at the protein level, i.e. 
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determine translational efficiency of the GOS1 mRNA to protein. If the level of Gos1 
protein is also strongly elevated, we have to conclude that both the disruption and 
overexpression of GOS1 support the overactive Gap1 allele.  
 
We sequenced the rest of the 40 kb region identified in the AMTEM screen and 
identified a point mutation within the ECM29 ORF. The nucleotide at bp 5524, an 
adenine in the Σ1278b wild-type parental strain, is substituted for a guanine in the 
seg1-1 mutant. This leads to an amino acid change where the amino acid residue at 
position 1842, an asparagine, is replaced by aspartic acid. This asparagine at position 
1842 is not evolutionary-conserved.  
 
The role that Ecm29 may play in the overactive signaling phenotype is not clear yet, 
and requires more investigation. Ecm29 was shown to enhance the stability of the 
proteasome by binding the organelle’s core catalytic particle to its regulatory particle, 
which in turn activates the proteasome’s de-ubiquitinating enzyme, Ubp6. Curiously, 
the disruption of UBP6 causes a two-fold decrease in the internalization of plasma 
membrane-localized Gap1 (Nikko and André, 2007a).  
 
Taken together, our results demonstrate a multi-faceted role for seg1-1. Expressing a 
secretion-incompetent Gap1 allele in the mutant background results in its localization 
to the plasma membrane where it exhibits wild-type function and stability. Moreover, 
expression in seg1-1 of a Gap1 allele lacking part of the C-terminus required for 
NH4+-induced downregulation, causes its overaccumulation at the plasma membrane 
(although this may be an indirect consequence of decreased ubiquitination and 
internalization). Hence, these results points to a mutation in a gene functioning within 
the secretory pathway, most probably in one of the principal genes regulating ER exit. 
However, when combined with the Gap1Δ6 allele(14aa), seg1-1 also results in 
constitutively-high PKA activity, a phenotype that was shown to be dependent on 
PKA itself. The high PKA phenotype is specific for the Gap1Δ6(14aa) allele, and is not 
observed when (much) longer or shorter truncations are employed, thus highlighting 
the importance of the specific truncation to the overall phenotype.  
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Glucose-induced activation of PP2A and PP1 
 
The second part of this study focuses on the glucose-induced activation of the 
ubiquitously-expressed protein phosphatases PP2A and PP1. Previous work in our 
laboratory has defined a role for the PP2A C subunits in nutrient-induced signaling: 
overexpression of PPH22 in wild-type cells was shown to trigger activation of the 
trehalase enzyme. On closer examination of the phenotype, it was revealed that 
PPH22-overexpression leads to the activation of all PKA targets investigated, i.e. a 
high PKA phenotype (Sugajska et al., 2001).  
 
In an earlier study by Somers (2006), it was shown that addition of glucose to 
glucose-derepressed cells triggers rapid activation of both PP2A and PP1. The 
activation is not blocked by addition of the protein synthesis inhibitor cycloheximide, 
which together with the rapidity of the response, indicates a post-translational 
mechanism. Maximum phosphatase activation is achieved with 20 mM glucose; 
employing higher or lower concentrations reduces the extent of activation.  
 
By using specific inhibitors, we were able to distinguish between PP2A and PP1 
activity in vitro. The contribution of PP2A to the total glucose-induced phosphatase 
activity was shown to be higher than that of PP1, with Pph21 supplying the bulk of 
the PP2A activity. We confirmed the role of the C-subunits in the carbon-induced 
activation of PP2A by reconstituting glucose-induced phosphatase activity in a 
pph21Δ pph22Δ strain with immunoprecipitated Pph21. Moreover, disruption of the 
PP2A-like catalytic subunits, PPG1, SIT4, and PPH3, had no influence on the 
glucose-induced stimulation of PP2A activity. Deletion of the regulatory subunit 
RTS1, however, completely abolished glucose-induced activation of PP2A. On the 
other hand, cells lacking Cdc55 or the structural subunit Tpd3 displayed no such 
defects. Although the exception rather than the rule, it was shown that 
functionally-stable PP2A complex do exist in the absence of Tpd3 (Koren et 
al., 2004). Interesting to note, is that Rts1 is 12 times as abundant as Cdc55, implying 
that there will always be a free pool of Rts1 in the cell (Janssens et al., 2008).  
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In a screen aimed at identifying components required for downregulation of the SPS 
amino acid-sensing pathway, Rts1 was isolated as a negative regulator of this 
pathway. Deletion of RTS1 caused the constitutive expression of SPS-responsive 
genes, such as AGP1 and BAP2 coding for amino acid transporters. These results 
propose a role for PP2A involvement in the SPS pathway, suggesting a 
dephosphorylation event may be required to downregulate signaling in the absence of 
extracellular amino acids (Eckert-Boulet et al., 2006). Recently, Rts1 was also 
identified as a novel upstream regulator of nutrient-dependent G1 cyclin transcription, 
the latter being required for entry into the cell cycle (Artiles et al., 2009). Together 
with our discovery of a role for Rts1 in glucose-induced activation of PP2A, the role 
of Rts1 as an integrator of nutrient signals is thus firmly entrenched.  
 
The addition of glucose to glycerol-grown cells was shown to also cause methylation 
of the PP2A catalytic subunit. This is an important finding, as it identifies a role for a 
nutrient (glucose) in the generation of functional PP2A complexes. 
Carboxymethylation of the catalytic subunits plays an important role in the binding of 
Pph21 and Pph22 to Cdc55; binding of Rts1 and Tpd3 to catalytic subunits is, 
however, somewhat less affected by the absence of methylation (Janssens et al., 
2008). Hence, changes in PP2A methylation might regulate the specificity of the 
enzyme in cells. In contrast to its role in assembly, methylation of the PP2A C 
subunits is not an absolute requirement for phosphatase activity. This observation is in 
line with our own data on PP2A activity in ppm1Δ cells; deletion of the major 
methyltransferase in yeast, PPM1, reduced glucose-induced PP2A activity with about 
40%. This result also lends further support to our earlier findings on the requirement 
of Rts1 for PP2A activation by glucose. As the association between unmethylated C 
subunits and Rts1 (and Tpd3) are only reduced and not fully abrogated, PP2A activity 
in ppm1Δ cells is only minimally affected.  
 
Loss of methylesterase activity in ppe1Δ cells resulted in a significant increase in 
glucose-stimulated PP2A activity when compared to the wild-type. This is somewhat 
surprising, as no obvious phenotype has been described for yeast cells lacking Ppe1 
(Wu et al., 2000). Our results, however, may be explained in context of the new 
model for PP2A holoenzyme assembly recently offered by Hombauer et al. (2007). 
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The authors proposed a model whereby Ppe1 represents a surveillance mechanism 
that prevents untimely methylation of the catalytic subunits in the absence of the 
structural subunit. In doing so, Ppe1 limits the risk of unspecific dephosphorylation 
events originating from inappropriate C subunit activation. The latter is associated 
with debilitating conditions in mammals such as cancer and Alzheimer’s disease 
(Leulliot et al., 2004). Thus, the increase in phosphatase activity exhibited by ppe1Δ 
cells may well be due to the fact that the C subunits in such cells are all in a 
hypermethylated state (due to uncontrolled methylation), resulting in an increase in 
unregulated C-subunit catalytic activity. Western analysis of the C subunits in ppe1Δ 
cells confirmed their hypermethylated state. 
 
The Hombauer model is particularly attractive as it also incorporates the activities of 
the yeast homologs of mammalian phosphotyrosyl phosphatase activator (PTPA), 
Rrd1 and Rrd2, in the generation of catalytically-active PP2A holoenzymes. It was 
shown that Rrd2 physically associates with Tpd3 and that this Tpd3-Rrd2 interaction 
is an essential prerequisite for binding the (unmethylated) Pph21/Pph22-Ppe1 
complex. Once bound to the unmethylated C subunits, Ppe1 is replaced and 
Ppm1-directed methylation of the C subunits can occur (Hombauer et al., 2007). We 
showed that loss of Rrd function completely abolishes the glucose-induced 
stimulation of PP2A activity. The lack of phosphatase activity in the rrdΔ mutants 
may be attributed to the formation of PP2A enzymes comprised of biochemically- and 
conformationally-altered C-subunits. Typically, such enzymes exhibit an increase in 
phosphotyrosine activity combined with a loss of phosphoserine/phosphothreonine-
specific catalytic activity.  
 
We also investigated the role of the main regulatory subunits of PP1 in the 
glucose-induced stimulation of its activity. We found that deletion of SHP1 and GLC8 
completely abolished PP1 activity; cells deficient for Gac1 or Red1 show only a 
partial reduction in glucose activation of the enzyme. Our data on Glc8 fits with an 
earlier report by Tung et al. (1995) who showed that Glc8, the yeast ortholog of 
mammalian inhibitor-2, functions both as activator and inhibitor of Glc7. When 
overproduced under certain physiological conditions, Glc8 binds to Glc7 at a 
low-affinity site, causing immediate and permanent inhibition of PP1 catalytic 
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activity. However, when Glc8 is present in low concentrations, it binds Glc7 at a 
different, high-affinity site in a 1:1 ratio, resulting in the formation of a 
temporarily-inactive Glc8-Glc7 complex that can be activated through the 
phosphorylation of Glc8. This suggests a function of Glc8 as a Glc7 chaperone, and 
explains our lack of PP1 activity in glc8Δ cells.  
 
Both Gac1 and Shp1 are involved in Glc7-regulated glycogen synthesis (Zhang et al., 
1995; Wu et al., 2001). The partial decrease in Glc7 activity observed for the gac1Δ 
strain may be an indirect consequence of the weak association that characterizes 
Glc7-Gac1 complexes in the presence of glucose. As glycogen accumulation only 
starts once glucose becomes limiting, the loss of Gac1 in cells supplemented with 
glucose may have a very limited effect on PP1 catalytic activity.  
 
Similarly, it was demonstrated that both Red1 and Gip1 are required for entry into 
early meiosis (Stark, 1996; Tu et al., 1996). We believe that it is this overlap in 
function between the two proteins that perhaps masks the effect that losing only one 
of them may have on glucose-induced activation of PP1. It may therefore prove 
worthwhile to test the red1∆ gip1∆ mutant for glucose activation of Glc7 catalytic 
activity. In addition, we could also evaluate the deletions of the other PP1 regulatory 
subunits lacking a glucose-activation phenotype for their effect on PP1 activity when 
combined with the deletion of another glucose-unresponsive PP1 subunit.  
 
The physiological relevance of glucose-induced activation of PP2A and PP1 may 
stem from the crucial role this carbon source plays on yeast physiology and 
development. Both PP2A and PP1 have been implicated in cellular processes as 
diverse as cell cycle progression, meiosis, sporulation, DNA transcription and glucose 
repression. In fact, the only common denominator in these processes is that they are 
all regulated by the availability of nutrients, especially glucose. As glucose activation 
of PP2A and PP1 occurs under the same conditions as glucose activation of the 
cAMP-PKA pathway, it is tempting to envision a process whereby the 
glucose-induced activation of the protein kinase-mediated signaling pathways is kept 
in check by the glucose-induced downregulation of the pathways, i.e. glucose could 
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bring balance in the activity of signaling pathways by stimulating also the activity of 
the opposing enzymes.  
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6.1. STRAINS AND PLASMIDS 
 
6.1.1. Yeast strains  
 
Saccharomyces cerevisiae strains used in this study are listed in Table 6.1. All 
experiments were performed with isogenic wild-type and mutant strains.  
 
Table 6.1: Saccharomyces cerevisiae strains used in this study. 
 
Strain Relevant genotype Source/Reference 
Chapter II 
∑1278b (JT 4500) MATα ura3 Grenson et al., 1970 
BY4742 MATα his3 leu2 lys2 ura3 Brachmann et al., 1998 
W303-1A MATa leu2-3,112 trp1-1 can1-100 ura3-1 ade2-1 his3-11,15 GAL mal SUC2 R. Rothstein 
IH 73 ∑1278b gap1Δ::KanMX ura3 I. Holsbeeks 
25.969b (JT 4505) ∑1278b seg1-1 gap1Δ::KanMX ura3 B. André 
JK 8 ∑1278b seg1-1 GAP1 ura3 This study 
IH 24 ∑1278b seg1-1 GAP1ΔC6(14aa) ura3 I. Holsbeeks 
IH 26 ∑1278b seg1-1 GAP1ΔC14(42aa) ura3 I. Holsbeeks 
JK 32 ∑1278b + pFL38 This study 
JK 33 ∑1278b + pFL38-GAP1 This study 
JK 34 ∑1278b + pFL38-GAP1∆C6(14aa) This study 
JT 20425 ∑1278b + pYX212 I. Holsbeeks 
OL 9 ∑1278b + pYX212-SCH9 O. Lagatie 
JK 24 ∑1278b gap1Δ::KanMX + pYX212 This study 
OL 8 ∑1278b gap1Δ::KanMX + pYX212-SCH9 O. Lagatie 
JK 25 ∑1278b seg1-1 GAP1ΔC6(14aa) + pYX212 This study 
OL 11 ∑1278b seg1-1 GAP1ΔC6(14aa) + pYX212-SCH9 O. Lagatie 
JK 35 ∑1278b seg1-1 gap1Δ::KanMX sch9Δ::KanMX + pFL38-GAP1 This study 
JK 36 ∑1278b seg1-1 gap1Δ::KanMX sch9Δ::KanMX + pFL38-GAP1∆C6(14aa) 
This study 
JK 39 ∑1278b seg1-1 GAP1ΔC6(14aa) + pFL38 This study 
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JK 41 ∑1278b seg1-1 tpk1Δ::KanMX tpk2
ts 
tpk3Δ::URA3 GAP1 This study 
JK 42 ∑1278b seg1-1 tpk1Δ::KanMX TPK2 tpk3Δ::URA3 GAP1 This study 
JK 43 ∑1278b seg1-1 tpk1Δ::KanMX tpk2
ts 
tpk3Δ::URA3 GAP1ΔC6(14aa) 
This study 
JK 44 ∑1278b seg1-1 tpk1Δ::KanMX TPK2 tpk3Δ::URA3 GAP1ΔC6(14aa) 
This study 
JK 2 ∑1278b seg1-1 cyr1Δ::KanMX pde2Δ:: URA3 GAP1ΔC6(14aa) 
This study 
JK 1 ∑1278b seg1-1 cyr1Δ::KanMX pde2Δ:: URA3 GAP1 This study 
JK 50 ∑1278b seg1-1 gap1Δ::KanMX krh1Δ::hisG KRH2 + pFL38-GAP1 This study 
JK 51 ∑1278b seg1-1 gap1Δ::KanMX krh1Δ::hisG KRH2 + pFL38-GAP1∆C6(14aa) 
This study 
JK 52 ∑1278b seg1-1 gap1Δ::KanMX krh1Δ::hisG krh2Δ::hisG + pFL38-GAP1 This study 
JK 53 ∑1278b seg1-1 gap1Δ::KanMX krh1Δ::hisG krh2Δ::hisG + pFL38-GAP1∆C6(14aa) 
This study 
JT 20445 ∑1278b seg1-1 gap1Δ::KanMX + pFL38-GAP1∆C6(14aa) 
Donaton et al., 2003 
JK 55 ∑1278b seg1-1 gap1Δ::KanMX KRH1 krh2Δ::hisG + pFL38-GAP1 This study 
JK 56 ∑1278b seg1-1 gap1Δ::KanMX KRH1 krh2Δ::hisG + pFL38-GAP1∆C6(14aa) 
This study 
JK 57 ∑1278b SEG1 gap1Δ::KanMX krh1Δ::hisG KRH2 + pFL38-GAP1 This study 
JK 59 ∑1278b SEG1 gap1Δ::KanMX krh1Δ::hisG krh2Δ::hisG + pFL38-GAP1 This study 
OL 85 ∑1278b seg1-1 GAP1ΔC6(14aa) + pFL38-GAP1 O. Lagatie 
JK 46 BY gap1Δ::KanMX + pFL38-GAP1∆C6(14aa) This study 
JT 20545 W303-1A gap1Δ::KanMX + pFL38-GAP1∆C6(14aa) 
I. Holsbeeks 
JK 47 ∑1278b gap1Δ::KanMX + pFL38-GAP1∆C6(14aa) 
This study 
IH 88 ∑1278b seg1-1 gap1Δ::KanMX + pFL38-GAP1∆C7(3aa) 
I. Holsbeeks 
IH 91 ∑1278b seg1-1 gap1Δ::KanMX + pFL38-GAP1∆C11(15aa) 
I. Holsbeeks 
IH 92 ∑1278b seg1-1 gap1Δ::KanMX + pFL38-GAP1∆C12(20aa) 
I. Holsbeeks 
JT 20417 ∑1278b seg1-1 gap1Δ::KanMX + pFL38-GAP1∆C14(42aa) 
I. Holsbeeks 
JK 73 ∑1278b gap1Δ::KanMX + pFL38-GAP1∆C6(14aa) 
This study 
JK 74 ∑1278b gap1Δ::KanMX + pFL38-GAP1∆C7(3aa) This study 
JK 75 ∑1278b gap1Δ::KanMX + pFL38-GAP1∆C11(15aa) 
This study 
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JK 76 ∑1278b gap1Δ::KanMX + pFL38-GAP1∆C12(20aa) 
This study 
JK 77 ∑1278b gap1Δ::KanMX + pFL38-GAP1∆C14(42aa) 
This study 
OL 65 ∑1278b gap1Δ::KanMX + pFL44L-GAP1 O. Lagatie 
OL 66 ∑1278b npi1-1 + pFL44L-GAP1 O. Lagatie 
JK 80 ∑1278b gap1Δ::KanMX + pFL44L-GAP1∆C6(14aa) 
This study 
JK 81 ∑1278b npi1-1 + pFL44L-GAP1∆C6(14aa) This study 
JK 82 ∑1278b gap1Δ::KanMX + pFL44L This study 
JK 83 ∑1278b seg1-1 GAP1ΔC6(14aa) + pFL44L This study 
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OL 43 ∑1278b gap1Δ::KanMX / gap1Δ::KanMX seg1-1 / SEG1 + pFL38-GAP1∆C6(14aa) 
O. Lagatie 
OL 44 ∑1278b gap1Δ::KanMX / gap1Δ::KanMX seg1-1 / SEG1 + pFL38-GAP1∆C14(42aa) 
O. Lagatie 
JK 63 gap1Δ::KanMX erp2Δ::KanMX + pFL38-GAP1∆C6(14aa) 
This study 
JK 64 gap1Δ::KanMX erp4Δ::KanMX + pFL38-GAP1∆C6(14aa) 
This study 
JK 65 gap1Δ::KanMX vps26Δ::KanMX + pFL38-GAP1∆C6(14aa) 
This study 
JK 66 gap1Δ::KanMX vps29Δ::KanMX + pFL38-GAP1∆C6(14aa) 
This study 
JK 67 gap1Δ::KanMX vps35Δ::KanMX + pFL38-GAP1∆C6(14aa) 
This study 
JK 68 gap1Δ::KanMX stp2Δ::KanMX + pFL38-GAP1∆C6(14aa) 
This study 
JK 69 gap1Δ::KanMX dia4Δ::KanMX + pFL38-GAP1∆C6(14aa) 
This study 
JK 70 gap1Δ::KanMX caj1Δ::KanMX + pFL38-GAP1∆C6(14aa) 
This study 
JK 92 ∑1278b gap1Δ::KanMX gos1Δ::KanMX + pFL38-GAP1∆C6(14aa) 
This study 
JK 93 ∑1278b gap1Δ::KanMX wsc4Δ::KanMX + pFL38-GAP1∆C6(14aa) 
This study 
JK 96 ∑1278b gap1Δ::KanMX / gap1Δ::KanMX seg1-1 / seg1-1 + pFL38-GAP1 This study 
JK 97 ∑1278b gap1Δ::KanMX / gap1Δ::KanMX seg1-1 / gos1Δ::KanMX + pFL38-GAP1 This study 
JK 99 ∑1278b gap1Δ::KanMX / gap1Δ::KanMX seg1-1 / gos1Δ::KanMX + pFL38-GAP1∆C6(14aa) 
This study 
JK 98 ∑1278b gap1Δ::KanMX / gap1Δ::KanMX seg1-1 / seg1-1 + pFL38-GAP1∆C6(14aa) 
This study 
Chapter IV 
BY4742 MATα his3 leu2 lys2 ura3 Brachmann et al., 1998 
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Record nr. 13832 BY4742 pph21Δ::KanMX Giaever et al., 2002 
Record nr. 13886 BY4742 pph22Δ::KanMX Giaever et al., 2002 
JT 21039 BY4742 pph21Δ::KanMX pph22Δ::KanMX I. Somers 
JK 109 BY4742 pph21Δ::KanMX pph22Δ::KanMX + pYX142 This study 
JK 114 BY4742 pph21Δ::KanMX pph22Δ::KanMX + pYX142-HA-PPH21 This study 
JK 113 BY4742 + pYX142-HA-PPH21 This study 
JK 117 BY4742 cdc55Δ::LEU2 This study 
Record nr. 11790 BY4742 rts1Δ::KanMX Giaever et al., 2002 
JK 118 BY4742 rts1Δ::KanMX cdc55Δ::LEU2 This study 
Record nr. 16866 BY4742 tpd3Δ::KanMX Giaever et al., 2002 
JK 123 BY4742 ppm1Δ::KanMX This study 
JK 124 BY4742 ppe1Δ::KanMX This study 
JK 126 BY4742 ppm1Δ::KanMX ppe1Δ::KanMX This study 
JK 125 BY4742 ppe1Δ::KanMX + pYX142-HA-PPH21 This study 
Record nr. 12312 BY4742 rrd1Δ::KanMX Giaever et al., 2002 
Record nr. 12100 BY4742 rrd2Δ::KanMX Giaever et al., 2002 
JK 116 BY4742 rrd1Δ::KanMX rrd2Δ::KanMX This study 
Record nr. 13084 BY4742 shp1Δ::KanMX Giaever et al., 2002 
Record nr. 16451 BY4742 glc8Δ::KanMX Giaever et al., 2002 
Record nr. 12434 BY4742 gac1Δ::KanMX Giaever et al., 2002 
Record nr. 15172 BY4742 red1Δ::KanMX Giaever et al., 2002 
 
6.1.2. Bacterial strain  
 
The Escherichia coli strain used in this study is listed in Table 6.2. The E. coli TOP10 
strain was used for molecular cloning and plasmid propagation.  
 
Table 6.2: Escherichia coli strain used in this study. 
 
Strain Relevant genotype Source/Reference 
TOP10 
F- mcrA Δ(mrr-hsdRMS-mcrBC) φ80lacZΔM15 
ΔlacX74 nupG recA1 araD139 Δ(ara-leu)7697 galE15 
galK16 rpsL(StrR) endA1 λ- 
Invitrogen 
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6.1.3. Plasmids 
 
All plasmids used in this study are summarized in Table 6.3.  
 
Table 6.3: Plasmids used in this study 
 
Plasmid Insert Source/Reference 
Chapter II and Chapter III 
pFL38  Bonneaud et al., 1991 
pYX212  Ingenius, Madison, WI 
pFL44L  Bonneaud et al., 1991 
pFL38-GAP1 GAP1 Hein and André, 1997 
pFL38-GAP1∆C6(14aa) GAP1∆C6(14aa) I. Holsbeeks 
pFL38-GAP1∆C7(3aa) GAP1∆C7(3aa) I. Holsbeeks 
pFL38-GAP1∆C11(15aa) GAP1∆C11(15aa) I. Holsbeeks 
pFL38-GAP1∆C12(20aa) GAP1∆C12(20aa) I. Holsbeeks 
pFL38-GAP1∆C14(42aa) GAP1∆C14(42aa) I. Holsbeeks 
pYX212-SCH9 SCH9 I. Geyskens 
pFL44L-GAP1 GAP1 O. Lagatie 
pFL44L-GAP1∆C6(14aa) GAP1∆C6(14aa) This study 
pFL44L-multi-copy yeast 
genomic library 
S. cerevisiae genomic DNA; 
3 to 4 kb insert Bonneaud et al., 1991 
YCp50-single-copy yeast 
genomic library 
S. cerevisiae genomic DNA; 
5 to 10 kb insert Rose et al., 1987 
Chapter IV 
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6.2. METHODS 
 
6.2.1. Bacterial culture conditions 
 
Escherichia coli cells were grown at 37°C in Luria-Bertani medium (1% w/v NaCl, 
1% w/v Bactotryptone and 0.5% w/v yeast extract; pH 7.5). For Ampr selection, 
ampicillin was added to a final concentration of 100 µg/ml. Solid medium contained 
1.5% w/v agar in addition.  
 
6.2.2. Yeast culture conditions 
 
Yeast cells were cultured under continuous shaking at 30°C, unless stated otherwise. 
When selection for a specific nutritional marker was required, cells were grown in 
defined minimal media containing 0.17% w/v Yeast Nitrogen Base without amino 
acids and ammonium sulfate, 2% w/v glucose or 3% w/v glycerol, 0.5% w/v 
ammonium sulfate and supplemented with the appropriate synthetic amino 
acid/nucleotide mixture. The pH was adjusted to 5.5 with 4 M KOH. For solid 
medium, 1.5% w/v agar was added and the pH was adjusted to 6.5 with 4M KOH. 
When no minimal media was required for the selection of plasmids, cells were grown 
on nutrient-rich YP medium, containing 1% w/v yeast extract, 2% w/v Bactopeptone 
and 2% w/v glucose (for YPD) or 3% glycerol (for YPGly). In all experiments care 
was taken to use strains with identical autotrophies in order to avoid any potential 
marker effects on growth; when necessary, empty plasmids were introduced. For 
selection of geneticin-resistant mutants, geneticin was added to a final concentration 
of 100 µg/ml.  
 
For experiments with nitrogen-starved cultures, cells were first grown to 
mid-exponential phase (OD600 = 1.5 – 2.0), harvested under sterile conditions and 
resuspended in nitrogen starvation medium (0.17% w/v Yeast Nitrogen Base without 
amino acids and ammonium sulfate, supplemented with 4% w/v glucose). Cultures 
were then incubated under continuous shaking for 24 h, while care was taken that 
glucose levels remained high throughout the entire period of starvation.  
 
Chapter VI 
 
 163 
6.2.3. General molecular biology methods 
 
Polymerase chain reaction (PCR) was performed with PfuTurbo (Stratagene) or 
ExTaq (Takara) for cloning and diagnostic PCR respectively, according to the 
manufacturer’s recommendations. Cloning was performed using standard restriction 
and ligation procedures, as described by Sambrook et al. (1989). Restriction digests 
were performed by incubation of DNA with the specific restriction enzymes and 
supplied reaction buffers for 2 h at the required temperature. Ligations were 
performed with the rapid ligation kit (Roche). E. coli transformations were performed 
according to the CaCl2-procedure as described by Sambrook et al. (1989). Plasmid 
DNA was prepared from E. coli cells as described by Del Sal et al. (1988). DNA 
sequencing was performed by the dideoxy chain-termination method, unless stated 
otherwise. Detection was performed with an Applied Biosystems model 3100 Avant 
Genetic Analyzer according to the manufacturer’s instructions, unless stated 
otherwise. Genomic and plasmid DNA was extracted from yeast with PCI 
(phenol/chloroform/isoamyl alcohol; 25:24:1), according to Hoffman and Winston 
(1987). Yeast was transformed according to Gietz et al. (1995), with the exception 
that the heat-shock treatment of temperature-sensitive strains occurred at 37°C.  
 
6.2.4. Tetrad analysis 
 
Crossing and sporulation was done following standard procedures as described by 
Sherman and Hicks (1991). Diploid strains were sporulated for 5 to 7 days at 23°C on 
solid sporulation medium A (1% w/v potassium acetate and 1.5% w/v agar). The 
ascus walls of the tetrads were digested with lyticase (500 U/ml) for 10 min at room 
temperature. Individual tetrads were separated and dissected using a 
micromanipulator (MSM System Series 3000, Singer Instruments). Growth of all 
yeast strains derived from crossing and subsequent sporulation was tested on the 
appropriate selective media to determine the presence of the auxotrophic markers 
used to delete the genes. Genotype characterization of all segregants was additionally 
checked by PCR analysis.  
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6.2.5. Single-copy suppressor analysis of seg1-1  
 
Strain IH26 was transformed with 50 µg plasmid DNA from the single-copy yeast 
genomic library in YCp50 (Rose et al., 1987). Transformants were plated on MPDHis 
media (0.16% w/v D-histidine, 0.1% w/v L-proline, 1% w/v succinic acid, 0.6% w/v 
NaOH, 0.16% w/v Yeast Nitrogen Base without amino acids and ammonium sulfate, 
2% w/v glucose, and 1.5% w/v agar). The total number of transformants was 
estimated at 30,000. Plasmids were isolated from viable transformants and the 
genomic DNA inserts were identified by sequence analysis.  
 
6.2.6. Multi-copy suppressor analysis of seg1-1  
 
Similar to the single-copy suppressor analysis, strain IH26 was transformed with 
50 µg plasmid DNA from the multi-copy yeast genomic library in pFL44L (Bonneaud 
et al., 1991). Transformants were plated on MPDHis media. The total number of 
transformants was estimated at over 50,000. Plasmids were isolated from viable 
transformants and the genomic DNA inserts were identified by sequence analysis 
 
6.2.7. Marker-detection micro-array 
 
Micro-arrays were custom-made by Agilent. In total, 25 60 bp-probes were spotted 
per marker. These probes form a sliding window starting with a probe with 32 bases 
of the upstream sequence up to the end of the marker and sliding one base at a time to 
a probe with the marker followed by 32 bases of its downstream sequence. Of the 33 
possible probes obtained per marker in this way, 8 were omitted for purposes of slide 
design. 
 
Genomic DNA of a test strain and genomic DNA of the control strain (S288c without 
any artificial marker) was first digested with two mixtures of three enzymes (HindIII, 
BglII, XbaI and SacII, MjeI, DraI) and then mixed again. Labeling and subsequent 
purification was done with the BioPrime® Total Genomic Labeling System 
(Invitrogen), according to the manufacturer’s recommendations. A competitive 
hybridization was then performed according to the Agilent Oligo acGH/ChIP-on-Chip 
protocol.  
Chapter VI 
 
 165 
Statistical data analysis was performed on the processed Cy3 and Cy5 intensities, as 
provided by the Agilent Feature Extraction software version 9.1. The control spots 
(i.e. spots with Control Type equal to -1 or 1) were removed from the data set. Further 
analysis was performed in the R programming environment, in conjunction with the 
packages developed within the Bioconductor project (http://www.bioconductor.org; 
Gentleman et al., 2004). For each hybridization, we computed for each marker the 
regression coefficients of the regression line of the Cy5 intensities on the x-axis 
(control strain) vs. the Cy3 intensities on the y-axis (test strain). Plotting the intercepts 
vs. the slopes of the regressions showed a clear separation in the data. We clustered 
the data with K-means for K=2. The group of markers with slope values close to zero 
and high intercept values, consists out of present markers. The group with slope 
values close to one and intercept values close to zero corresponds to the absent 
markers 
 
6.2.8. Statistical analysis 
 
The probability of observing a given marker segregation by chance was calculated as 
a product of a binomial probability: 
 
    b(x; n, P) = nCx × Px × (1 - P)n - x 
 
where “x” is the number of successes that result from the binomial experiment (all 11 
segregants lack marker 250), “n” is the number of trials in the binomial experiment 
(total of 11 segregants checked), “P” is the probability of success on an individual 
trial (50% chance that an individual segregant contains a marker), b(x; n, P) is the 
binomial probability, i.e. the probability that an “n”-trial binomial experiment results 
in exactly “x” successes, when the probability of success on an individual trial is “P”, 
and nCr is the number of combinations of “n” things, taken “r” at a time.  
 
6.2.9. Determination of trehalose and glycogen content 
 
Nitrogen-starved, glucose-repressed cells were cooled on ice for 30 min, harvested by 
centrifugation, washed with ice-cold 25 mM MES buffer pH 6.0, and resuspended at a 
cell density of 25 mg/ml cells (wet weight) in fresh nitrogen starvation medium 
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supplemented with 4% glucose. Cells were pre-incubated at 30°C for 20 min before 
sampling started at the indicated time points. Samples of 25 to 35 mg cells were 
collected by filtration, washed twice with ice-cold water, weighed and flash-frozen in 
liquid nitrogen. Frozen cells were thawed on ice, resuspended in 500 µ l 0.25 M 
Na2CO3 and incubated for 1 h at 95°C. Trehalose and glycogen levels were 
determined as described previously by Colombo et al. (1998). The samples for 
trehalose determination were spun down and 10 µl of the clear supernatant was used. 
The samples for glycogen determination were instead mixed well and used directly 
(10 µ l). All samples were neutralized by addition of 5 µ l of 1 N acetic acid. For 
trehalose determination, 25 µl trehalase (extracted from Humicola) in buffer (60 mM 
NaAc, 6 mM CaCl2; pH 5.5) was added, and samples were incubated for 1 h at 40°C. 
For glycogen determination, 25 µ l amyloglucosidase (extracted from 
Aspergillus niger) in buffer (400 mM NaAc; pH 4.7) was added and incubated for 1 h 
at 40°C. After centrifugation, 20 µ l of the supernatant from both the trehalose and 
glycogen samples were transferred to a microtiter plate. To determine the amount of 
glucose liberated from trehalose and glycogen, 200 µ l GOD-PAP reagent (Dialab) 
were added and absorbance measured at 505 nm. Trehalose and glycogen levels are 
expressed as % of trehalose or glycogen, i.e. mg trehalose or glycogen per 100 mg 
cells, wet weight.  
 
6.2.10. Real-time quantitative PCR (qPCR) 
 
Culture samples for total RNA extraction were harvested by centrifugation; the pellet 
was flash-frozen in liquid nitrogen, and stored at -80°C. Total RNA was extracted 
from yeast cells using PCI. From 1 µg of total RNA, first-strand cDNA was prepared 
with the Promega AMV Reverse Transcription system according to the 
manufacturer’s instructions. The relative quantification of genes was determined by 
qPCR using the KAPA fast SYBR mix (KAPA Biosystems). The PCR reaction was 
made up to 20 µ l, consisting of 10 µ l KAPA fast SYBR mix, 0.4 µ l of each primer 
(10 µM), 5 µl of cDNA (10 ng/µl) and 4.2 µl RNase-free H2O. Primers were designed 
according to the manufacturer’s instructions and were probed for dimer formation. 
The qPCR was monitored with the ABI Prism 7000 Sequence Detection System 
(Applied Biosystems). The expression of RDN18-1 (18S) was used as a reference.  
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6.2.11. Immunopurification of yeast proteins 
 
To prepare crude extracts of yeast cells expressing tagged proteins, cells were 
resuspended in 500 µ l ice-cold lysis buffer (PBS buffer, 0.1% Triton X-100, 10% 
glycerol, 2.5 mM MgCl2, 1 mM EDTA pH 8.0, 1 mM DTT, 10 mM NaF, 
0.4 mM Na3VO4, 0.1 mM β-glycerophosphate, containing protease inhibitor cocktail 
(complete, EDTA-free; Roche)). The same volume glass beads were added and cells 
were lysed by vigorous vortexing (4 × 1 min, with cooling on ice in between 
vortexing steps). Lysates were cleared by centrifugation (10 min, 14,000g, 4°C). The 
supernatant was transferred to a new Eppendorf tube, and centrifuged for a second 
time at the specifications described before. Cleared cell extracts were incubated with 
100 µl of a 50:50 slurry of protein G agarose beads (washed with lysis buffer; Roche) 
and 5 µ l of the appropriate antibody for 1 h on a rollerdrum (4°C). Bead-bound 
immunocomplexes were collected by centrifugation and beads were extensively 
washed with lysis buffer. Finally, beads were resuspended in SDS-supplemented 
sample buffer (added to a final concentration of 50 mM Tris pH 8.0, 
10 mM β-mercapto-ethanol, 0.1% w/v bromophenol blue, 10% v/v glycerol, and 
2% w/v SDS), boiled for 5 min at 95°C, and proteins were analyzed via SDS-PAGE 
and western blotting.  
 
6.2.12. Western blotting 
 
Total protein concentrations of crude cell extracts were determined using the Bradford 
method (Bradford, 1976). After the addition of sample buffer, samples were boiled for 
5 min at 95°C. Solubilized proteins were separated via SDS-PAGE (NuPAGE® 
4-12% Bis-Tris gel; Invitrogen) in NuPAGE® MOPS SDS running buffer (Invitrogen) 
at a constant voltage of 120 V. After electrophoresis, proteins were transferred onto 
nitrocellulose membranes (HybondC extra; GE Healthcare) by blotting for 90 min at 
300 mA in blotting buffer (NuPAGE® MOPS SDS running buffer supplemented with 
20% v/v methanol). Aspecific antibody binding was prevented by incubating the 
membrane in blocking buffer (5% w/v skim milk powder in TBS-Tween (TBST) 
buffer (25 mM Tris-HCl pH 8.0, 150 mM NaCl, and 0.05 % v/v Tween-20)) for 1 h at 
room temperature. Subsequently, blots were incubated overnight at 4°C with the 
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appropriate primary antibody dissolved in blocking buffer. Following overnight 
incubation, blots were washed three times with TBST buffer and incubated with the 
appropriate secondary antibody dissolved in blocking buffer. After washing three 
times with TBST, membranes were incubated with Supersignal chemiluminescence 
substrate (Pierce). Proteins were visualized either by exposure of the membrane to 
light-sensitive film (TebuBio) or by the LAS4000 mini digital system (Fujifilm). 
Signals were quantified with Aida software.  
 
6.2.13. Antibodies used 
 
Anti-HA (12CA5; Roche) for immunoprecipitation of HA-tagged proteins 
 
Primary antibodies  
• Anti-HA (high affinity, mouse; Roche), 1:1000 in TBST + 2.5% milk, coupled 
to HRP, used for detection of HA-tagged proteins in Western blot 
• Anti-Gap1 (rabbit; gift from Bruno André, Université Libre de Bruxelles), 
1:5000 in TBST + 2.5% milk 
• Anti-methylated PP2A C subunit (clone 2A10, mouse; Millipore), 1:1000 in 
TBST + 2.5% milk 
• Anti-unmethylated PP2A C subunit (clone 1d6, mouse; Millipore), 1:200 in 
TBST + 2.5% milk 
 
Secondary antibodies  
• Anti-mouse, HRP-conjugated (GE Healthcare), 1:5000 in TBST + 2.5% milk 
• Anti-rabbit, HRP-conjugated (GE Healthcare), 1:5000 in TBST + 5% BSA 
 
6.2.14. Phosphatase activity assay 
 
6.2.14.1. Preparation of 32P-phosphorylase a 
 
To obtain 32P-labeled phosphorylase a, 30 mg of glycogen phosphorylase b (Sigma) 
was dissolved in 1 ml of buffer (pH 7.5) containing 50 mM β-glycerophosphate, 10 % 
v/v glycerol, 0.1% v/v β -mercapto-ethanol, and 0.1 mM EDTA. To this solution, 
155 µl 2 mM ATP, 125 µl 50 mM Mg·(CH3COO)2, 5 µl 100 mM CaCl2, 80 µl 0.5 M 
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Tris-HCl pH 8.0, 100 U glycogen phosphorylase kinase (Sigma), 520 µ l H2O, and 
15 µl of [γ32P]ATP (10 µCi/µ l) was added to initiate the phosphorylation of 
phosphorylase b. After 90 min at 30°C, proteins were precipitated by addition of 2 ml 
ice-cold saturated ammonium sulfate (pH 7.0). EDTA (3 mM) and NaF (15 mM) 
were added to inhibit the glycogen phosphorylase kinase. After 2 h on ice and 
subsequent centrifugation (10 min, 14,000g, 4°C), the pellet is dissolved in dialysis 
buffer (50 mM Tris-HCl pH 7.0, 0.1% v/v β-mercapto-ethanol) and dialyzed (4 × 1 L, 
4°C). The 32P-labeled phosphorylase a substrate was stored for no longer than one 
week at 4°C.  
 
6.2.14.2. Sampling 
 
Cultures (1 L) of glucose-deprived cells were harvested by centrifugation (3000g, 
5 min, 4°C), washed with ice-cold MES buffer (25 mM, pH 6.0), and resuspended in 
40 ml growth medium lacking glucose. Cells were pre-incubated at 30°C for 20 min 
before sampling started at the indicated time points. Four samples of 3 ml containing 
approximately 100 mg cells were removed prior to induction with 20 mM glucose. 
Following induction at time “0”, additional samples were taken at time 0.5, 1, 1.5, 
2.5, and 15 min. All samples were immediately spun down, flash-frozen in liquid 
nitrogen, and stored at -80°C.  
 
6.2.14.3. Phosphatase activity assay 
 
Cell pellets were thawed on ice and dissolved in 100 µ l of ice-cold lysis buffer 
(50 mM Tris-HCl pH 7.4, 0.1 mM EDTA, 0.1% v/v β -mercapto-ethanol) to which 
protease inhibitors (complete, EDTA-free; Roche) were added. The same volume 
glass beads were added and cells were lysed by vigorous vortexing (4 × 1 min, with 
cooling on ice in between vortexing steps). After clearing the lysates by centrifugation 
(10 min, 14,000g, 4°C), 10 µl of the supernatant was added to 10 µl of Buffer I (lysis 
buffer supplemented with 1 mg/ml BSA). In the experimental conditions where 
specifically PP2A activity was measured, inhibitor-2 (rabbit skeletal muscle; New 
England Biolabs) was included at a final concentration of 0.2 µM. The phosphatase 
reaction was initiated by addition of 10 µ l of a glycogen phosphorylase a solution 
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(30% v/v 32P-labeled phosphorylase a, 50% v/v lysis buffer, and 20% v/v caffeine 
(75 mM)). After incubating the reaction for 30 min at 30°C, it was stopped by 
addition of 30 µl ice-cold TCA (30% v/v). Following centrifugation (10 min, 14,000g, 
4°C), the supernatant was transferred to scintillation liquid and counted in a 
scintillation counter (Beckman Coulter LS6500). Protein concentrations of the 
samples were determined using the Bradford method (Bradford, 1976). Specific 
phosphatase activity is expressed as nmol phosphatase released per min per mg 
protein. Phosphatase release from glycogen phosphorylase a by phosphatases present 
in cell extracts was linear over at least 30 min.  
 
6.2.15. Disruption of PP2A complexes and isolation of the monomeric catalytic 
subunit 
 
Monomeric HA-Pph21 was isolated by immunoprecipitation of cell lysates, which 
had been treated with a basic pH shift to disrupt PP2A complexes, followed by 
neutralization. The lysates were generated as described before, except that the lysis 
buffer contained 10 mM instead of 50 mM Tris-HCl (section 6.2.14.3.). The basic pH 
shift (pH 11.5) was obtained by adding 6.25 µl of triethylamine (Sigma) to 500 µl of 
cell lysates. After 5 min incubation at room temperature, the reaction was neutralized 
by adding 330 µl of 0.1 N HCl and was used for immunoprecipitation experiments.  
 
6.2.16. Demethylation of the PP2A catalytic subunit 
 
Lysates were generated as described before, except that cell extracts were prepared in 
the presence of 2 nM okadaic acid to prevent further methylation and demethylation 
of C subunits. 20 µl of each lysate was placed on ice and demethylated by addition of 
10 µ l of 0.5 M NaOH. After 5 min incubation, the samples were neutralized by 
addition of 10 µ l of 0.5 M HCl and 5 µ l of 2 M Tris (pH 6.8), and used for 
immunoprecipitation experiments.  
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Reproducibility of results 
 
All experiments in this study were repeated at least twice. The results always showed 
consistent trends, i.e. differences between strains and mutants were highly 
reproducible. In all cases, results from representative experiments are shown.  
 
The results of single time point measurements (e.g. accumulation of trehalose) are 
based on three independent measurements and standard deviations are indicated by 
means of the error bars in the graphs. Time course experiments (e.g. mobilization of 
trehalose after addition of L-citrulline) are repeated at least twice. The output of the 
time course experiments depicted in this study are the results of one of those 
experiments. The relative order of activation of the used strain was compared to the 
proper controls included in each experiment. The relative order of activation was 
highly reproducible.  
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SUMMARY 
 
 
For microorganisms, nutrients represent one of the key environmental determinants 
controlling many aspects of cell function, including growth and proliferation. For 
example, addition of amino acids to nitrogen-deprived, glucose-grown cells of the 
yeast Saccharomyces cerevisiae triggers a rapid reversal of the stationary phase 
phenotype that characterizes such cells, i.e. trehalose and glycogen are mobilized, and 
cells lose their overall stress resistance and resume growth. Two major 
nutrient-sensing pathways in yeast, the cAMP-Protein Kinase A (PKA) pathway and 
the Fermentable Growth Medium-induced (FGM) pathway, couple nutrient cues to 
the cell’s physiological and developmental program. Whereas the cAMP-PKA 
pathway is activated in response to fermentable carbon sources, activation of the 
FGM pathway requires a complete growth medium in which nitrogen, sulphur, 
phosphate and a fermentable carbon source are present in adequate amounts.  
 
In addition to its well-documented function as an amino acid transporter, it has 
recently been shown that the general amino acid permease Gap1 also acts as a 
receptor. The dual function of Gap1 as amino acid transporter/receptor (transceptor) 
was supported by the isolation of constitutively activating alleles. These Gap1 mutant 
alleles contain short truncations, e.g. 14 amino acids for Gap1ΔC6(14aa), of the extreme 
carboxyl tail of the permease, with their expression resulting in a constitutively high 
PKA phenotype. This was observed under all growth conditions tested, even in 
medium with ammonium as sole nitrogen source. 
 
In the first part of this study, we focused on characterizing the high PKA phenotype 
observed in cells carrying these truncated Gap1 mutant proteins. By blocking known 
nutrient signaling pathways, either through the disruption of an activating protein or 
the use of specific inhibitors, we show that the phenomenon is not caused by 
overactivation of either the rapamycin-sensitive TORC1 kinase, the phosphoinositide 
4-kinase Stt4 or the protein kinase Sch9. We also provide experimental evidence that 
the mutant proteins mediate the overactive PKA phenotype in a cyclic AMP 
(cAMP)-independent, but PKA-dependent manner. Subsequent work showed that the 
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overactive signaling phenotype is synergistically dependent on both the truncated 
permease and a background mutation in the specific Σ1278b gap1Δ strain used, called 
seg1-1. The seg1-1 mutation, for “Suppressor of ER exit-deficient Gap1”, causes the 
secretion to the plasma membrane of truncated Gap1 alleles that lack a 
C-terminally-based ER exit signal which, in wild-type cells, are retained in the ER by 
the organelle’s quality control system.  
 
Genetic evidence indicated that the seg1-1 mutation is both single and recessive. We 
employed a novel genetic mapping technology developed in our laboratory, AMTEM, 
for identification of the wild-type counterpart of seg1-1. AMTEM makes use of 
artificially-marked yeast strains which contain 600 different markers, inserted at 
neutral positions throughout the whole genome. In the screening process, we 
identified a 40 kb region between bp 18,226 and 58,935 near the beginning of 
chromosome VIII that is linked to the high PKA phenotype. Based on our earlier data, 
we first focused on a candidate gene (within the determined region) which functions 
within the yeast’s secretion pathway, namely the Golgi-localized v-SNARE GOS1. 
Through detailed biochemical analyses, we showed that the expression of 
Gap1ΔC6(14aa) in gos1Δ cells causes PKA phenotypes identical to those observed in 
seg1-1 Gap1ΔC6(14aa) cells, i.e. trehalose levels remain very low, even when these 
mutants are starved for nitrogen. Sequence analysis of the GOS1 ORF, promoter and 
terminator regions in the seg1-1 background, however, did not reveal any missense or 
other potentially relevant mutations.  
 
We sequenced the rest of the 40 kb region, and identified a point mutation within the 
ECM29 ORF, located at bp 5524. ECM29 is the next gene on chromosome VIII, but 
located on the opposite strand to GOS1. The nucleotide at bp 5524, an adenine in both 
the S288c and the Σ1278b wild-type strains, is changed to a guanine in the seg1-1 
mutant. This leads to an amino acid change in which the amino acid residue at 
position 1842, an asparagine (N), is substituted for aspartic acid (D). The role that 
Ecm29 may play in the overactive signaling phenotype is not clear yet, and requires 
further investigation.  
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The next part of this study deals with the mechanism by which glucose addition to 
glucose-deprived yeast cells causes rapid activation of the serine/threonine protein 
phosphatases PP2A and PP1. Previous work has shown that both PP2A and PP1 are 
under direct control of glucose sensing. Here, we convincingly demonstrate that 
glucose-induced activation of PP2A requires the catalytic subunits Pph21 and Pph22. 
Of the PP2A regulatory subunits, only Rts1 is involved; Cdc55 appears to be 
dispensable for this activity. Furthermore, we show that cells deficient in catalytic 
subunit methylation exhibit a slight decrease in PP2A activation upon glucose 
addition. Moreover, methylation of PP2A’s catalytic subunits increases in response to 
glucose re-addition.  
 
We also identified four different regulatory subunits required for glucose-induced 
activation of PP1, namely Shp1, Glc8, Gac1 and Red1. Strains lacking Gac1 or Red1 
show only a partial decrease in glucose-induced activation of PP1, compared to the 
shp1Δ and glc8Δ mutants that exhibit a complete loss of PP1-specific activation. We 
attribute the partial decrease in PP1 activation observed in gac1Δ and red1Δ cells to 
an overlap in function.  
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SAMENVATTING 
 
 
Nutriënten zijn voor microorganismen één van de voornaamste factoren die vele 
aspecten van celfuncties, waaronder groei en proliferatie, controleren. Zo resulteert 
toevoeging van aminozuren aan Saccharomyces cerevisiae cellen gegroeid in 
aanwezigheid van glucosemaar zonder stikstofbron in een snelle omkering van het 
stationaire fase fenotype dat deze cellen kenmerkt. Trehalose en glycogeen worden 
gemobiliseerd, cellen verliezen hun verworven stress-resistentie en herstellen hun 
groei. De twee belangrijkste nutrient-geïnduceerde signaalwegen die hierbij 
tussenkomen zijn de cAMP proteïne kinase A (PKA) signaalweg en de ‘Fermentable 
Growth Medium’ geïnduceerde (FGM) signaalweg. De cAMP-PKA signaalweg 
wordt geacitveerd door een fermenteerbare koolstofbron, activatie van de FGM 
signaalweg daarentegen vereist een volledig groeimedium waarin naast een 
fermenteerbare koolstofbron ook stikstof, fosfaat en sulfaat aanwezig zijn. 
 
Naast zijn reeds lang gekende functie als aminozuurtransporter, werd recent 
aangetoond dat de algemene aminozuurtransporter Gap1 ook een functie heeft als 
receptor. Deze dubbele functie van Gap1 als aminozuurtransporter/receptor 
(transceptor) werd ondersteund door de isolatie van constitutief activerende allelen 
van Gap1. Deze Gap1 mutanten bevatten korte truncaties van bv. 14 aminozuren 
(Gap1ΔC6(14aa)) in het carboxyl uiteinde van de transporter die resulteren in een 
constitutief hoog PKA fenotype. Dit fenotype werd waargenomen in verschillende 
groei condities, zelfs in medium met ammonium als enige stikstofbron.  
 
In het eerste deel van dit werk hebben we het hoge PKA fenotype van cellen met de 
getrunceerde Gap1 mutanten gekarakteriseerd. Door gekende nutriënt signaalwegen te 
blokkeren, door uitschakeling van een activerend proteïne of door gebruik van 
specifieke inhibitoren, konden we aantonen dat dit fenotype niet het gevolg is van een 
overactivatie van het rapamycine gevoelige TORC1 kinase, het fosfoinositide 
4-kinase Stt4, of het proteïne kinase Sch9. Er werd ook aangetoond dat dit overactief 
PKA fenotype cAMP-onafhankelijk, maar PKA-afhankelijk is. Vervolgens werd 
aangetoond dat het overactieve signaleringsfenotype een gevolg is van zowel truncatie 
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van de transporter als een achtergrondmutatie in de specifieke Σ1278b gap1Δ stam, 
verder seg1-1 genoemd. De seg1-1 mutatie, voor ‘Suppressor of ER exit-deficient 
Gap1’ induceert secretie naar de plasmamembraan van het getrunceerde Gap1 dat het 
C-terminale ER-exit signaal mist. In wild type cellen worden deze getrunceerde Gap1 
proteïnen weerhouden in het ER door het kwaliteitscontrole systeem.  
 
Genetisch onderzoek heeft aangetoond dat de seg1-1 mutatie zowel enkelvoudig als 
recessief is. Met behulp van een nieuwe genetische mapping tehnologie, ontwikkeld 
in ons labo, genaamd AMTEM, hebben we getracht het wild type gen van het mutante 
seg1-1 gen te identificeren. AMTEM is gebaseerd op het gebruik van kunstmatig 
gemerkte giststammen die 600 verschillende merkers bevatten, geïnserered op 
neutrale posities over het hele genoom. Tijdens deze screen werd een regio van 
40 kbp tussen 18,226 en 58,935 bp aan het begin van chromosoom VIII 
geïdentificeerd. Deze regio is gekoppeld aan het hoge PKA fenotype. Gebaseerd op 
vroegere gegevens hebben we ons initiëel gefocusseerd op een kandidaatgen (gelegen 
binen deze regio), GOS1, dat een functie heeft in de secretie weg, het codeert 
namelijk voor een Golgi gelokaliseerde v-SNARE. Na biochemische analyse konden 
we aantonen dat expressie van Gap1ΔC6(14aa) in gos1Δ hetzelfde PKA fenotype 
vertoont als dat in de seg1-1 Gap1ΔC6(14aa) stam, namelijk een laag trehalose gehalte 
zelfs na deprivatie voor stikstof. Desondanks konden geen mutaties gevonden worden 
met behulp van sequentie analyse in de GOS1 ORF, promoter en terminator gebieden. 
 
Na sequenering van het volledige 40 kbp grote gebied, werd echter een mutatie 
gevonden in het ECM29 ORF, gelegen op 5524 bp. ECM29 is het volgende gen op 
chromosoom VIII, op de tegenovergestelde streng van GOS1. Het nucleotide op 
positie 5524, heeft een adenine in zowel S288c als Σ1278b wilde type achtergrond, 
die veranderd is naar een guanine in de seg1-1 mutant. Hierdoor is er een verandering 
in aminozuur op positie 1842, asparagine (N) is vervangen door een aspartaat (D). 
Welke rol Ecm29 zou spelen in het overactieve signaleringsfenotype is nog niet 
opgehelderd en vereist verder onderzoek. 
 
Het volgende deel van deze studie handelt over de mechanismen die tussenkomen in 
de activatie van de serine/threonine fosfatasen PP2A en PP1 door toevoeging van 
glucose aan glucose-gederepresseerde cellen. Eerder werd aangetoond dat zowel 
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PP2A als PP1 direct gereguleerd worden door glucose. In deze studie konden we 
aantonen dat de katalytische subeenheden Pph21 en Pph22 nodig zijn voor de 
glucose-geïnduceerde activatie van PP2A. Enkel de PP2A regulatorische subeenheid 
Rts1, en niet Cdc55, is betrokken bij deze signalering. Er werd ook aangetoond dat 
deficiëntie in methylatie van de katalytische subeenheden resulteert in een reductie 
van PP2A activatie na toevoegen van glucose. Bovendien neemt methylatie van de 
katalytische subeenheden van PP2A toe als respons op glucose. 
 
Er werden vier verschillende regulatorische subeenheden, Shp1, Glc8, Gac1 en Red1, 
gekarakteriseerd als zijnde essentiëel voor de glucose-geïnduceerde activatie van PP1. 
Deletie van GAC1 en RED1 resulteert in gedeeltelijke daling van de activatie van 
PP1, bij deletie van SHP1 en GLC8 daarentegen is de PP1 activatie volledig teniet 
gedaan. De gedeeltelijke reductie in PP1 activatie is vermoedelijk een gevolg van een 
overlap in functies. 
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